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1.1 UNDERSTANDING COMPLEX MOTOR CONTROL IN THE BRAIN
Already since the earliest endeavors to study the brain, researchers have been fascinated by 
how activity in the brain enables us to interact with the world around us. For example, more 
than a century ago it was found that disruption of the afferent nerve leads to impairments in 
limb use (Mott, 1895). Studies on human participants have shown that movement is encoded 
by the brain, as it can be initiated by stimulation of certain brain areas (Penfield, 1937). 
The recent advances in brain imaging methods have enabled researchers to investigate 
the encoding of movement in the brain in high detail. In turn, this has led to investigation 
of the encoding of more complex movements in the brain. For example, a comprehensive 
assessment of brain regions involved in the movement of facial muscles has only been 
conducted recently (Krippl et al., 2015). The ability to produce speech and spoken language 
requires a high degree of control over the activation of facial musculature (Redle et al., 2015). 
Multiple brain regions involved in complex motor control, such as motor cortex, caudate/
putamen and substantia nigra are crucial for speech motor control (Wildgruber et al., 2001), 
and are highly active when participants perform spoken language tasks (Gracco et al., 2005; 
Hervais-Adelman et al., 2015). Furthermore, in disorders which disrupt speech and spoken 
language skills, activity within these regions is affected (for review see (Liegeois et al., 2014)). 
Thus, detailed investigation of brain circuits involved in complex motor sequencing can reveal 
how human spoken language might be encoded in the brain.
It is known that disorders which impair basal ganglia circuit function result in impairments of 
complex motor sequencing and speech difficulties in humans, as well as deficits in complex 
motor sequencing in animal species such as fruitflies, mice and songbirds. In some cases, these 
disorders may have a monogenic origin, where heterozygous mutation leads to impairments 
in speech sequencing, accompanied by deficits in expressive and receptive language. Such 
monogenic disorders, while rare, can provide important avenues to investigate how impaired 
circuit function can result in behavioral impairments. One of these monogenic causes for 
impaired motor circuit function, which leads to a very recognizable phenotype, is FOXP21-
associated childhood apraxia of speech. In this chapter we will introduce the concepts 
explored in the different thesis chapters, and explain why FoxP2 is an ideal entry point to 
investigate how circuit dysfunction in the brain can lead to impairments in complex motor 
sequencing and speech / spoken language difficulties. 
1   Throughout the thesis we will use the standard accepted nomenclature to refer to the gene/protein in different species: FOXP2/
FOXP2 refers to humans, Foxp2/Foxp2 refers to mice and FoxP2/FoxP2 refers to other chordates.
  Kaestner, K.H., Knochel, W., and Martinez, D.E. (2000). Unified nomenclature for the winged helix/forkhead transcription factors. 
Genes & development 14, 142-146..
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1.2.1 Brain circuits in complex motor sequencing behavior and speech production
The uniquely human ability to generate spoken language is one of the most complex movement 
paradigms in nature. Groups of muscles in the face, larynx (Ziegler and Ackermann, 2013) and 
tongue (Sanders et al., 2013) must work in concert to produce coherent speech patterns. 
Fluent production of speech reaches a speed of, on average, 5 syllables per second (Baese-
Berk and Morrill, 2015), which necessitates fast coordination of activation and inactivation 
between these muscle groups. This is different from non-speech oral tasks, which generally 
are less complex and require lower spatiotemporal coordination of orofacial musculature 
(Bunton, 2008). In order to understand how such complex motor sequences necessary for 
speech are generated, we can explore how movement in general is encoded in the brain. 
Movement, and especially the generation of complex sequences of movement, is governed 
by the cortico-striato-thalamic circuitry (Doyon et al., 2003). Within this circuitry, movement 
is initiated in the cortex and activity is sent along downward projections toward the striatum, 
which in humans consists of the caudate and the putamen. Corticostriatal connections 
terminate on two major cell classes in the striatum: medium spiny neurons (MSNs) of the 
striatonigral direct pathway, and MSNs of the striatopallidal indirect pathway. The separation 
between these pathways and their involvement in the modulation of activity plays a key role 
in motor control and motor sequence learning (Calabresi et al., 2014). Regulation of striatal 
activity in these two projection pathways is thought to be highly important for complex motor 
sequence learning and execution of complex motor tasks, including the production of spoken 
language (Gracco et al., 2005; Simonyan et al., 2016).
1.2.2 The cortico-striato-thalamic circuit
Corticostriatal connections are excitatory and activate neurons of both the direct and 
indirect pathway (Shepherd, 2013). These two striatal cell classes can be distinguished by 
unique protein expression in addition to their downstream projection patterns (Gittis and 
Kreitzer, 2012). Direct pathway striatal MSNs express the dopamine 1 receptor (D1R), 
substance P and dynorphin (D1R-MSNs). By contrast, the indirect pathway MSNs express 
the dopamine 2 receptor (D2R), enkephalin and A2a adenosine receptors (D2R-MSNs). All 
striatal MSNs are GABAergic and send inhibitory projections to downstream targets, which 
ultimately affects activity in the substantia nigra (SNr) (Figure 1a). The direct projection of 
the D1R-MSNs inhibits the substantia nigra. By contrast, the striatopallidal projections of 
the D2R-MSNs inhibit the globus pallidus and subthalamic nucleus. Projections from these 
areas normally inhibit the SNr as well. However, indirect pathway activity modulates the 
inhibitory drive from these regions by increasing inhibition within the globus pallidus and 
STN. This way, increased D2R-MSN activity leads to disinhibition of the SNr. Additionally, 
MSNs are also able to regulate activity within the striatum, as D1R-MSNs and D2R-MSNs 
project unidirectionally to other D1R-MSNs or DR2-MSNs, respectively (Taverna et al., 2008). 
Increased activity in D1R- or D2R-MSNs therefore results in a negative feedback loop, which 
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affects the downstream inhibitory drive of the striatum (Saklayen et al., 2004). From the SNr, 
inhibitory projections are sent toward the thalamus, which ultimately affect thalamocortical 
drive. Activity within the entire cortico-striato-thalamic circuit can therefore be affected by 
changes in activity and downstream targeting of the striatum. This in turn directly affects 
motor activity within the cortex and motor behavior (Kravitz and Kreitzer, 2012). Activation of 
the direct pathway is necessary for the initiation of movement as well as the maintenance of 
movement paradigms and reinforcement of motor sequence learning. By contrast, activation 
of the indirect pathway governs switching of motor paradigms as well as the learning of 
novel motor sequences (Bateup et al., 2010). Concurrent activation of the direct and indirect 
pathway has been shown to occur in vivo when movement is initiated (Cui et al., 2013), 
which suggests tight regulation of activity within and between these pathways is essential for 
complex locomotion.
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Figure 1: Pathways involved in the generation of coordinated movement. 
(a) Two pathways can be distinguished at the level of the striatum and balanced activation of these pathways is 
necessary to generate complex motor circuitry output necessary for motor sequencing behavior. (b) Different brain 
circuits govern unique aspects of coordinated locomotion, which have to work in concert to result in the generation 
of complex behavioral output such as motor learning or spoken language.
1.2.3 Complex motor sequencing is affected often in disorders which affect cognitive 
function
Disruption of activity within the direct or the indirect pathway has been implicated in 
disorders where (complex) motor sequencing is affected. Neurodegenerative disorders such 
as Parkinson’s disease (PD) or Huntington’s disease (HD) lead to significant reductions in 
motor function, and areas such as the striatum and substantia nigra are among those most 
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significantly affected by PD or HD (Huot et al., 2007; Przedborski, 2005). Another aspect of 
disrupted motor sequencing which is often seen in individuals with autism spectrum disorder 
(ASD) or Tourette’s syndrome is motor stereotypy. These stereotypies are described as 
rhythmic and repetitive movements without a clear purpose, and include hand flapping, arm 
waving, and rocking back and forth. Aberrant striatal morphology (Hollander et al., 2005) and 
disrupted activation of striatal circuits have been the focus of recent investigation into motor 
stereotypies (for review, see: (Peter et al., 2017). For example, in Tourette’s syndrome, it is 
thought that aberrant activation of small groups of striatal MSNs could be responsible for 
stereotypical movement generation (Gittis and Kreitzer, 2012). Additionally, dysfunction of 
the autism-associated gene Neuroligin-3 (NL-3) (Levy et al., 2011; Sanders et al., 2011) has 
been shown to cause motor stereotypy in a mouse model with heterozygous nl-3 knockout 
(Rothwell et al., 2014). However, individuals affected by ASD, Tourette’s or PD often show 
cognitive dysfunction in addition to their motor phenotypes (Beitz, 2014; Cavanna and Seri, 
2013; Payakachat et al., 2012). The effects of neurodevelopmental and neurodegenerative 
disorders on cognitive ability complicate investigation into the specifics of how motor 
sequencing and motor behaviors are encoded. A disorder in which only motor-circuit 
associated behaviors are affected would be an ideal tool to enable detailed investigation into 
striatum specific effects on motor behavior.
1.2.4 Speech as a complex motor sequencing challenge
The active vocalization of speech during spoken language production is a highly complex 
motor task, and can be described as the combination of vocalizations and muscle 
manipulations necessary to convey intelligible speech. For much of the research in this area, 
comprehension and production of spoken language have been thought of as intertwined 
processes (Macdonald, 2013). Traditional views focusing on classically defined speech 
comprehension and production centers such as Broca and Wernicke areas (Jurgens, 2002), 
have developed into contemporary cognitive models which recognize that spoken language 
depends on distributed circuits involving multiple additional brain regions (Tremblay and 
Dick, 2016). Undoubtedly the ability to produce meaningful speech requires an internal 
lexicon combined with an understanding of grammar and sentence structure (Giraudo and 
Dal Maso, 2016; Libben and Jarema, 2002; Marslen-Wilson and Warren, 1994). However, the 
complex motor sequencing aspects of speech production are probably not governed by such 
higher cognitive processes. The production of spoken language also involves the mechanical 
process of forming coherent motor patterns by the underlying facial musculature (Ziegler and 
Ackermann, 2013). This process could be governed by the same (or similar) pathways involved 
in the production of complex motor sequences in the brain, thus regulation of striatal activity 
could be required (Ackermann et al., 2014). Disentangling the cognitive and motor processes 
which are involved in the production of spoken language is an intriguing issue in the field of 
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language sciences. Investigation of neuronal pathways involved in the production of complex 
motor sequences can help understand how such aspects of speech production are encoded
1.3.1 FOXP2 and spoken language production 
Impairments in speech production have been described in neurodevelopmental disorders 
(Koolen and de Vries, 1993; Mei et al., 2018; Morgan et al., 2018; Rodenas-Cuadrado et al., 
2014; Rodenas-Cuadrado et al., 2016; Sia et al., 2013; Snijders Blok et al., 2018). Especially 
genetic disruptions which affect spoken language production are highly interesting as they 
provide a molecular stepping stone toward understanding the pathophysiology of speech 
impairment. In many neurodevelopmental disorders, speech impairment is part of a larger 
phenotype which includes ASD and intellectual disability. There are however individuals in 
which speech and/or language impairments may be seen without other developmental delays. 
Prominent forms of these disorders include specific language impairment (SLI, also known as 
developmental language disorder, DLD) and childhood apraxia of speech (CAS) (Bishop, 2006; 
Chen et al., 2017b; Reilly et al., 2014). The familial aggregation of developmental speech and 
language disorders suggests a genetic origin (Gopnik and Crago, 1991; Tallal et al., 2001; Tallal 
et al., 1989; Whitehouse, 2010). Currently, only a few genes associated with developmental 
speech and language disorders are known (Reader et al., 2014). Investigation of a familial 
case of CAS (the KE family) led to the identification of the transcription factor Forkhead box-
protein 2 (FOXP2) as being extensively involved in speech production (Lai et al., 2001).
Individuals with heterozygous mutations in the gene FOXP2 are affected by CAS. Their 
language production is severely impaired, especially in complex word production (Lai et 
al., 2001; MacDermot et al., 2005; Morgan et al., 2017; Watkins et al., 2002a). Although 
proficiency can be improved with intensive speech therapy, underlying problems remain 
present. CAS is described as ‘a disorder of speech motor programming or planning that affects 
the production, sequencing, timing and stress of sounds’ (Morgan et al., 2017). In people with 
heterozygous FOXP2 mutations, CAS is the most prominent feature, but it is accompanied 
by wide-ranging impairments in expressive and receptive language, affecting spoken and 
written modalities (Morgan et al., 2017; Watkins et al., 2002a). Given that the phenotype 
associated with CAS suggests underlying impairments in the production of complex motor 
sequences, it is plausible that activity within the cortico-striato-thalamic circuitry might be 
altered in affected individuals. As mutations in FOXP2 have been linked to CAS in multiple 
cases, investigation into how FOXP2 regulates neuronal cellular and circuit function can help 
us understand how the human brain enables production of proficient speech.
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1.3.2 Mutations of FOXP2
In the KE family, a single nucleotide change within the gene FOXP2 is thought to be 
responsible for the CAS in affected individuals (Lai et al., 2001) FoxP2 belongs to the Forkhead 
box family of transcription factors. Within this large group of proteins, the FoxP subfamily 
consists of 4 different proteins, of which only FoxP3 is not expressed in the brain (Lai et 
al., 2003; Takahashi et al., 2008a; Tamura et al., 2003). FoxP1, 2 and 4 are all localized to 
the nucleus (Li et al., 2004a; Spiteri et al., 2007; Vernes et al., 2006). Compared to FOXP2, 
mutations in FOXP1 and FOXP4 lead to different phenotypes. Mutation of FOXP1 results in 
a more severe neurodevelopmental deficit with global developmental delay, ID and ASD, 
in addition to speech and language impairments (Bacon and Rappold, 2012; Bowers and 
Konopka, 2012; Hamdan et al., 2010; Sollis et al., 2017; Sollis et al., 2016). This suggests 
FOXP1 has a more essential role in brain development and function compared to FOXP2. 
A single case of heterozygous mutation of FOXP4 has currently been described, in which 
the affected individual shows developmental delay as well as motor problems (Charng et 
al., 2016). However, in mouse models the function of FOXP4 has mainly been investigated 
in other regions than the brain. Homozygous knockout of FOXP4 in mice leads to abnormal 
cardiac development and early embryonal death (Li et al., 2004b). Though brain expression 
of FOXP4 has been shown, it’s function in the brain currently remains unresolved (Takahashi 
et al., 2008a; Teufel et al., 2003). Since the initial discovery of a FOXP2 mutation responsible 
for CAS in the KE family, multiple independent mutations disrupting FOXP2 in other cases/
families have been described, all of which result in CAS (for review, see (Morgan et al., 2017)). 
Two disruptions of FOXP2 which have received most attention. These are the R553H mutation 
found in the KE family, and the R328X mutation found cosegregating with CAS in the AD 
family (MacDermot et al., 2005). The R553H mutation affects the DNA-binding domain of 
FOXP2 (Lai et al., 2001; Vernes et al., 2006), whereas the R328X mutation introduces an 
early stop codon in exon 7, yielding protein truncation and nonsense mediated RNA decay 
(Groszer et al., 2008; MacDermot et al., 2005). Mutation of FOXP2 has been related to 
alterations in brain morphology and activity in individuals of the KE family. MRI comparisons 
between affected family members, unaffected siblings and controls show that grey matter 
density is reduced in the parts of the cortex, caudate/putamen and thalamus, which are all 
part of the canonical motor circuit (Watkins et al., 2002b). Furthermore, when participants 
perform a language task and activity is measured by fMRI, activity in the multiple regions of 
the canonical motor circuit is decreased in affected individuals of the KE family (Liegeois et 
al., 2003). This suggests that FOXP2 affects brain morphology and function in areas relevant 
for complex motor sequencing and speech production.
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1.3.3 Evolutionary conservation of FoxP2 and face validity of animal models
FoxP2 is highly conserved throughout mammalian evolution, especially with regard 
to the sequence of the encoded protein (Campbell et al., 2009; Enard et al., 2002). 
Between humans and chimpanzees, two amino acid substitutions within exon 
7 have been described (T303N and N325S). Only a single additional amino acid 
substitution (D80E) differentiates mouse Foxp2 from chimpanzee FoxP2 (Figure 2). 
Figure 2: Conservation of Foxp2 between mouse and primates (From (Enard et al., 2002)).
FoxP2 is highly conserved between distantly related species, such as mouse, primates and humans. Black vertical 
bars denote both nucleotide changes. Grey squares show amino-acid changes.
Furthermore, FoxP2 in other species shows remarkable overlap with mammalian FoxP2 
either in amino acid sequence, proposed function, or both. For example, the DNA-binding 
domain of Foxp2 is identical between songbirds and humans, and dysfunction in songbirds 
leads to impaired song production (Haesler et al., 2007). Even distant analogues of FoxP2 
seem to affect motor function. In Drosophila melanogaster (the common fruit fly) FoxP is 
the only member of the FoxP family (Lawton et al., 2014), and disruption of FoxP expression 
leads to aberrant coordinated movement (Mendoza et al., 2014), as well as disrupted 
cognitive function (DasGupta et al., 2014). Since speech production is a highly complex motor 
sequencing task (Ackermann et al., 2014), functional specialization of FOXP2 and its putative 
roles in regulation of motor circuit activity might have contributed to the development of 
spoken language on the human lineage (Enard, 2011). Nonetheless, complex motor sequence 
impairments are a common phenotype shared between different species with dysfunctions 
in FoxP2. This suggests that FoxP2 similarly affects brain function between species, including 
species without speech or even without vocalizations. This is an example of deep homology 
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in biology and it lends face validity to the use of different animal models to understand how 
FoxP2 influences brain activity and motor behaviors.
1.3.4 FoxP2 expression is restricted in animal and human brain
As FoxP2 is essential in motor circuit function, we might expect the expression of this gene 
to be prevalent in neuronal circuits and neurons embedded within the motor circuits. The 
motor circuit is grossly similar between mammalian species, but markedly different between 
mammals, songbirds and insects. Intriguingly however, FoxP (for Drosophila) and FoxP2 are 
in all species that have currently been investigated expressed in neuronal structures known 
to be involved in locomotion. In Drosophila, FoxP expression is highly localized and especially 
high in the protocerebral bridge. This is a section of the insect brain central complex and 
is thought to be analogous to mammalian basal ganglia (Lawton et al., 2014). In songbirds 
FoxP2 expression is prevalent in the striatum, and highly expressed in the striatal vocal 
nucleus area X (Haesler et al., 2004; Teramitsu et al., 2004). Furthermore, FoxP2 expression in 
area X is dependent on singing behavior during development and in adulthood and changes 
in Foxp2 expression in area X affect the quality and stability of birdsong (Murugan et al., 
2013; Rochefort et al., 2007; Teramitsu and White, 2006). In mammals, FoxP2 expression is 
high in many regions of cortico-striato-thalamic motor circuit, as well as in the cerebellum. 
In humans, FOXP2 expression is confirmed in the cortex, striatum, thalamus and cerebellum 
(Ferland et al., 2003; Lai et al., 2003; Teramitsu et al., 2004), with especially high expression in 
the caudate and putamen in humans and nonhuman primates (Lai et al., 2003; Takahashi et 
al., 2008b). This confirms that FOXP2 is well placed to impact on neuronal function in human 
motor circuits. Furthermore, expression patterns of Foxp2 have been assessed especially in 
detail in mice. Here, Foxp2 is highly expressed in deeper layers of the cortex. Layer VI shows 
Foxp2 expression throughout the cortex, whilst in layer V Foxp2 is highly expressed in the 
motor cortex and parts of the somatosensory cortex (Hisaoka et al., 2010). The excitatory 
neurons in these layers mainly identify as corticothalamic and corticostriatal projection 
neurons, and Foxp2 is suggested to have functions in regulation of activity in these neurons 
(Sia et al., 2013). As noted above, Foxp2 expression is notably high in the striatum, where 
it is primarily localized to D1R-MSNs (Fong et al., 2018; van Rhijn et al., 2018; Vernes et 
al., 2011). Foxp2 is typically absent from interneurons, both in cortex and striatum (Fong et 
al., 2018; Haesler et al., 2007; Hisaoka et al., 2010). The restricted expression of Foxp2 to 
D1R-MSNs suggests that this transcription factor might regulate striatal activity in a pathway 
specific manner. Furthermore, Foxp2 is also expressed in the substantia nigra, thalamus, and 
multiple subthalamic regions. Currently, it is not known if Foxp2 is expressed within specific 
cell populations in these areas or if Foxp2 is able to affect activity within these regions. Lastly, 
in the cerebellum Foxp2 is localized to Purkinje cells and deep cerebellar nuclei (Ferland et 
al., 2003; Fujita and Sugihara, 2012), and it has been shown that mutations of Foxp2 affect 
cerebellar activity (French et al., 2018; Groszer et al., 2008). Though the cerebellum is not 
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part of the canonical motor circuit, it is involved in motor function, especially in coordination 
and smooth movement control (Manto et al., 2012; Zhang et al., 2014). Figure 3 shows an 
overview of Foxp2 expression in the mouse brain and how the relevant parts of the motor 
circuit are interconnected. The expression of Foxp2 in the cerebellum suggests Foxp2 might 
be involved in other aspects of motor control which are not governed by the canonical 
motor circuit. Combined, the high conservation of Foxp2 expression throughout mammalian 
evolution and the nature of this conserved expression pattern suggest that it has essential 
functions in the motor circuit.
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Figure 3: Foxp2 expression in mouse brain. 
Also highlighted are the pathways described in Figure 1, which underlines the importance of both Foxp2 and the 
striatum within the cortico-striato-thalamic motor circuit.
1.4.1 Investigating Foxp2 function in cell and animal models
The previously described data from human MRI and fMRI studies shows that mutations 
in FOX2 affect brain morphology and activity. To further study the mechanisms by which 
this gene affects brain function, animal models have been used in which FoxP2 function is 
affected. For example, multiple mouse models have been developed with mutations in Foxp2 
(French and Fisher, 2014). Two mouse models of disrupted Foxp2 function are of particular 
interest: mice with the R552H missense mutation, which equivalent to the human DNA-
binding domain R553H mutation and mice with the S321X nonsense mutation, which is 
considered analogous to the loss of function R328X mutation found in the AD family (Groszer 
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et al., 2008). Furthermore, mice in which Foxp2 can be conditionally knocked out in specific 
cell populations have been developed, and these can be used to investigate brain region 
specific functions of Foxp2 (French et al., 2007). Lastly, mice have been developed in which 
the human specific T303N and N325S amino-acid substitutions have been introduced into 
mouse Foxp2 (Enard et al., 2009). In songbirds, manipulation of FoxP2 expression has been 
achieved through ShRNA mediated interference (Haesler et al., 2007; Murugan et al., 2013). 
Mouse and songbird models of Foxp2 dysfunction have been used routinely to investigate 
how Foxp2 functions as a transcription factor, if mutation of Foxp2 affects motor circuit 
function and whether this results in changes in motor and vocal behaviors in these animals. 
1.4.2 FoxP2 regulates genes involved in synapse development and neuronal activity
As FoxP2 is a nuclear transcription factor, it has the possibility to regulate a plethora of 
genes and regulatory processes (Spiteri et al., 2007; Vernes et al., 2006; Vernes et al., 2011; 
Vernes et al., 2007). Chromatin immunoprecipitation followed by promoter microarray study 
(ChIP-chip) shows that Foxp2 is able to directly regulate expression of proteins involved 
in neurodevelopment (Spiteri et al., 2007; Vernes et al., 2011) as well as possibly proteins 
involved in synaptic activity (Vernes et al., 2011). In both songbird and mouse, dysregulation 
of FoxP2 function has been shown to affect neurodevelopment and synapse formation 
(Schulz et al., 2010; Vernes et al., 2011). Furthermore, it has been shown that Foxp2 regulates 
expression of genes involved in synapse maturation, and as such it seems that Foxp2 is an 
upstream regulator of neurodevelopmental processes. For example, Foxp2 regulates the 
expression of the Sushi Repeat-containing Protein X-lined 2 (SRPX2), the Myocyte Enhancer 
Factor 2C (MEF2C) and the Retinoic Acid receptor Beta (RARβ) (Chen et al., 2016; Devanna et 
al., 2014; Roll et al., 2010; Sia et al., 2013). Foxp2 normally represses the expression of MEF2C 
and SRPX2, whilst Foxp2 promotes RARβ expression. Introduction of the R552H mutation into 
rat primary cortical neurons leads to a loss of SRPX2 repression and increased generation 
of excitatory synapses (Sia et al., 2013). Heterozygous knockout of Foxp2 leads to increased 
expression of MEF2C, which acts as a brake on corticostriatal synapse formation (Chen et 
al., 2016). Furthermore, a downstream effect of the dysregulation of MEF2C expression 
following Foxp2 heterozygous knockout is a reduction in α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR) expression at the synapse (Chen et al., 2016). 
Lastly, in vitro cell models show that FOXP2 overexpression increases RARβ expression and 
leads to increased neurite outgrowth (Devanna et al., 2014). Both RARα and RARβ are highly 
expressed in mouse brain, but they show distinct expression patterns. There are multiple 
regions where expression of both overlaps, however, whilst RARβ is highly expressed in the 
striatum, RARα is absent from this region (Dolle, 2009; van Rhijn and Vernes, 2015). For 
both RARα and RARβ it is known that they affect synaptic plasticity (Chiang et al., 1998; Sarti 
et al., 2012). Blockade of synaptic transmission in cultured hippocampal neurons leads to 
increased GluA1 AMPAR subunit expression through a RARα dependent mechanism (Aoto et 
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al., 2008; Chen et al., 2014). RARα mediated synaptic scaling requires RARα expression at the 
synapse, whereas canonically RARs are known as nuclear transcription factors (Germain et 
al., 2006; Huang et al., 2014; Zhang et al., 2015b). Currently, it is unknown whether RARβ can 
modulate synaptic plasticity through synaptic mechanisms, as synaptic expression of RARβ 
has not been established. In RARβ knockout mice, induction of long-term depression (LTD) is 
impaired. However, this lack of LTD induction doesn’t seem to be due to changes in pre- or 
postsynaptic expression of proteins involved in neurotransmission (Chiang et al., 1998). As 
FoxP2 regulates RARβ expression and LTD induction is impaired in mice with both the R552H 
and the S321X mutation (Groszer et al., 2008; van Rhijn et al., Chapter 3), establishing the 
relationship between FoxP2, RARβ and LTD could reveal whether the functions of RARβ in 
neuronal plasticity might depend on FoxP2.
1.4.3 Neuronal activity is altered by disruption of FoxP2 function
Multiple aspects of neuronal activity and plasticity are affected by mutations in Foxp2. As 
noted above, LTD I the dorsolateral striatum is impaired in mice with heterozygous R552H or 
S321X mutations of Foxp2. Furthermore, LTD is affected as well in mice in which the human 
lineage specific changes (T303N and N325S) to Foxp2 have been introduced (Schreiweis et 
al., 2014). Interestingly, a subregion specific effect was observed. LTD in the dorsolateral 
striatum was increased, whilst dorsomedial LTD was reduced in these mice, which suggests 
Foxp2 might have striatal subregion dependent functionality. In addition, evidence from 
both heterozygous Foxp2 mutant mice as well as the T303N/N325S mice suggests Foxp2 
modulates excitatory synaptic strength in mouse striatum (Chen et al., 2016; Enard et al., 
2009; Schreiweis et al., 2014; van Rhijn et al., 2018). Lastly, in vivo recordings from mice 
with the heterozygous R552H Foxp2 mutation suggest that this transcription factor is 
important for correctly modulating behavior dependent activity (French et al., 2012). In 
songbirds, reduction of FoxP2 expression in area X by ShRNA mediated knockdown leads 
to aberrant signal propagation in the song circuit (Murugan et al., 2013). The song circuit 
includes cortical, striatal and thalamic regions in songbirds which are involved as well in 
complex motor sequencing with similarities to how motor skill learning in mouse and speech 
production in human are encoded (Brainard and Doupe, 2013). Currently research on the 
effects of disrupted FoxP2 function on neuronal activity has shown modulation of striatal 
excitatory activity. However, both the striatum in mammals and area X in birds are entirely 
comprised of inhibitory GABAergic MSNs (Carrillo and Doupe, 2004; Gittis and Kreitzer, 2012). 
The previously published data on gene expression which can be regulated by FoxP2 (Vernes 
et al., 2011) suggests that it is able to regulate inhibitory activity. Additionally, the expression 
of FoxP2 in inhibitory neurons in the striatum makes the R552H and S321X mouse models 
for Foxp2 dysfunction highly useful tools to investigate if this transcription factor affects 
inhibitory striatal function.
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1.4.4 Behavioral effects of Foxp2 dysfunction
Mice with homozygous mutations in Foxp2, both the R552H DNA-binding mutations and the 
S321X loss of function mutation, are highly impaired in their development and motor functions. 
Homozygous mutant mice show dramatic reductions in growth rate by postnatal day 8 and do 
not survive past the third postnatal week (Groszer et al., 2008). By contrast, littermates with 
heterozygous Foxp2 mutations are not impaired in their development, reproduce normally 
and do not show any overt impairments in natural motor behavior (French et al., 2012; Groszer 
et al., 2008). Behavioral impairments in heterozygous mice only become apparent when they 
are challenged on a task which requires motor skill learning and complex motor sequencing. 
Foxp2 heterozygous mutant mice carrying either the R552H missense mutation or the S321X 
nonsense mutation have been subjected to an accelerating rotarod task. This task requires 
mice to increase their running speed on a rotating beam which increases rotation speed from 
4 to 40 rpm over a 5-minute time course. Each mutation leads to a decrease in the latency to 
fall from the rotarod, as well as a reduction in learning rate (French et al., 2012; Groszer et al., 
2008). Furthermore, in zebra finches, reduced FoxP2 expression has a large impact on song 
reproduction and song quality. During development, male zebra finches learn their song from 
an adult tutor (Gobes and Bolhuis, 2007). However, juvenile zebra finches in which FoxP2 
expression is reduced by ShRNA interference show increased variability in song reproduction. 
This results in reduced song complexity and decreased performance in song learning (Haesler 
et al., 2007; Murugan et al., 2013). Though the behavioral data suggests Foxp2 is important 
in complex motor function, it is currently unclear if the alterations on the genetic, cellular 
and behavioral level following FoxP2 dysfunction are related. Unraveling how Foxp2 affects 
motor circuitry at the single-cell level can help us connect the genetic regulatory functions of 
Foxp2 to striatal cellular physiology and ultimately to how alterations in circuit function lead 
to behavioral changes.
1.5.1 Does FoxP2 affect striatal function at the single cell level?
In this thesis, we explore how Foxp2 affects activity at the level of the striatum and how this 
might relate to the behavioral phenotypes associated with heterozygous Foxp2 mutations. 
Firstly, it has been suggested that Foxp2 is predominantly expressed in cells of the striatal 
direct pathway (Fong et al., 2018; Vernes et al., 2011). The dissociation between the direct 
and indirect pathway in the striatum has been shown to be important for motor skill learning, 
both in mice and songbirds (Calabresi et al., 2014; Farries et al., 2005). Therefore, we first 
asked the question if Foxp2 differently affects activity in striatal cell populations which govern 
the direct and indirect pathway. Furthermore, the presence of Foxp2 both during early 
development and in adulthood (Ferland et al., 2003) and its effects on neurodevelopment 
(Devanna et al., 2014; Vernes et al., 2011) prompted us to investigate whether it is involved in 
the development and maturation of striatal MSNs at the synaptic level. Next, the overlapping 
behavioral phenotype of the heterozygous R552H and S321X mutations in these two mouse 
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models, as well as in affected individuals with similar mutations, led us to ask if these different 
disruptions lead to similar effects on striatal activity in mouse brain. Furthermore, initial 
evidence of an interaction between Foxp2 and retinoic acid signaling (Devanna et al., 2014) 
made us assess whether interaction between retinoic acid signaling and Foxp2 might be 
informative for investigating how Foxp2 influences striatal development and synaptic activity. 
Lastly, we and others have extensively used mouse models to investigate Foxp2 dysfunction. 
However, the limited translational ability of results from mouse models has prompted us to 
examine if the phenotypes on the single cell level found in mouse striatum can be replicated 
in a human neuronal model for FOXP2 dysfunction. Taken together, all these questions 
resulted in a detailed investigation of FoxP2 function at the single cell level in the striatum 
and in human neurons, of which we present the results in this thesis.
1.5.3 Main questions and chapter summary 
To answer the previously posed questions, we will use multiple mouse models for Foxp2 
dysfunction and explore how this transcription factor affects striatal function at a single cell 
level in segregated striatal cell populations. Our ability to differentiate between different 
cell populations in mouse striatum through genetic fluorescent labeling enables us target 
specifically cells of the striatal direct and indirect pathways. We then use whole-cell patch 
clamp to investigate if mutations in Foxp2 affect striatal excitatory and inhibitory activity. 
We furthermore aim to assess if the changes in activity we find are correlated with aberrant 
expression of proteins involved in synaptic activity. Lastly, we want to utilize our conclusions 
from the electrophysiological and molecular experiments to perform in vivo interventions 
aimed at amelioration of the motor skill learning deficits present in mice with heterozygous 
Foxp2 mutations.
In chapter 2, we assess whether Foxp2 affects the striatum in a cell population specific 
manner and find that heterozygous loss of Foxp2 function only affects striatal D1R-MSNs 
and that both excitatory and inhibitory activity are strongly affected by loss of Foxp2 function 
during development and in adulthood. We are the first to show that Foxp2 affects inhibitory 
activity and provide a novel molecular mechanism by which Foxp2 mutation leads to increased 
inhibitory drive in D1R-MSNs through increased presynaptic GABA production. Lastly, we 
correlate the increased striatal inhibitory activity with the motor skill learning deficits in Foxp2 
loss of function mice. In chapter 3 we investigate if Foxp2 affects the maturation of excitatory 
synapses, by examining AMPA receptor subunit expression during striatal development. 
We demonstrate that maturation of AMPA receptor expression occurs between PND8 and 
11 in the striatum, with a switch from calcium-permeable AMPAR expression to calcium-
impermeable AMPAR expression that coincides with the start of coordinated locomotion. 
Reduced Foxp2 expression delays this maturation and leads to delayed emergence of 
coordinated locomotion. In chapter 4 we question whether heterozygous nonsense mutation 
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and heterozygous DNA-binding mutation of Foxp2 might differently affect striatal activity. 
We show that the way in which disruption of Foxp2 affects striatal circuitry is mutation-
specific. This could have important consequences for the genetic characterization of FOXP2 
mutations and how these might uniquely affect brain function. In Chapter 5 we investigate 
the possible functions of retinoic acid signaling through RARβ as one of the latest targets 
found to be regulated by Foxp2. We review the current literature regarding the functions of 
RA signaling on neuronal activity, the functions of RARβ in the striatum and its relationship 
to disorders of movement. RARβ could be a novel regulatory protein with an important 
role in the striatal motor circuit. Lastly, in chapter 6 we describe the possibility to generate 
human dopaminergic neurons which express FOXP2. We show that homozygous knockout of 
FOXP2 in these human dopaminergic neurons leads to markedly similar deficits in excitatory 
activity to those we have seen in mouse striatal neurons with heterozygous loss of FOXP2 
function. These human dopaminergic neurons present a new tool which will generate novel 
opportunities to investigate function of FOXP2 on a genetic and cellular level. 
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ABSTRACT
Heterozygous mutations of the Forkhead-box protein 2 (FOXP2) gene in humans cause 
childhood apraxia of speech. Loss of Foxp2 in mice is known to affect striatal development 
and impair motor skills. However, it is unknown if striatal excitatory/inhibitory balance is 
affected during development and if the imbalance persists into adulthood. We investigated 
the effect of reduced Foxp2 expression, via a loss-of-function mutation, on striatal medium 
spiny neurons (MSNs). Our data show that heterozygous loss of Foxp2 decreases excitatory 
(AMPA receptor-mediated) and increases inhibitory (GABA receptor-mediated) currents in 
D1 dopamine receptor positive MSNs of juvenile and adult mice. Furthermore, reduced 
Foxp2 expression increases GAD67 expression, leading to both increased presynaptic content 
and release of GABA. Lastly, pharmacological blockade of inhibitory activity in vivo partially 
rescues motor skill learning deficits in heterozygous Foxp2 mice. Our results suggest a novel 
role for Foxp2 in the regulation of striatal direct pathway activity through managing inhibitory 
drive.
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INTRODUCTION
Balanced neuronal activity between cortex, striatum and thalamus is essential for the 
generation of voluntary movements (Shepherd 2013). Imbalanced activity within the striatum 
is known to disrupt complex motor behaviors, such as the production of spoken language 
(Peach 2004; Square-Storer 1990). FOXP2, the first single gene linked to a speech and 
language disorder (Lai et al. 2001), is important for the correct execution of complex motor 
behaviors used for speech. Individuals with mutations in the FOXP2 gene have problems 
executing coordinated sequences of orofacial movements, which impede their speech 
(diagnosed as developmental verbal dyspraxia or childhood apraxia of speech (CAS)), while 
their general cognitive functioning and other aspects of motor coordination are usually less 
severely affected(MacDermot et al. 2005; Morgan et al. 2017). Mice with heterozygous Foxp2 
mutations display impairments in motor skill learning, shown by decreased performance on 
the accelerating rotarod (French et al. 2012; Groszer et al. 2008), suggesting that similar 
neurobiological substrates could underlie the behavioral phenotypes in human and mouse. 
FoxP2 codes for a transcription factor (Devanna et al. 2014; Vernes et al. 2007; Vernes et al. 
2006) and plays important roles during the early development of the central nervous system 
as well as in the postnatal brain(Spiteri et al. 2007; Vernes et al. 2011; Groszer et al. 2008). 
Mutations of this gene affect both cortical and striatal activity in human cases and animal 
models (French et al. 2012; Groszer et al. 2008; Liegeois et al. 2003). Of particular note, striatal 
long-term depression is affected in adult mice with heterozygous Foxp2 mutations(Groszer 
et al. 2008; Enard et al. 2009), which suggests that Foxp2 regulates molecular mechanisms 
involved in synaptic plasticity. Additionally, evidence from in vivo recordings shows that Foxp2 
mutant mice display abnormal ongoing striatal activity and dysregulated firing rates during a 
motor-learning task (French et al. 2012). Lastly, Foxp2 has been reported to regulate genes 
involved in synapse formation (Sia et al. 2013; Vernes et al. 2011) and was recently shown to 
affect excitatory synaptic activity during early postnatal development through inhibition of 
the Mef2c gene (Chen et al. 2016). 
Studies using mouse models to investigate the functions of Foxp2 have made use of two well 
described mutations which differentially affect Foxp2 and are similar to mutations described 
in patients with CAS. These mutations lead to either disruption of the DNA binding domain 
of Foxp2 or a stop-gain mutation in exon 7 and nonsense mediated decay of Foxp2 protein 
(MacDermot et al. 2005; Morgan et al. 2017). Though neurobiological mechanisms affected 
by these different mutations could differ, there is currently no data to suggest this. Moreover, 
heterozygous Foxp2 mice with either the DNA binding domain mutation or the loss of function 
mutation display similar impairments in motor skill learning (French et al. 2012; Enard et al. 
2009; Groszer et al. 2008). 
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To date, investigations into the functions of Foxp2 in striatum have focused on how Foxp2 
affects excitatory activity (Groszer et al. 2008; Enard et al. 2009; French et al. 2012; Chen 
et al. 2016; Schreiweis et al. 2014). Although the striatum receives numerous excitatory 
connections from the cortex (Shepherd 2013) and thalamus (Smith et al. 2009; Smith et 
al. 2004), it is itself entirely composed of inhibitory neurons (Kreitzer and Malenka 2008). 
GABAergic medium spiny neurons (MSNs) make up 95% of the striatum, and two major 
populations can be distinguished: MSNs that express either the D1 dopamine receptor (D1R-
MSNs) or the D2 dopamine receptor (D2R-MSNs) (Gittis and Kreitzer 2012). These MSN 
populations differentially affect the downstream neural sites to which they ultimately project, 
and each regulate separate aspects of motor behavior (Calabresi et al. 2014; Surmeier et 
al. 2007; Gittis and Kreitzer 2012). D1R-MSNs innervate the direct pathway, which leads to 
increased activation of the cortico-striatal-thalamic motor circuit. In contrast, D2R-MSNs 
belong to the indirect pathway, inactivating this motor circuit. Balanced excitation and 
inhibition (E/I balance) of cells within both striatal pathways is crucial for the generation of 
complex motor behaviors (Schroll et al. 2015).
How Foxp2 affects neuronal function has been investigated in both early development and 
adulthood, but knowledge of how Foxp2 affects striatal circuits during (motor) development 
is lacking. This is especially important to address since E/I balance is dynamic. Changes in E/I 
balance during development are tightly regulated and have been described in multiple cell 
types in hippocampus (Liu 2004) and cortex (Zhang et al. 2011) of juvenile mice. A disrupted 
E/I balance during development can severely affect adult behavior (Peixoto et al. 2016). 
Indeed, aberrant E/I balance in striatal cells is known to lead to impaired motor learning in 
adult mice (Rothwell et al. 2014), similar to the deficits observed in adult mice with mutations 
in Foxp2 (French et al. 2012; Groszer et al. 2008). 
We examined the effects of reduced Foxp2 expression from early development into adulthood 
in the striatum, using a heterozygous mouse model for the stop-gain Foxp2 mutation (S321X). 
Foxp2 protein expression is absent in Foxp2S321X/S321X mice and reduced to intermediate levels 
in Foxp2S321X/+mice (Groszer et al. 2008; Vernes et al. 2011). We provide evidence that Foxp2 
plays a role in the regulation of striatal E/I balance, regulates inhibitory activity through 
repression of GAD67, and regulates inhibitory presynaptic strength of D1R-MSNs, but not 
D2R-MSNs. Lastly, we show that pharmacological blockade of striatal inhibition partially 
rescues the motor skill learning deficits observed in heterozygous Foxp2 mutant mice. 
Taken together, our results reveal a developmental circuit defect caused by reduced levels 
of functional Foxp2, which suggests that E/I imbalances in striatal activity may contribute to 
(vocal)motor problems in humans with FOXP2 mutations. 
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RESULTS
Reduced Foxp2 expression affects D1R-MSN excitatory synaptic inputs
Previous studies have suggested that Foxp2 is differentially expressed in D1R- versus D2R-
expressing MSNs in the striatum (Vernes et al. 2011). To directly assess the expression of 
Foxp2 in D1R- and D2R-MSNs, we performed immunocytochemistry for Foxp2 on mice 
containing bacterial artificial chromosome (BAC)-TRAP GFP constructs (Heiman et al. 2008; 
Doyle et al. 2008) under the D1R or D2R promoter, which have been shown to faithfully 
label D1R- or D2R-expressing MSNs, respectively (Heiman et al. 2008). Upon investigation of 
expression in juvenile mice (PND11-14) we found that Foxp2 is expressed in nearly all striatal 
D1R-MSNs, in contrast to only a small fraction of D2R-MSN (Fig 1a).
We next investigated whether heterozygous Foxp2 loss of function differentially affects striatal 
MSN subtypes at the synaptic level. To enable a targeted single-cell characterization of how 
reduced Foxp2 expression affects striatal activity, we crossed Foxp2S321X/+ mice with (BAC)-
TRAP D1R-GFP mice. We performed patch-clamp recordings on GFP-positive D1R-MSNs and 
non-GFP putative D2R-MSNs. Although Foxp2 expressing MSNs are spread throughout the 
striatum, we chose to focus on cells in the dorsolateral striatum, because of its connection to 
the motor cortex (Hunnicutt et al. 2016). Moreover, previous experiments regarding Foxp2 
function have shown aberrant activity in dorsal striatum of heterozygous Foxp2 mutant/
knockout mice (French et al. 2012; Groszer et al. 2008; Reimers-Kipping et al. 2011), and 
reduced motor skill learning suggests areas involved in motor control might be more severely 
affected by reduced Foxp2 expression. We measured excitatory synaptic strength through 
glutamatergic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor 
activation by analysis of miniature excitatory postsynaptic current (mEPSC) amplitude and 
frequency. In D1R-MSNs of heterozygous postnatal day (PND) 10-14 juvenile mice, mEPSC 
amplitude was reduced, whereas mEPSC frequency was similar between genotypes (Fig 1c). 
No changes in D2R-MSN amplitude or frequency were observed (Fig 1d). Lastly, we measured 
AMPA/NMDA ratio in D1R-MSNs of juvenile Foxp2+/+ and Foxp2S32X/+ mice. AMPA/NMDA ratio is 
significantly increased in Foxp2S32X/+ mice, which suggests that NMDA currents are decreased 
as well in addition to the previously observed reduction in AMPAR-mediated activity (Suppl 
Figure 1). These results show that reduced Foxp2 expression leads to decreased excitatory 
postsynaptic strength of only direct pathway MSNs, which is consistent with the predominant 
expression of Foxp2 in D1R-MSNs. 
Inhibitory synaptic inputs are increased in D1R-MSNs of Foxp2S321X/+ mice
Physiological effects of heterozygous Foxp2 mutations have only been investigated in the 
context of excitatory synaptic transmission (Chen et al. 2016; Reimers-Kipping et al. 2011; 
Schreiweis et al. 2014).
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Figure 1: Foxp2 is predominantly expressed in D1R-MSNs in dorsolateral striatum and affects synaptic activity
 (a) D1R-GFP, D2R-GFP and Foxp2 are expressed in a subset of striatal cells in juvenile (PND11-14) mice, arrows point 
to cells with overlapping D1R and Foxp2 expression (top row) or D2R expression without Foxp2 expression (bottom 
row). Scale bar 50µm. (b) 83.7 ± 16% of D1R-GFP positive cells express Foxp2, compared to 16.9 ± 4% of D2R-GFP 
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cells (N = 3 mice). (c) Striatal D1R-MSN mEPSC amplitude is decreased following reduced Foxp2 expression. Example 
of mEPSC activity in striatal D1R-MSNs from juvenile (PND14) Foxp2+/+ and Foxp2S321X/+ mice. Scale bar 200ms/20pA. 
Cumulative distribution of mEPSC amplitude (Foxp2+/+ = 19.4±0.69pA, Foxp2S321X/+ = 14.3±0.36 pA, P<0.0001) 
and frequency (Foxp2+/+ = 1.12±0.1Hz, Foxp2S321X/+ = 1.19±0.11Hz, NS) in striatal D1R-MSNs. Foxp2+/+ N/n = 3/31, 
Foxp2S321X/+ N/n = 3/32. (d) Example traces of mEPSC activity in striatal D2R-MSNs from juvenile (PND14) Foxp2+/+ 
and Foxp2S321X/+ mice Scale bar 200ms/20pA. Cumulative distribution of mEPSC amplitude (Foxp2+/+ = 15.64±0.53pA, 
Foxp2S321X/+ = 16.14±0.62pA, NS) and frequency (Foxp2+/+ = 0.92±0.12Hz, Foxp2S321X/+ = 0.89±0.1Hz, NS) in striatal D2R-
MSNs. Foxp2+/+ N/n = 3/22, Foxp2S321X/+ N/n = 3/19. (e) Example traces of mIPSC activity in striatal D1R-MSNs from 
juvenile (PND14) Foxp2+/+ and Foxp2S321X/+ mice. Scale bar 200ms/10pA. Cumulative distribution of mIPSC amplitude 
(Foxp2+/+ = 8.6±0.27pA, Foxp2S321X/+ = 11.9±0.83pA, P<0.001) and frequency (Foxp2+/+ = 0.18±0.036Hz, Foxp2S321X/+ = 
0.71±0.14Hz, P<0.01) in striatal D1R-MSNs. Foxp2+/+ N/n = 3/20, Foxp2S321X/+ N/n = 3/17. *** P<0.01. N: number of 
mice, n: number of cells. All data analyzed by two-sided students T-test. 
Since E/I balance is important for the development and maintenance of neuronal circuitry, we 
examined the role of Foxp2 in striatal inhibition. Striatal inhibition is accomplished through 
extra-striatal as well as intra-striatal sources. From the cortex, GABAergic interneurons project 
to the striatum and provide inhibitory input  (Melzer et al. 2017). However, corticostriatal 
GABAergic interneurons do not express Foxp2. We therefore expect differences in inhibitory 
activity between wild-type and Foxp2S321X/+ mice through changes in intra-striatal inhibition, 
which is regulated through MSNs and striatal interneurons (Taverna et al. 2008; Lalchandani 
and Vicini 2013). We measured inhibitory activity only in D1R-MSNs, since unidirectional 
connections between D1R-MSNs are common, while connections between D1R-MSNs and 
D2R-MSNs are rare (6%) (Taverna et al. 2008). Though D2R-MSNs synapse on D1R-MSNs 
(27%) the lack of Foxp2 expression in D2R-MSNs, combined with the lack of an excitatory 
phenotype, suggests that D2R-MSNs cannot be cell-autonomously affected by Foxp2.
We measured miniature inhibitory postsynaptic currents (mIPSCs), which are mediated 
by GABA and reflect inhibitory synaptic strength. In D1R-MSNs of juvenile (PND10-14) 
Foxp2S321X/+ mice, we found that mIPSC amplitude and frequency were increased compared to 
wild-type controls (Fig 1e). Our data show that reduced Foxp2 expression differentially affects 
excitatory and inhibitory synaptic strength. There is no compensation for the decreased 
excitatory activity, but rather this is aggravated by increased inhibition.
E/I imbalance persists in dorsolateral striatum of adult Foxp2S321X/+ mice
In mice, Foxp2 is present during the entire lifespan (Ferland et al. 2003), and expression does 
not change strongly between juvenile and adult animals (Ferland et al. 2003; Takahashi et al. 
2003). However, given that this gene is important for early neuronal development (Vernes 
et al. 2011; Chen et al. 2016), it is conceivable that functional effects of reduced Foxp2 
expression differ between juvenile and adult animals. In previous studies the effects of Foxp2 
mutations on striatal physiology have only been investigated in adult (French et al. 2012; 
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Groszer et al. 2008) or juvenile mice separately (Chen et al. 2016), and thus a developmental 
profile of synaptic changes due to reduced Foxp2 expression is lacking. We hypothesizethat 
the E/I imbalance present in D1R-MSNs of juvenile Foxp2S321X/+ mice might persist until 
adulthood, since adult Foxp2 heterozygous mice show clear deficits in motor skill learning. 
We measured the GABA/AMPA ratio as an index of E/I balance in juvenile (PND11, PND14, 
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Figure 2:  Decreased excitation and increased inhibition persist in adult mice with decreased Foxp2 expression
(a) Example traces show AMPA response (negative) and GABA response (positive) in D1R-MSNs of Foxp2+/+ and 
Foxp2S321X/+ mice during development and in adulthood. Scale bar 200/50pA. GABA/AMPA ratio in D1R-MSNs of 
Foxp2+/+ (PND11 = 0.32±0.037, PND14 = 0.29±0.035, PND17 = 0.50±0.077, PND60 = 2.04±0.47) and Foxp2S321X/+ 
(Foxp2S321X/+ PND11 = 0.53±0.049, PND14 = 0.6±0.078, PND17 = 0.94±0.12, PND60 = 4.5±0.85), mice during 
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development and in adulthood (2-factor ANOVA (genotype X age) = P<0.001 for both factors). N: number of mice, 
n: number of cells. Foxp2+/+ N/n = 3/31 (PND11), 3/26 (PND13), 3/14 (PND17), 3/18 (PND60), Foxp2S321X/+ N/n = 3/31 
(PND11), 3/26 (PND13), 3/15 (PND17), 3/17 (PND60). (b) Example traces of mEPSC activity in striatal D1R-MSNs from 
adult (PND60) Foxp2+/+ and Foxp2S321X/+ mice. Cumulative distribution of mEPSC amplitude (Foxp2+/+ = 12.9±0.64pA, 
Foxp2S321X/+ = 10.2±0.4pA, P<0.01, two-sided students T-test) and frequency (Foxp2+/+ = 1.68±0.16Hz, Foxp2S321X/+ = 
1.42±0.2Hz, NS, two-sided students T-test) in striatal D1R-MSNs. Foxp2+/+ N/n = 3/13, Foxp2S321X/+ N/n = 3/12. (c) 
Example traces of mIPSC activity in striatal D1R-MSNs from adult (PND60) Foxp2+/+ and Foxp2S321X/+ mice. Cumulative 
distribution of mIPSC amplitude (Foxp2+/+ = 11.36±0.41pA, Foxp2S321X/+ = 12.9±0.82pA, P<0.01, two-sided students 
T-test) and frequency (Foxp2+/+ = 0.67±0.07Hz, Foxp2S321X/+ = 0.81±0.09Hz, NS, two-sided students T-test) in striatal 
D1R-MSNs.Foxp2+/+ N/n = 4/11, Foxp2S321X/+ N/n = 6/19. Scale bar in (b, c) 200ms/10pA. *** P<0.001.
PND17 as well as adult (PND60) mice, which comprises a developmental profile at ages around 
the critical time points for the emergence of motor coordination (Dehorter et al. 2011) and 
striatal synaptic integration and circuit formation in mice (Lee and Sawatari 2011). During 
development in wild type mice, the GABA/AMPA ratio increases sharply in D1R-MSNs (Fig 2a). 
Interestingly, both during development and in adulthood the GABA/AMPA ratio of D1R-MSNs 
was significantly higher in Foxp2S321X/+ mice than in wild-type controls (Fig 2a), which indicates 
that the E/I imbalance we uncovered in juvenile mice indeed persists into adulthood. We 
subsequently measured mEPSCs and mIPSCs in D1R-MSNs of adult (PND60) Foxp2S321X/+ mice 
to determine if the increased GABA/AMPA ratios in Foxp2S321X/+ mice reflect persistent changes 
in excitatory and/or inhibitory synaptic strength. Our results show that the increased GABA/
AMPA ratio in adult heterozygous mice is due to decreased mEPSC amplitude (Fig 2b) coupled 
with an increased mIPSC amplitude (Fig 2c). However, the increased mIPSC frequency we 
had observed in our juvenile mice was not present in adult mice (Fig 2c), which indicates that 
some form of compensation might be present. This compensation is however insufficient to 
return activity to baseline levels, and therefore we conclude that the changes in E/I balance 
are persistent into adulthood. Changes in inhibitory synaptic strength can indicate changes at 
either the pre- or the postsynapse, such as increased presynaptic neurotransmitter release 
or increased expression of postsynaptic GABA receptors, respectively. We therefore set out 
to assess the effect of reduced Foxp2 expression on striatal synapses at the molecular level. 
Decreased Foxp2 expression leads to increased GAD67 expression around D1R-MSN 
somata
Foxp2 might modulate inhibitory activity by transcriptionally regulating genes involved 
in GABA signaling (Vernes et al. 2007; Vernes et al. 2011; Fujita et al. 2008). One target 
gene identified in an in vivo chromatin immunoprecipitation (ChIP)-chip screen for Foxp2 
binding in mouse brain was Gad (Vernes et al. 2011), the gene that codes for GAD67, a key 
enzyme in the production of GABA at the synapse (Lau and Murthy 2012). By contrast, other 
genes involved in GABAergic activity, such as VGAT or GAD2, were not detected in this ChIP 
screen. Moreover, GAD2 expression has been shown to be unaltered in striatal tissue from 
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Foxp2 heterozygous knockout embryos (French et al. 2007). Based on these findings we 
hypothesized that reduced Foxp2 expression could lead to changes in GAD67 expression and 
thus contribute to aberrant GABAergic activity. 
We compared GAD67 expression around D1R-MSN somata in the striatum of juvenile Foxp2+/+ 
and Foxp2S321X/+ mice (Fig 3a). GAD67 puncta surrounding striatal D1R-MSNs originate mostly 
from D1R-MSN - D1R-MSN pairs (Taverna et al. 2008) and to a lesser extent from extrastriatal 
GABAergic interneurons (Melzer et al. 2017) and striatal interneurons (Taverna et al. 2008). 
However, of these cells only D1R-MSNs express Foxp2. Thus, aberrant GAD67 expression 
levels can be related to changes in Foxp2 expression. This could either be through direct 
regulation of GAD67 expression by Foxp2 or by indirect effects of altered Foxp2 levels. Foxp2 
is known to affect development of striatal cells in primary cell culture (Vernes et al. 2011) 
and impaired D1R-MSN development in vivo may account for changes in protein expression 
such as reduced GAD67 levels. We found that GAD67 expression was significantly increased 
around D1R-MSN somata in Foxp2S321X/+ mice compared to wild-type controls (Fig 3b), whilst 
GAD67 was not changed around D2R-MSNs (Suppl Figure 2). Furthermore, protein expression 
analysis by western blot in dissected striatum from juvenile Foxp2+/+ and Foxp2S321X/+ mice 
showed GAD67 expression to be increased (Fig 3c). 
To assess whether or not the increased GAD67 expression could be due to a general 
increase in expression of key components of GABA transmission, we quantified vesicular 
GABA transporter (VGAT) expression around D1R-MSN somata (Fig 3a). No change in VGAT 
expression was observed between Foxp2+/+ and Foxp2S321X/+ mice, which suggests that Foxp2 
specifically regulates GAD67 but does not affect the number of synapses. The increase in 
GAD67 levels of mice with reduced Foxp2 expression is consistent with the hypothesis that 
Foxp2 normally acts to repress the transcription of Gad1 and is supported by the prior ChIP-
chip data (Vernes et al. 2011). Differences in GAD67 expression have been described as 
a cause for changes in presynaptic GABA content and inhibitory activity (Lau and Murthy 
2012). Thus, reduced Foxp2 expression could lead to increased inhibitory drive of D1R-MSNs 
through increased GABA production. 
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Figure 3: Increased GAD67 expression in Foxp2S321X/+ mice (ai, aii) 
Overview of GAD67 and VGAT expression levels in striatal slices of juvenile (PND10-14) Foxp2+/+ and Foxp2S321X/+ mice. 
Insets show puncta which surround D1R-MSN somata. These perisomatic puncta were used for intensity analysis, in 
order to restrict analysis to D1R-MSNs (b) Comparison of GAD67 expression (both cumulative distribution in arbitrary 
units (AU) and normalized expression) around D1R-GFP positive somata in dorsolateral striatum of juvenile (PND10-
14) Foxp2+/+ and Foxp2S321X/+ mice. (Normalized expression: Foxp2+/+ = 1.0±0.04, Foxp2S321X/+ 1.44±0.15, P<0.05, two-
sided student’s T-test). Kolmogorov-Smirnov (KS) test for cumulative distributions was used for the cumulative 
distribution data, P<0.001. N: number of animals, n: number of slices. Foxp2+/+ N/n = 3/10, Foxp2S321X/+ N/n = 3/10. (c) 
Quantification and representative western blot of GAD67 protein expression in juvenile Foxp2+/+ and Foxp2S321X/+ mice 
(Foxp2+/+ 1.04 ± 0.05, Foxp2S321X/+ 1.28 ± 0.04, P<0.01, two-sided students T-test). Expression is normalized to Foxp2+/+ 
expression (Foxp2+/+ and Foxp2S321X/+ N=6). (d) Comparison of VGAT expression (both cumulative distribution in 
arbitrary units (AU) and normalized expression) around D1R-GFP positive somata in dorsolateral striatum of juvenile 
(PND10-14) Foxp2+/+ and Foxp2S321X/+ mice. (Normalized expression: Foxp2+/+ = 1.0±0.03, Foxp2S321X/+ 0.94±0.06, NS, 
two-sided student’s T-test). KS test for cumulative distribution data: NS. N: number of animals, n: number of slices. 
Foxp2+/+ N/n = 3/11, Foxp2S321X/+ N/n = 4/14 * P<0.05, **P<0.01, ***P<0.001.
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Presynaptic GABA content is increased upon heterozygous loss of Foxp2 function
As GAD67 levels directly correlate with presynaptic GABA production, we explored if the 
increased GAD67 levels following reduced Foxp2 expression lead to elevated presynaptic 
GABA concentration. Presynaptic GABA is stored in vesicles, and is released upon electrical 
or pharmacological stimulation of the neuron (Alabi and Tsien 2012). A 10 second 10Hz 
stimulation protocol has been described that efficiently depletes the entire readily releasable 
GABA vesicle pool (RRP) (Maas et al. 2017; Chen et al. 2017). This depletion protocol can 
be used to compare the quantal content of the GABA RRP between D1R-MSNs of wild-type 
and Foxp2S321X/+ mice. We show that this stimulation protocol indeed depletes the RRP in 
juvenile wild-type and Foxp2S321X/+ mice (Fig 4a, b). However, in Foxp2S321X/+ mice the average 
current transferred per stimulation, as well as the cumulative current transferred after 100 
stimulations, was significantly increased compared to wild-type controls (Fig 4c). However, 
we did not observe a difference in the kinetics of release when release was normalized, which 
indicates that vesicle recycling was not affected in Foxp2S321X/+ mice (Fig 4b).
Changes in GABA concentration at the synapse can affect synaptic strength and vesicle release 
probability (Olpe et al. 1994; Jensen et al. 1999). We therefore examined both excitatory and 
inhibitory paired pulse ratios (PPRs) in juvenile Foxp2S321X/+ mice and littermate controls. No 
differences in excitatory PPRs were found between genotypes (Fig 4d). However, in contrast 
to the expected increase in inhibitory PPR Foxp2S321X/+ mice showed a lack of inhibitory paired 
pulse depression, specifically at longer inter stimulus intervals (Fig 4e). The lack of inhibitory 
PPD can be explained increased GABA release per stimulation (figure 4a). If only a fraction 
of the total released GABA is necessary to saturate postsynaptic GABA, then reduction of 
vesicles released with subsequent stimulations would not lead to PPD, because enough GABA 
is still released to saturate the postsynaptic GABA receptors that are present.
Next, we sought to confirm the increased presynaptic GABA release pharmacologically, to 
exclude aberrant effects from recurrent stimulation. Local application of 500 mM sucrose for 
10 seconds (Lipstein et al. 2017) efficiently induced vesicle exocytosis in juvenile Foxp2+/+ 
and Foxp2S321X/+ mice (Fig 4f). The total current transfer during sucrose application was 
increased by approximately 50% in D1R-MSNs fFoxp2S321X/+ mice, similar to the increase 
in current transfer observed upon electrical stimulation (Fig 4f). Lastly, the increase in 
mIPSC amplitude (Fig 2b and 3h) in mice with reduced Foxp2 expression also suggests 
postsynaptic GABA receptor abundance might be increased. We used local application of 
GABA to investigate if postsynaptic GABAA receptor presence was affected by reduced Foxp2 
expression. GABA application elicited a strong response in D1R-MSNs of both Foxp2+/+ and 
Foxp2S321X/+ mice (Fig 4g). No difference in peak response amplitude or total current transfer 
could be observed between genotypes (Fig 4g). Taken together, our data suggest that D1R-
MSNs exhibit increased GABA content at the presynapse following reduced Foxp2 expression, 
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leading to a heightened quantal GABA release. This in turn leads to elevated inhibition of the 
striatal direct pathway. 
a
Foxp2 +/+
Foxp2 S321X/+
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Figure 4: Presynaptic GABA content in juvenile (PND10-14) striatal D1R-MSNs is increased upon decreased 
Foxp2 expression. 
(a) Example traces of vesicle depletion following train stimulation (10Hz, 100 stimuli) in Foxp2+/+ and Foxp2S321X/+ 
D1R-MSNs, every 10th response is shown. Scale 100ms/50pA. (b) Normalized (to first pulse) IPSC response during 
train stimulation. (c). Cumulative IPSC amplitude during train stimulation of D1R MSNs, (Foxp2+/+ = intercept 
294.24±85.3pA, cumulative 3112.9±286.4pA, Foxp2S321X/+ = intercept 498.9±301.3 pA, cumulative 5142.1±484.6pA, 
P<0.001, two-sided students T-test) N: number of mice, n: number of cells. Foxp2+/+ N/n = 3/16, Foxp2S321X/+ N/n 
= 3/16 (D) Example trace of excitatory PPR at different inter stimulus intervals (ISI) in D1R-MSNs of Foxp2+/+ and 
Foxp2S321X/+ mice. Scale 100ms/50pA. Quantification of paired pulse ratio (PPR) (50, 100, 150, 200, 500ms: Foxp2+/+ 
1.573±0.08, 1.284±0.06, 0.958±0.02, 0.955±0.04, 0.856±0.02 vs Foxp2S321X/+ 1.864±0.13, 1.357±0.1, 1.244±0.1, 
1.131±0.06, 0.884±0.04, NS, Repeated measures ANOVA). Foxp2+/+ N/n = 2/8, Foxp2S321X/+ N/n = 3/11. (e) Same as 
(d) but for inhibitory PPR, (50, 100, 150, 200, 500ms: Foxp2+/+ 0.936±0.05, 0.872±0.05, 0.832±0.04, 0.798±0.04, 
0.718±0.03 vs Foxp2S321X/+ 0.983±0.06, 0.973±0.07, 1.016±0.05, 0.947±0.03, 0.894±0.04. P<0.001 for 150, 200, 
500ms, repeated measures ANOVA). Foxp2+/+ N/n = 3/23, Foxp2S321X/+ N/n = 3/20. PPR is normalized to the first pulse. 
(f) Example trace of postsynaptic inhibitory response to forced vesicle exocytosis during 10 second local application 
of 500mM sucrose. Scale 2s/50pA. Normalized (to wild-type) current transfer during 10 second sucrose application 
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(Foxp2+/+ = 9.1*105±1.26*105 pA, Foxp2S321X/+ = 13.4*105±1.6*105pA, P<0.01, two-sided students T-test). Foxp2+/+ N/n 
= 2/15, Foxp2S321X/+ N/n = 3/16. (g) Example trace of postsynaptic response during 10 second local application of 
100µM GABA. Scale 2s/200pA. Quantification of peak amplitude and total current transfer during GABA application 
(Foxp2+/+ = 1.00*103±66.7pA, Foxp2S321X/+ = 1.04*103±125pA, NS, total current transfer Foxp2+/+ = 4.8*106±3.4*105pA, 
Foxp2S321X/+ = 5.4*106±5.5*105pA, NS, two-sided students T-test). Foxp2+/+ N/n = 2/14, Foxp2S321X/+ N/n = 2/12). * 
P<0.05, *** P<0.001.
Pharmacological manipulation of inhibition partially rescues motor skill learning deficits 
in Foxp2S321X/+ mice
Because aberrant regulation of direct pathway inhibitory activity has been shown to produce 
motor skill learning deficits (Rothwell et al. 2014; Zhang et al. 2015), we next investigated 
whether blocking inhibitory activity might be an effective in vivo intervention. One of the 
most pronounced behavioral deficits displayed by mice with heterozygous mutations in 
Foxp2 is decreased motor skill learning, shown by impaired performance on the accelerating 
rotarod (Groszer et al. 2008; French et al. 2012). Increased inhibition of the direct pathway 
as demonstrated herein could help explain why Foxp2 mutations lead to impaired rotarod 
performance, since successful acquisition of this task is dependent on precise regulation of 
striatal activity. Cui and colleagues (Cui et al. 2008) showed that increases in presynaptic 
GABA content cause learning and memory deficits when present in hippocampal neurons. 
Intriguingly, they found that learning and memory improved dramatically after a low 
concentration intraperitoneal (IP) injection with picrotoxin (PTX), a compound that blocks 
GABAA receptor mediated inhibition (Cui et al. 2008). We therefore hypothesized that a 
low dose of PTX might be able to ameliorate the motor skill learning deficits present in the 
Foxp2S321X/+ mice in a similar manner. 
We first validated the presence of motor skill learning deficits in our Foxp2S321X/+ mice 
by measuring their performance and learning rate on the accelerating rotarod during 5 
consecutive training days and comparing them to littermate controls (Fig 5a, b). The impaired 
rotarod performance in adult Foxp2S321X/+ mice that we observed is consistent with previous 
reports on Foxp2 heterozygous mutant mice (French et al. 2012; Groszer et al. 2008). Next, 
we assessed a viable treatment dose. Injection of 1mg/kg PTX produced grand mal seizures 
in both Foxp2+/+ and Foxp2S321X/+ mice, whereas both 0.01mg/kg and 0.05mg/kg did not have 
any effect on rotarod performance (Suppl. Figure 3). An intermediate dose of 0.1mg/kg did 
not induce seizures, but had a notable negative effect on the rotarod performance of pre-
trained wild-type mice (Suppl. Figure 4), whereas the rotarod performance of pre-trained 
heterozygous mice was not affectWe therefore injected wild-type and Foxp2S321X/+ mice with 
0.1mg/kg PTX 10 minutes prior to each training session and subjected them to the same 
motor learning paradigm as the vehicle-injected (DMSO) mice. Interestingly, this 0.1mg/kg 
PTX injection differentially affected rotarod performance of wild-type and Foxp2S321X/+ mice. 
Both wild-type and Foxp2S321X/+ mice still show an increase in performance and a positive 
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learning rate during sessions (Fig 5c,d). Treatment with PTX had a profound negative effect 
on rotarod performance in Foxp2+/+ mice, whilst in Foxp2S321X/+ mice, rotarod performance 
was significantly increased compared to mice without treatment. These opposite effects 
of PTX treatment resulted in a comparable performance of Foxp2+/+ and Foxp2S321X/+ mice 
when comparing average rotarod speed (RPM) at fall from the last 2 trials, (Fig 5e) with 
PTX treatment. This shows that decreasing inhibitory activity might be a viable method to 
ameliorate motor deficits induced by decreased expression of Foxp2 and corroborates our 
data that in mice with reduced Foxp2 expression the E/I balance is shifted towards increased 
inhibition.
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Figure 5: Pharmacological blockade of inhibition modulates rotarod performance and motor skill learning. 
(a) Foxp2S321X/+ mice show impaired motor skill learning, shown by the decreased latency to fall (in seconds) across 
training sessions (day 1-5: Foxp2+/+ 75.3±9.7, 120.4±14.4, 164.7±13.6, 165.5±12.2, 160.7±10.8. Foxp2S321X/+ 34.4±3.1, 
52.5±7.4, 53.1±8.7, 55.0±8.15, 82.6±8.38. P<0.01, Repeated measured ANOVA). Each session consists of 5 trials 
of 5 minutes, during which the rotarod accelerated from 4-40rpm. (b) Both Foxp2+/+ and Foxp2S321X/+ mice show a 
positive learning rate during most sessions, with Foxp2+/+ mice having a significantly higher learning rate (day 1-5: 
Foxp2+/+, 10±7.5, 17.8±3.5, 16.3±3.00, -1.4±6.3, 10±2.7. Foxp2S321X/+, 0.9±2.7, 5.7±2.2, -8.2±1.6, 3.2±5.6, 8.5±2.2. 
P<0.05, Repeated measures ANOVA), learning rate was calculated as: . (c,d) Foxp2+/+ mice subjected to 0.1mg/
kg intraperitoneal injection of PTX show decreased rotarod performance and learning rates, whereas these were 
increased in Foxp2S321X/+ mice (Latency to fall: day 1-5: Foxp2+/+ 71.7±12.4, 91.7±5.5, 96.4±4.7, 104.4±1.2, 114±3.2. 
Foxp2S321X/+ 33.8±4.5, 59.8±5.7, 77.4±5.3, 91.8±1.1, 103.2±3.61. NS Learning rate: Foxp2+/+ 7.2±2.5, 5±2.3, 3.4±1.9, 
-0.1±4.0, 3.6±3.8. Foxp2S321X/+, 0.76±1.2, 5.9±2.5, 6.4±1.9, 0.0±1.8, 4.3±3.9. NS, Repeated Measures ANOVA). (e) 
Average RPM at which mice fail the accelerating rotarod task during session 4 and 5 in vehicle and PTX conditions 
(vehicle, Foxp2+/+ 24.1±0.94 RPM, Foxp2S321X/+ 12±0.96 RPM, P<0.001. PTX, Foxp2+/+ 16.7±0.4RPM, Foxp2S321X+ 
15.3±0.372RPM, NS, two-sided students T-test). For all treatment conditions, N = 5 mice. *** P<0.001. 
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DISCUSSION
Mutations in FoxP2 affect striatal circuitry both in human cases of speech/language disorder 
and in animal models of FoxP2 dysfunction (Liegeois et al. 2003; Schulz et al. 2010; Groszer et 
al. 2008; French et al. 2012). Here we show that Foxp2 affects both excitatory and inhibitory 
striatal activity in a cell-specific manner during development and in adulthood. Foxp2 is 
predominantly expressed in striatal direct pathway D1R-MSNs. Decreased Foxp2 expression 
leads to reduced excitatory activity and increased inhibitory activity in D1R-MSNs. Molecular 
evidence suggests that the increase in inhibitory activity is due to a de-repression of GAD67 
expression. The number of GAD67-positive puncta around the somata of D1R-MSNs increases 
when Foxp2 expression is reduced, which is accompanied by increased presynaptic GABA 
content and increased inhibition of the striatal direct pathway. Intriguingly, blocking inhibition 
with PTX results in a partial rescue of motor skill learning deficits in Foxp2S321X/+ mice, whereas 
wild-type littermates show impaired motor skill learning after treatment.
Striatal excitatory connections are formed exclusively by projections from external sources 
(Hunnicutt et al. 2016). Subpopulations of cortical and thalamic projection neurons form 
excitatory connections to the striatum (Pan et al. 2010; Hintiryan et al. 2016), and these brain 
regions contain Foxp2-positive cells as well (Lai et al. 2003; Takahashi et al. 2003; Vargha-
Khadem et al. 2005; Hisaoka et al. 2010; Sia et al. 2013). However, it is currently unknown if 
the cortical and thalamic neurons that express Foxp2 project to the striatum. Our data show 
that reduced Foxp2 expression decreases D1R-MSN mEPSC amplitude, without influencing 
mEPSC frequency or excitatory PPR. This suggests that only postsynaptic excitatory strength is 
affected, and excitatory inputs to the striatum are not affected by reduced Foxp2 expression. 
Furthermore, the lack of excitatory presynaptic changes in striatal MSNs indicates that 
excitatory cortical and thalamic cells which do express Foxp2 either do not project to MSNs in 
the dorsolateral striatum or that Foxp2 has no presynaptic function in these neurons. 
Concurrent with the decrease in excitatory activity, we observed an increase in inhibitory 
activity of striatal D1R-MSNs. Gene ontology analysis following Foxp2-ChIP experiments 
(Vernes et al. 2011), which groups significantly regulated genes among common biological 
pathways, has suggested GABA signaling pathways are regulated by Foxp2. Striatal MSNs 
express both GAD67 and GAD65, two catalytic enzymes involved in the production of GABA 
(Laprade and Soghomonian 1999). To our knowledge, GAD65 has not been identified as a 
regulatory target of Foxp2, and mRNA levels of Gad2 (the gene which codes for GAD65) 
are unaltered when Foxp2 expression is reduced (French et al. 2007). In contrast, the Gad1 
gene is clearly a regulatory target of Foxp2, shown by ChIP (Vernes et al. 2011), and we 
show that expression of its protein product GAD67 is increased around striatal D1R-MSNs of 
Foxp2S321X/+ mice. Interestingly, increased GAD67 expression levels have been causally linked 
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to increased presynaptic GABA content (Chao et al. 2010; Hibbert et al. 2004) and enhanced 
GABA transmission (Krishnan et al. 2015), both of which occur in D1R-MSNs from Foxp2S321X/+ 
mice.
Spine formation and excitatory activity in striatal MSNs are affected in homozygous Foxp2 
knockout mice during early postnatal development, possibly through increased Mef2C 
expression. Mef2C is a transcription factor, which acts as a developmental brake on 
glutamatergic synapse formation and is regulated by Foxp2 (Chen et al. 2016). However, 
we show that decreased excitatory activity in D1R-MSNs is present in both juvenile and 
adult Foxp2S321X/+ mice. Mef2C expression is virtually absent in adolescent mouse striatum 
(Chen et al. 2016). This suggests that the decrease in excitatory activity could be caused by 
impaired generation of glutamatergic synapses during early development, which can have 
lasting effects on physiology and behavior in adult mice  (Harrington et al. 2016). Intriguingly, 
Mef2C, has been shown to regulate the activity of both excitatory and inhibitory synapses 
in cortex in a cell-autonomous way (Harrington et al. 2016). Knockout of Mef2C decreased 
excitation and increased inhibition in cortex, similar to the physiological changes that we 
show in striatal D1R-MSNs of Foxp2S321X/+ mice. Dysregulation of striatal Mef2C expression 
following heterozygous Foxp2 loss of function could therefore be partially responsible for the 
striatal E/I imbalance that we measured. 
Our findings show that reduced Foxp2 expression disrupts striatal E/I balance, which is 
dynamically regulated through pre-and postsynaptic mechanisms (Abbott and Nelson 
2000; Bolshakov and Siegelbaum 1994; Bi and Poo 1998; Yang and Calakos 2013). Whilst 
the decreased excitatory activity seems to originate postsynaptically, our data suggest that 
reduced Foxp2 expression leads to increased presynaptic GABA production. D1R-MSNs 
form extensive connections toward the substantia nigra (SN), such that reduced activation 
of D1R-MSNs leads to reduced inhibition of the SN. Increased release of GABA could be a 
cell-autonomous mechanism to increase the inhibitory drive of D1R-MSN projections toward 
the SN. However, intra-striatal inhibition is governed by MSNs as well: D1R-MSNs project 
to other D1R-MSNs (Taverna et al. 2008). This means that a feedback loop could occur to 
increase inhibitory drive, which would result in stronger inhibition of striatal D1R-MSNs. 
Paired recording of striatal D1R-MSNs in Foxp2+/+ and Foxp2S321X/+ could help to determine 
whether such a feedback loop is present and if such a mechanism can negate the effect of the 
increased presynaptic GABA production in presynaptic terminals within the SN. 
Furthermore, the striatal E/I imbalance following reduced Foxp2 expression is maintained 
throughout development and in adult mice. This can explain why impaired striatal plasticity 
and motor skill learning deficits are present in adult mice with heterozygous Foxp2 mutations 
(French et al. 2012; Groszer et al. 2008). Interestingly, in a mouse model for neuroligin-3 
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(NL-3) dysfunction, known to produce similar behavioral and physiological phenotypes as 
mutation of Foxp2, adult re-expression of NL-3 rescues motor skill learning deficits (Rothwell 
et al. 2014). Restoration of E/I balance in adulthood could therefore be a viable strategy to 
ameliorate the motor learning deficits observed upon reduced Foxp2 expression. Modulation 
of GABAergic activity using GABAA antagonists has been shown to improve learning and 
memory in mouse models for cognitive disorders (Rueda et al. 2008; Cui et al. 2008) and 
phase I clinical trials are underway to test GABA A antagonists on people with Down syndrome 
(Contestabile et al. 2017). We show that modulation of GABAergic activity by partially blocking 
inhibitory activity increases motor skill learning in Foxp2S321X/+ mice. Intriguingly, wild-type 
mice were adversely affected by the same PTX treatment, which indicates that successful 
modulation of GABAergic activity might be highly dose dependent. 
Taken together, we show for the first time that reduced Foxp2 expression bidirectionally 
affects both excitatory and inhibitory activity of striatal direct pathway MSNs, throughout 
development as well as in adult mice. Partially blocking inhibitory activity in vivo might 
restore this E/I imbalance, and we found that this intervention had a positive effect on 
motor skill learning in mice with reduced Foxp2 expression. Restoring the E/I balance by 
pharmacologically modulating inhibitory activity might be a feasible therapeutic intervention 
for complex motor disorders.
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MATERIALS & METHODS
Mouse lines 
The experimental procedures were approved by the Animal Ethics Committee of the Radboud 
University Nijmegen, under DEC application number 2014-098 (Nijmegen, the Netherlands) 
and conducted in accordance with the Dutch legislation. Every effort was made to minimize 
animal discomfort and the number of animals used.
The Foxp2-S321X line was maintained on a C57BL/6J background, and heterozygotes and 
wildtype littermates between PND11 and PND17 (juvenile) or PND55-65 (adult) were used 
for the immunofluorescent stainings and electrophysiological recordings. The generation, 
marker-assisted backcrossing and genotyping of this strain are fully described in  (Groszer 
et al. 2008; Keays et al. 2006; Coghill et al. 2002). BACtrap mice carrying GFP under the D1R 
promoter (D1R-GFP) or D2R promoter (D2R-GFP) were originally generated by the GENSAT 
(Gene Expression Nervous System Atlas) (Gong et al. 2003) and backcrossed to C57BL6/J 
mice.
Electrophysiology
Experiments were conducted on 350µm thick coronal slices. Mice (PND11-17 or PND55-
65) were sacrificed by decapitation following isoflurane anesthesia. Slices were cut using a 
vibratome (HM650V Thermo Scientific) in cooled (4°C) artificial cerebrospinal fluid containing 
(in mM): 87 NaCl, 11 Glucose, 75 Sucrose, 2.5 KCl, 1.25 NaH 2PO4, 0.5 CaCl2, 7 MgCl2, 26 
NaHCO
3
), continuously oxygenated with 95%O2/5%CO2. Collection of slices started when 
the striatum became visible and slices were collected until the hippocampus was visible. 
After collection, slices were incubated at 32°C in oxygenated ACSF for at least 1h before 
recording. Slices were transferred to the recording setup 10 minutes prior to recording and 
incubated in recording ACSF containing (in mM): 124 NaCl, 3 KCl, 1.25 NaH 2PO4, 2 CaCl2, 1 
MgCl2, 26 NaHCO3, 10 Glucose, continuously oxygenated and heated to 32°C. Patch pipettes 
(3.5 – 5.5 MΩ) were made from borosilicate glass capillaries and filled with intracellular 
solution containing: 115 CsMeSO3; 10 CsCl; 10 HEPES; 2.5 MgCl2; 4 Na2ATP; 0.4 NaGTP; 
10 Na-Phosphocreatine; 0.6 EGTA, 10 QX-314. Activity was recorded using a Digidata 1440A 
digitizer and a Multiclamp 700B amplifier (Molecular Devices). Sampling rate was set at 
20KHz and a lowpass 1KHz filter was used during recording. All recordings were conducted in 
the dorsolateral quadrant of the striatum.
Miniature postsynaptic currents
mEPSCs were recorded in the prescience of Tetrodotoxin (TTX, 1µM, Tocris) and Picrotoxin 
(PTX, 100µM, Tocris) at a holding voltage of -60mV. mIPSCs were recorded in the presence of 
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Tetrodotoxin (TTX, 1µM, Tocris), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 5 µM, Tocris) 
and (2R)-amino-5-phosphonovaleric acid (APV, 100 µM, Tocris) at a holding voltage of +10mV.
GABA/AMPA ratio
All stimulation experiments were conducted by stimulation of afferent corticostriatal and 
intrastriatal axons using a bipolar concentric stimulus electrode (FHC, Bowdoin, Maine) 
placed in the dorsolateral striatum. GABA/AMPA ratio was measured in the presence of APV 
(100µM). Cells were voltage-clamped at -60mV and a 1ms stimulus from a bipolar tungsten 
electrode was given to record the AMPA response. Subsequently cells were clamped at 0mV 
and the GABA response was measured. 
Paired Pulse ratio
Excitatory PPR was measured in the presence of PTX (100µM) and APV (100µM) with 
voltage clamped at -60mV. Inhibitory PPR was measured in the presence of CNQX (5µM) 
and APV (100µM) with voltage clamped at -60mV. Stimulation strength was set to evoke 
an approximately 200 pA response to the first stimulus. Two 1 ms pulses were given with a 
50 ms, 100 ms, 150 ms, 200 ms, 500 ms or 9000 ms (inhibitory PPR only) interval. PPR was 
calculated as the peak2/peak1 ratio after correcting for any residual current at the second 
pulse.
GABA 
Vesicle depletion
1ms pulses were given at 10Hz for 10 seconds to entirely deplete the presynaptic GABA 
vesicle pool. After each 10 second stimulus train, cells were given 0.2Hz stimulations for 40 
seconds to assess the recovery of the vesicle pool between each stimulus train. One recording 
consisted of 10 consecutive stimulus trains. Cells were recorded in the presence of CNQX and 
at a holding voltage of -60mV.
Compound application
Sucrose (500mM) or GABA (20µM) was applied using a pressure ejection system (PDES-2DX, 
NPI, Tamm, Germany). The injection pressure was set to 5psi/0.4 bar and injection duration 
was set to 10 seconds. Interinjection interval was set to 1 minute. Compounds were delivered 
using a micropipette positioned at 30µm from the target cell soma.
Immunofluorescence
Animals were sacrificed by decapitation and whole mouse brain was fixed in 4% 
paraformaldehyde (PFA) / 4% sucrose for 24 hours. 60 µm coronal sections including the 
striatum were cut using a vibratome (Leica VT1000S, Leica microsystems). Slices were 
transferred to 1x Phosphate buffered saline (PBS) for immunofluorescent staining. The 
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following antibodies were used: FoxP2 (Santa Cruz Sc-21069, 1:500), GAD67 (Millipore 
MAB5406, 1:200). Imaging was done using a Zeiss upright fluorescent microscope with 
apotome (Zeiss Axio Images, Oberkochen, Germany) using a 63X oil immersion objective. 
Images were analyzed offline using FIJI (Fiji is just imageJ) image analysis software.
Intraperitoneal injection
Foxp2S321X/+ mice and wild-type littermate controls were injected intraperitoneally with either 
vehicle (DMSO) or 0.1mg/kg picrotoxin (Tocris, Bristol, UK). Injection was done by hand and 
mice were placed back in their home cage for 10 minutes following injection, after which 
mice were placed on the accelerating rotarod.
Accelerating rotarod
Foxp2S321X/+ mice (6-8 weeks old) and wild-type littermate controls were placed on an 
accelerating rotarod (LE8200, Harvard apparatus) which increased rotation speed from 4 
r.p.m. to 40 r.p.m. over a 5-minute period. Mice were trained for 5 consecutive days, with 
5 trials per day. Latency to fall (in seconds or RPM at fall) was scored, and mice were placed 
back in their home cage for 5 minutes between trials.
Western blot 
PND10-15 Foxp2S321X/+ animals and wild-type controls were sacrificed by decapitation. The 
striatum was dissected from separated hemispheres, frozen in liquid nitrogen and kept at 
-80°C. Samples were homogenized in 200 µl of lysis buffer (50 mM Hepes pH 7.4, 140 mM NaCl, 
0.1% Triton-X100, 1% Tween 20, 0.1% deoxycholate) containing protease inhibitor mix (Roche 
Diagnostics). Protein levels were assessed using BCA. Sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) on 10% (w/v) at 200V for 30 minutes was carried out using 
a Mini-Protean system (Bio-Rad, USA). Protein (50 µg) was loaded in each lane with loading 
buffer (0.25 M Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.25% bromophenolblue, 4% beta-
mercaptoethanol). After electrophoresis, proteins were transferred to a polyvinylidene 
fluoride membrane (PVDF, Amersham, Hybond-P), using an electrophoretic transfer system 
(Bio-Rad, USA). The membranes were then blocked with 5% skimmed milk dissolved in TBS-
tween 0.1% for one hour. The membranes were incubated overnight at 4 °C with the primary 
antibodies diluted in blocking buffer containing 1% skimmed milk dissolved in a TBS-Tween. 
The primary antibodies were the following: mouse monoclonal anti- bodies GAD67 (1:1000, 
Abcam), and GAPDH as a control (1:1000, Cell signaling). After being washed for one hour 
with 1% skimmed milk in TBS-T (0.05%), the membranes were incubated for one hour in the 
dark at room temperature with goat-anti-mouse secondary antibody (1:5000; Bio-Rad, Goat-
anti-mouse HRP conjugated). The membranes were imaged using a Chemidoc Touch imaging 
system (Bio-rad, Hercules, CA) and the generated pictures were quantified using ImageJ 
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software. The levels of protein expression were normalized to GAPDH. Protein expression 
values are normalized to Foxp2+/+ expression (relative intensity).
Statistics
Sample size was calculated assuming power of 0.8 and effect size d=0.8, data are acquired 
from at least 3 mice for each genotype. All data are shown as mean ± SEM. Analysis between 
two groups was done using students’ T-test, analysis between multiple groups using repeated 
measures ANOVA. All statistical analysis was conducted in PRISM (Graphpad PRISM 7.00, 
Graphpad Software, San Diego, CA). 
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SUPPLEMENTARY FIGURES
Supplementary figure 1 AMPA/NMDA ratio is increased in Foxp2S321X/+ juvenile mice (PND11-13). 
(a) Example traces of AMPA/NMDA measurement by stimulation at -60mV (AMPA) and +40mV (NMDA) in the 
presence of PTX to block GABAergic neurotransmission. The AMPA response was measured as the peak response, 
whereas the NMDA response was measured as the average (pA/ms) of the area between 60-65ms after the AMPA 
peak (grey shaded area). (b) AMPA/NMDA ratio (Foxp2+/+ 0.94±0.09 N/n = 3/22, Foxp2S321X/+ 1.75±0.27 N/n = 3/22). 
Scalebar = 100ms/50pA, ** = P<0.01. All data is reported as mean ± SEM. N/n = animals/cells
Supplementary Figure 2: The number of GAD67 puncta surrounding D2R-MSN somata is not changed. 
We counted GAD67 positive puncta surrounding D1R-negative (putative D2R) MSNs. No differences between the 
number of GAD67 puncta per soma were found between Foxp2+/+ or Foxp2S321X/+ mice. (Foxp2+/+ = 1.6±0.04 puncta/
D2R-MSN soma, Foxp2S321X/+ 1.4±0.136 puncta/D2R-MSN soma, NS, two-sided students T-test). Foxp2+/+ N/n = 3/8, 
Foxp2S321X/+ N/n = 3/9. N/n = mice/brain slices
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Supplementary Figure 3. Low dose (0.01 or 0.05 mg/kg) IP PTX injection does not affect rotarod performance of 
Foxp2+/+ or Foxp2S321X+ mice. 
The last trial day (day 5) and 2 subsequent days (0.01mg/kg injection or 0.05 mg/kg) are shown. Average RPM at fall 
is not affected by injection and not different between experimental days (Foxp2+/+ 23.6±1.28, 25.9±2.4, 26.2±0.81 
N.S. Foxp2S321X/+ 14±1.13, 12.5±0.92, 15.7±0.59, NS, 2 Factor ANOVA, factors experimental day and PTX treatment). 
N = 5. 
Supplementary Figure 4. Pre-trained Foxp2S321X/+ mice are not affected by PTX injection. 
Average RPM at fall for pre-trained mice injected with either 0.01mg/kg PTX or 0.1mg/kg PTX. (Foxp2+/+ 25.9±0.63, 
23.2±0.71, P<0.05, Foxp2S321X/+ 12.5±0.75, 14.04±0.58, NS, two-sided students T-test). N = 5.
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A fast shift from striatal Calcium-permeable AMPAR 
to Calcium-impermeable AMPAR expression coincides 
with the start of coordinated locomotion and is 
delayed in heterozygous Foxp2 loss of function mice
Jon-Ruben van Rhijn, Simon E Fisher, Sonja C Vernes, Nael Nadif Kasri.
In preparation for submission 
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ABSTRACT
Maturation of excitatory synapses during postnatal development is highly spatiotemporally 
regulated. Heterozygous loss of Foxp2 function leads to impaired striatal development as 
well as deficits in excitatory spine maturation. Furthermore, excitatory activity is reduced 
in these mice during development and in adulthood. Adult mice with heterozygous Foxp2 
mutations show motor skill learning deficits, however, no behavioral phenotype in juvenile 
animals with heterozygous loss of Foxp2 function has been described. We describe a fast 
shift from immature calcium-permeable to mature calcium-impermeable α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) between postnatal day 9 
and 11 in control animals. Critical period maturation of excitatory dorsal striatal synapses is 
thought to coincide with the start of coordinated locomotion. AMPAR maturation coincided 
with an increase in performance on the hanging bar test, a behavioral task which requires 
coordinated locomotion. AMPAR maturation and hanging bar performance are impaired in 
juvenile mice with heterozygous loss of Foxp2 function mutations. Furthermore, we show that 
AMPAR trafficking and long-term depression (LTD) are impaired in adolescent heterozygous 
mice, which could contribute to the delayed AMPAR maturation. Taken together, our data 
show that AMPAR maturation is highly temporally regulated in the dorsal striatum and that 
this maturation is delayed in mice with a heterozygous loss of Foxp2 function, affecting the 
initiation of coordinated locomotion during postnatal development in these mice.
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INTRODUCTION
Rapid changes in synapse physiology and neuronal connectivity lead to the formation of 
synapses with mature receptor expression and mature neuronal activity (Lee and Sawatari, 
2011; Zhang et al., 2011). A large proportion of synaptic maturation is dependent on external 
input during tightly constrained time windows known as critical periods in early postnatal 
life (Bassani et al., 2013; Kilb, 2012; Mackowiak et al., 2014). These critical periods coincide 
with developmental milestones. For example, the critical period for visual cortex maturation 
in mice coincides with eye opening (for review, see: (Hensch, 2005)). Aberrant temporal 
specificity of changes in synapse physiology during critical periods has been implicated in 
cognitive disorders such as autism and intellectual disability (Krishnan et al., 2015; Peixoto et 
al., 2016). Currently, there is only tentative evidence that similar critical periods are involved 
in the maturation brain circuits involved in complex movement. 
The striatum is the principal brain region where excitatory inputs from cortex and thalamus, 
as well as dopaminergic inputs from the substantia nigra are integrated (Hunnicutt et al., 
2016). This complexity of striatal connections has implicated it as a central hub involved in 
motor control (Kravitz and Kreitzer, 2012). It is known that striatal medium spiny neurons 
(MSNs) mainly express calcium permeable AMPA receptors (CP-AMPARs) that consist of 
homomers of the GluA1 subunit, during early postnatal development (figure 1a,b). During 
neuronal maturation, CP-AMPARs are replaced by calcium impermeable AMPA receptors (CI-
AMPARs), that consist of heteromers of GluA1, and GluA2 or GluA3 (Henley and Wilkinson, 
2016). In adult mice striatal MSNs predominantly express CI-AMPARs at the synapse (Bellone 
et al., 2011) (Fig. 1b). CP-AMPARs show inward rectification of responses to stimulation at 
positive membrane voltages, whilst CI-AMPARs show a linear relationship between responses 
to stimulation at negative and positive holding voltages (Figure 1c). Expression of CI-AMPARs 
is essential for mature excitatory striatal activity (Isaac et al., 2007). The expression of CI-
AMPARs is essential for the ability of adult mice to perform complex motor tasks, as mice 
which lack the GluA2 subunit are highly impaired in coordinated locomotion (Christie et al., 
2010; Jia et al., 1996). The shift from CP-AMPAR to CI-AMPAR expression at striatal synapses 
could be dependent on locomotion behavior. Maturation of striatal synaptic activity has been 
shown to coincide with the start of coordinated locomotion, which occurs between postnatal 
day 9-11 in mice (Dehorter et al., 2011). Furthermore, it is known that the shift from CP-
AMPAR to CI-AMPAR expression occurs between the second and fourth postnatal week 
(Bellone et al., 2011). However, a more detailed time course of the shift between CP- and 
CI-AMPARs and the relation to the start of locomotion could further inform us how striatal 
maturation enables the emergence of coordinated locomotion.
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Modulation of striatal circuit activity affects complex motor sequencing (Boecker et al., 
2008; Desmurget and Turner, 2010; Kawashima et al., 2012) and is involved in the generation 
of speech (Ackermann et al., 2014; Ziegler and Ackermann, 2013). Impaired basal ganglia 
activity has been shown in speech disorders (Redle et al., 2015; Wildgruber et al., 2001), 
including childhood apraxia of speech (CAS). CAS is a condition characterized as ‘a disorder of 
speech motor programming or planning that affects the production, sequencing, timing and 
stress of sounds’ (Morgan et al., 2017). A genetic cause for CAS was discovered in a family 
in which more than half of the family members are affected with CAS. This family, known as 
the KE-family, shows heterozygous mutation by a single amino-acid change (R553H) of the 
DNA-binding domain of the transcription factor FOXP2 (Lai et al., 2001). (f)MRI investigation 
of affected individuals from the KE family, and comparison with unaffected family members 
and controls, has shown that striatal morphology and activity are affected by heterozygous 
mutation of FOXP2 (Liegeois et al., 2003; Watkins et al., 2002). Furthermore, animal models 
in which Foxp2 function is disrupted have shown that striatal development and function is 
impaired. In mice with heterozygous loss of Foxp2 function mutations synaptic maturation 
and excitatory activity are impaired (Chen et al., 2016; van Rhijn et al., 2018). Furthermore, 
FoxP2 has been shown to regulate genes involved in synapse formation such as SRPX2 (Sia 
et al., 2013) and VLDLR (DiBattista et al., 2015; Mendoza and Scharff, 2017) and mice with 
heterozygous mutations of Foxp2 display aberrant motor skill learning as adults (French et 
al., 2012; Groszer et al., 2008; van Rhijn et al., 2018). The reduced striatal excitatory activity 
remains present in adult mice (van Rhijn et al., 2018), concomitant with a reduction in AMPAR 
expression in striatal MSNs (Chen et al., 2016). Currently, only in adult mice with heterozygous 
mutations in Foxp2 motor skill learning impairments have been described. However, the 
morphological and physiological phenotypes suggest synapse development and maturation 
of striatal MSNs might be affected by mutations in Foxp2. These impairments could affect 
motor coordination at an early age. This makes Foxp2 dysfunction an exciting opportunity to 
investigate striatal AMPAR maturation and to link regulation of striatal excitatory activity to 
the emergence of coordinated locomotion.
We investigated the shift from CP-AMPAR to CI-AMPAR expression during early juvenile (PND 
7-17) development and found that this shift happens between PND 9 and 11 in wild-type 
animals. We next used a Foxp2 loss of function mouse model in which a STOP codon is inserted 
in exon 7 (S321X) to investigate if Foxp2 is involved in AMPAR maturation. In Foxp2S321X/+ mice, 
the CP-AMPAR to CI-AMPAR shift is both more gradual and delayed compared to Foxp2+/+ 
mice. We show that impaired AMPAR trafficking could underlie this delay, as internalization 
of CP-AMPARs and mGluR1 mediated LTD induction are impaired in Foxp2S321X/+ mice. Lastly, 
we show AMPAR maturation coincides with the emergence of coordinated locomotion 
and that juvenile Foxp2S321X/+ mice show reduced performance on a task which necessitates 
coordinated locomotion. Our data show for the first time that the emergence of coordinated 
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locomotion correlates with a shift from CP-AMPAR to CI-AMPAR expression and that Foxp2 
is involved in striatal synaptic maturation and early coordinated locomotion by regulating 
AMPAR subtype expression.
RESULTS
Rectification index measures relative abundance of CP- and CI-AMPARs
AMPAR subunit composition shifts between immature and mature excitatory 
synapses. Immature synapses mostly contain CP-AMPARs, which are homomeric 
receptors comprised exclusively of the GluA1 subunit (Figure 1A-B) (Chan et al., 
2003; Henley and Wilkinson, 2016). During development, these CP-AMPARs are 
replaced by CI-AMPARs which consist of heteromers of GluA1 and GluA2 (Figure 1a-b).
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Figure 1: schematic overview of AMPAR development and GluA subunit properties. 
(a) Overview of the differences between CP and CI-AMPARs. CP-AMPARS consist of homomeric GluA1 subunits are 
permeable to both sodium and calcium. CI-AMPARs include GluA1 and GluA2 subunits and are only permeable to 
calcium. (b) AMPA receptor expression in striatal excitatory postsynapses during different stages of development. 
Low abundance of CI-AMPAR expression and a high expression of CP-AMPARs early in development. During 
development, relatively more CI-AMPARs are expressed. Later in development and in adulthood most AMPARs are 
CI CI-AMPARs. (c) Inward rectification at positive membrane potentials during development. Early in development 
there is a strong inward rectification at positive membrane potentials (top). This inward rectification reduces (middle) 
during development and is no longer present during adulthood (bottom).
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The ratio between CP- and CI-AMPARs can be calculated by the rectification index (RI). 
Rectification leads to a reduced response at positive membrane potentials (Figure 1c and 
methods). CP-AMPARs are responsible for this inward rectification at positive membrane 
voltages, as these are sensitive to polyamine block at positive membrane potentials, the 
method commonly used to investigate AMPAR composition (Bowie and Mayer, 1995; Donevan 
and Rogawski, 1995). By contrast, CI-AMPARS do not show inward rectification, instead they 
display similar responses to stimulation at negative and positive membrane potentials. 
Therefore, a RI larger than 1.0 indicates more synaptic CP-AMPARs, whilst a synapse which 
almost exclusively harbors CI-AMPARs has a RI of approximately 1.0 (Bellone et al., 2011). 
AMPAR maturation is delayed in D1R-MSNs of Foxp2S321X/+ mice
We investigated how temporally constrained the shift in GluA subunit expression is in the 
striatum and if disruptions in Foxp2 might affect AMPAR maturation. Foxp2 is predominantly 
expressed in the striatal cell population which expresses the Dopamine type 1 receptor (D1R-
MSNs) (van Rhijn et al., 2018; Vernes et al., 2011). In juvenile Foxp2+/+ mice of postnatal 
day (PND) 7-9, immature RI is visible. However, already by PND 11-13 mature RI values of 
approximately 1.0 are measured in D1R-MSNs of Foxp2+/+ mice. RI remains stable further 
during development, and in early adulthood (Figure 2a). By contrast, Foxp2S321X/+ mice show a 
delay in the shift from CP-AMPAR to CI-AMPAR expression. RI values are equally high in PND 
7-9 Foxp2+/+ and Foxp2S321X/+ mice. However, at PND 11-13, the RI remains significantly higher 
in Foxp2S321X/+ mice compared to wild-type littermates (Figure 2b compared to d). Despite the 
delay in AMPAR maturation, the RI in Foxp2S321X/+ mice is comparable to the RI in wild-type mice 
by PND15 and values remain similar into adulthood. In comparison to the RI developmental 
profile shown by D1R-MSNs from Foxp2+/+ mice, D1R-MSNs from Foxp2S321X/+ show a much 
more gradual change in RI (Figure 2e). Whilst RI is significantly decreased between PND 7-9 
and PND 11-13 in D1R-MSNs from Foxp2+/+ mice, this decrease is only significant in Foxp2S321X/+ 
mice when comparing PND 7-9 and PND 15-16. 
To further corroborate our data, we used the CP-AMPAR selective antagonist 1-Naphthyl acetyl 
spermine trihydrochloride (NASPM) to extracellularly block CP-AMPARs (Figure 3a). At PND 11-
13 D1R-MSNs from Foxp2+/+ mice show a RI of 1.0, which suggests CP-AMPARs are absent, whilst 
the increased RI of D1R-MSNs from Foxp2S321X/+ suggests CP-AMPARs still remain at the synapse. 
Blockade of CP-AMPARs should therefore not affect the response to stimulation in D1R-MSNs 
of Foxp2+/+ mice, whilst it would reduce stimulus-response in Foxp2S321X/+ mice. We bath applied 
NASPM to striatal slices of PND 11-13 mice and measured stimulus evoked response before, 
during and after NASPM application. Stimulus response was not reduced in D1R-MSNs of 
Foxp2+/+ mice, but a reduction in response strength of 35% was seen in D1R-MSNs of Foxp2S321X/+ 
mice during NASPM application (Figure 3b, c). This further indicates CP-AMPARs are still present 
to a high degree in D1R- MSNs of Foxp2S321X/+ mice, in contrast to Foxp2+/+ mice in which CP-
AMPARs have been exchanged for CI-AMPARs by PND 11. 
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Figure 2: AMPA receptor maturation is delayed in D1R-MSNs of Foxp2S321X/+ mice. 
(a) Representative traces of response to stimulation at -60, 0 and +40 mV during development in Foxp2+/+ mice. 
(b) Rectification index: RI 
 
/ 1.5 of D1R-MSNs of juvenile Foxp2+/+ mice during development. (c), 
same as (a) but for Foxp2S321X/+ mice. (d) same as (b) but for Foxp2S321X/+ mice. scale bar in (a,c) 60ms/20pA Average 
RI values during development between genotypes: (Foxp2+/+ / Foxp2S321X/+ PND7-9 RI=1.18±0.07 / 1.13±0.06, NS, 11-
13 RI=0.97±0.03 / 1.09±0.04, P<0.05, 15-16 RI=0.98±0.05 / 1.01±0.03 NS, 21-23 RI=0.91±0.05 / 1.03±0.04 NS). (e) 
Average RI during development in D1R-MSNs of Foxp2+/+ and Foxp2S321X/+ mice. (Compare Foxp2+/+ PND7-9 and PND 
11-13: 1.18±0.07 / 0.97±0.03, P<0.05. Compare Foxp2S321X/+ PND 7-9 and. PND 15-16: 1.13±0.06 / 1.01±0.03, P<0.05. 
all other comparisons between ages are NS) * = P<0.05. Statistical analysis of data in (e) by multiple ANOVA. 
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Regulation of CP-AMPAR expression is impaired in Foxp2S321X/+ mice
As maturation of AMPAR expression is an active process which requires molecularly 
regulated AMPAR trafficking at the synapse, we next investigated the molecular 
mechanisms related to AMPAR trafficking that could be affected by heterozygous loss 
of Foxp2 function. One of the described mechanisms by which AMPARs are cycled at the 
synapse is through metabotropic glutamate receptor (mGluR) mediated endocytosis 
(Kelly et al., 2009; Sung et al., 2001; Zhang et al., 2008). In the dorsolateral striatum, this 
is governed through mGluR1, activation of which has modulatory effects on AMPAR 
expression depending on the brain region (Luscher and Huber, 2010; Wolf and Tseng, 2012). 
Commonly, mGluR1 activation induces LTD through a change in the CI:CP AMPAR ratio. 
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Figure 3: AMPAR block by NASPM in D1R-MSNs of Foxp2S321X/+ mice. 
(a) Schematic overview of molecular mechanisms investigated in Figures 3 and 4. NASPM specifically blocks GluA1 
receptors extracellularly, which impairs CP-AMPAR function. RO67-7476 is an mGluR1 specific agonist. mGluR1 
activation leads to increased endocytosis of GluA2 containing AMPA receptors in striatal medium spiny neurons (see 
figure 4). (b,c) Bath application of NASPM reduces response to stimulation in D1R-MSNs of Foxp2S321X/+ whereas it has 
no effect on D1R-MSNs of Foxp2+/+ mice (average response during NASPM bath application Foxp2+/+ = 0.95±0.04, N/
n=3/8, Foxp2S321X/+ NASPM = 0.52±0.08, N/n = 3/5, P<0.01. Normalized to baseline before NASPM application). N/n = 
mice/cells. ** = P<0.01 Statistical comparison by nonparametric Mann-Whitney U test. 
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Figure 4: mGluR1 mediated endocytosis of AMPARs is impaired in D1R-MSNs of Foxp2S321X/+ mice 
Endocytosis of CI-AMPARs leads to a relative increase in expression of CP-AMPARs, which results in an increase of the 
rectification index to values >1.0. (a) Representative traces of response to stimulation at -60mV, 0mV and +40mV in 
sham (DMSO) and RO67-7476 bath application, scale bar 20ms/20pA. (b) Application of the mGluR1 agonist RO67-
7476 leads to endocytosis of CI-AMPARs in D1R-MSNs of Foxp2+/+ mice, but has no effect on D1R-MSNs of Foxp2S321X/+ 
mice (rectification index Foxp2+/+ DMSO compared to RO67-7476: 1.072± 0.08 vs. 1.225±0.214, Foxp2S321X/+ DMSO 
compared to RO67-7476: 1.153± 0.05 vs 1.104±0.06). (c) LTD cannot be induced in D1R-MSNs of Foxp2S321X/+ mice. 
(c) Example trace of the response to stimulation before (dark line) and after (light line) LTD induction. (d). Average 
normalized response to stimulation (averaged to baseline before LTD) is reduced in D1R-MSNs Foxp2+/+ mice after 
theta burst stimulation, whilst there is no different in response strength in D1R-MSNs from Foxp2S321X/+ mice. (Foxp2+/+ 
baseline 0.89±0.07, LTD 0.52±0.09, P<0.05. Foxp2S321X/+ baseline 0.84±0.04, LTD 0.73±0.07, NS) * = P<0.05, Student’s 
T-test
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For example, in the ventral tegmental area (VTA), mGluR1 activation leads to endocytosis 
of CP-AMPARs and insertion of CI-AMPARs (Bellone et al., 2011). As CI-AMPARs are less 
conductive compared to CP-AMPARs, this results in LTD. However, in the dorsal striatum the 
effect of mGluR1 activation on CI:CP AMPAR ratios is unclear. It is suggested that mGluR1 
agonist application in dorsal striatum induces endocytosis of CI-AMPARs (Figure 3a) (Ahn and 
Choe, 2010), in contrast to CP-AMPAR endocytosis in the VTA. We first investigated if mGluR1 
activation in dorsal striatum indeed leads to changes in the CI:CP-AMPAR ratio, by measuring 
the effect of the synthetic agonist RO67-7476 on RI.
Our results show that bath application of RO67-7476 leads to an increase in RI in D1R-MSNs 
of wild-type mice (Figure 4a). The increase in RI upon mGluR1 activation suggests a relative 
increase in the abundance of CP-AMPARs at striatal excitatory synapses. This could be either 
through insertion of CP-AMPARS, endocytosis of CI-AMPARs, or an exchange of CI-AMPARs 
for CP-AMPARs. However, in Foxp2S321X/+ mice this increase in RI was absent, which suggests 
that mGluR1 mediated AMPAR trafficking is impaired or occluded in these mice (Figure 
4b). Impairments in AMPAR trafficking could mean that both endocytosis and/or insertion 
of AMPARs are impaired. However, occlusion would mean that mGluR1 activation normally 
leads to insertion of additional CP-AMPARs at the synapse, which in the case of the already 
high CP-AMPAR expression in Foxp2S321X/+ mice would not additionally increase RI.
As CP-AMPARs are more conductive compared to CI-AMPARs, an exchange of CI-AMPARs 
for CP-AMPARs at the synapse would result in long term potentiation (LTP). This is the 
inverse of how LTD in the VTA is induced through an exchange of CP-AMPARs for CI-AMPARS. 
Alternatively, it is possible that mGluR1 activation in dorsal striatum exclusively leads to CI-
AMPAR endocytosis but does not increase CP-AMPAR expression. This process results in LTD, 
as overall AMPAR expression would be reduced. We therefore activated mGluR1 through high-
frequency stimulation (Atwood et al., 2014; Calabresi et al., 1992; Calabresi et al., 1994; Groszer 
et al., 2008) and measured if this leads to LTD induction in dorsal striatum. We were able to 
induce LTD in D1R-MSNs from Foxp2+/+ mice, which suggests activation of mGlur1 leads to 
endocytosis of CI-AMPARs, without a concomitant increase in CP-AMPARs (Figure 4c, d). Next, 
we assessed if LTD could still be induced in D1R-MSN of Foxp2S321X/+ mice. Though it is known 
that the R553H DNA-binding mutation of Foxp2 affects striatal LTD in mice (Groszer et al., 2008), 
the mechanism which is affected and leads to the absence of LTD is unknown. Application of 
LTD stimuli to the striatum of Foxp2S321X/+ mice failed to initiate LTD (Figure 4d) in D1R-MSNs of 
these mice. Additionally, the lack of an increase in RI following chemical mGluR1 activation in 
Foxp2S321X/+ mice suggests the CI:CP-AMPAR ratio cannot be altered in these mice by mGluR1 
activity. This could be due to impaired CI-AMPAR endocytosis. Alternatively, it is also possible CI-
AMPAR expression is already reduced at the synapse, as it has been shown AMPAR expression 
in general is reduced in Foxp2+/- mice. This way, an effect of further reduction of CI-AMPAR might 
be occluded.
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The emergence of coordinated locomotion is delayed in Foxp2S321X/+ mice
The emergence of coordinated movement occurs during the second postnatal week. 
During this timeframe, mice go from uncoordinated limb movement to coordinated walking 
(Dehorter et al., 2011; Heyser, 2004). We have shown here that in wild-type mice AMPAR 
subunit expression undergoes changes between PND 9 and PND 11, resulting in mature CI-
AMPAR expression. Therefore, we explored if this change in AMPAR expression might be 
correlated to behavioral changes in coordinated locomotion during the second postnatal 
week. This correlation would be suggestive of a specific critical period during striatal 
development related to motor behavior. Additionally, the delay in AMPAR subunit maturation 
we measured in Foxp2S321X/+ mice suggests these mice could be delayed in the development 
of coordinated locomotion.
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Figure 5: Hanging bar and negative geotaxis test performance is impaired in Foxp2S321X/+‑ mice 
(a) Schematic representation of the hanging bar setup. Beginning situation (left) and scoring paradigm (right). (c) 
Schematic representation of the negative geotaxis task. Beginning situation (left), and end situation (rig ht) are 
shown. The time it takes for the animal to complete the 180-degree turn is recorded. (b) latency to fall in seconds 
for the hanging bar test in Foxp2+/+ or Foxp2S321X/+ mice during the second postnatal week. (Foxp2+/+ PND8, 9, 10, 
13 (4.2±1.7, 3.1±1.1, 5.2±0.74, 19.1±2.1) Foxp2S321X/+ (4.7±1.3, 1.84±1.1, 5.2±0.74, 6.2±2.0) P<0.001 for PND13 (d) 
Time to turn in seconds for the negative geotaxis experiments in Foxp2+/+ and Foxp2S321X/+ mice during the second 
postnatal week. (Foxp2+/+ PND8, 9, 10, 13 (12.5±3.7, 5.6±1.0, 6.6±1.7, 3.4±0.1) Foxp2S321X/+ (18.3±3.3, 6.2±1.6, 
7.3±1.1, 3.8±0.6)). *** = P<0.001, 2-Way ANOVA with genotype and postnatal day as factors.
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In order to assess coordinated locomotion development, juvenile Foxp2+/+ and Foxp2S321X/+ 
mice (PND 8-13) were subjected to a hanging bar test and negative geotaxis test. The hanging 
bar tests measures grip strength and coordinated locomotion (Figure 5a). Grip strength is a 
measure for skeletal muscle function and indicated not to be affected by Foxp2 mutation 
(Enard et al., 2009). However, the ability for the mouse to use its hindlimbs to maintain 
position results in a better performance on this hanging bar test and this ability develops 
quickly during the second postnatal week (Aartsma-Rus and van Putten, 2014). The negative 
geotaxis test measures the ability for an animal to orient itself from an inverted (head 
down) position to a normal position when placed on an inclined surface (Figure 5b). This is 
especially difficult for very young animals but does not require a high degree of coordinated 
locomotion, which makes this test an ideal control for general motor impairment between 
Foxp2+/+ and Foxp2S321X/+ mice. Additionally, these tasks do not require any learning and are as 
such suited to investigate coordinated motor behavior at very young ages. At PND 8, Foxp2+/+ 
and Foxp2S321X/+ mice are unable to hold on to the hanging bar. Intriguingly, between PND 10 
and PND 13 Foxp2+/+ mice drastically increase their performance on the hanging bar test, 
whilst Foxp2S321X/+ mice remain low in their performance (Figure 5c). Furthermore, we did 
not observe any differences in performance between Foxp2+/+ and Foxp2S321X/+ mice on the 
negative geotaxis test. Both genotypes increased performance between PND 8 and PND 9 
already, with no further reduction in time to turn between PND 9 and PND 13 (Figure 5d). 
This suggests that loss of Foxp2 expression affects the performance of juvenile mice on a 
specific set of tasks, which require coordinated locomotion. Together our data indicate that 
AMPAR maturation in the striatum and coordinated locomotion may be causally related.
DISCUSSION
Synaptic AMPAR composition changes drastically during development and mature AMPAR 
composition is essential for mature brain activity (Henley and Wilkinson, 2016). In the 
striatum, CP-AMPARs are predominantly expressed during early development, whilst CI-
AMPARs show high expression in adult striatum (Bassani et al., 2013). However, the exact 
time-course by which these changes occur in the dorsal striatum is currently unclear. Here we 
show that AMPAR subunit composition at striatal D1R-MSNs changes quickly during juvenile 
development. However, this change is delayed and more gradual in D1R-MSNs of Foxp2S321X/+ 
mice. Aberrant AMPAR trafficking at the synapse seems to underlie the impaired AMPAR 
maturation, as mGluR1 mediated receptor trafficking is absent in D1R-MSNs of Foxp2S321X/+ 
mice. Furthermore, the change in AMPAR subunit expression is correlated with a critical 
period for the initiation of coordinated locomotion. The performance of wild-type mice on 
the hanging bar test increases during the same developmental time window in which a shift 
from CP-AMPAR expression to CI-AMPAR expression occurs. As Foxp2S321X/+ mice are impaired 
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at the hanging bar test compared to wildtype mice at PND 13, the delayed AMPAR subunit 
composition switch during development might be associated with decreased coordinated 
locomotion.
Foxp2 has been shown to regulate molecular mechanisms involved in neurogenesis, neuronal 
development and network maturation (Vernes et al., 2011). For example, the expression of 
MEF2C (Chen et al., 2016) and SRPX2 (Roll et al., 2010) is affected by Foxp2: aberrant Foxp2 
expression results in dysregulation of MEF2C and SRPX2, which affects synapse formation 
and development of cortical and striatal networks (Harrington et al., 2016; Sia et al., 2013). 
Though it is not known if Foxp2 is able to directly regulate AMPAR expression, intermediate 
targets can help understand how Foxp2 affects excitatory activity. The transient delay in 
AMPAR maturation could be due to other intermediate targets which are regulated by Foxp2 
and affect AMPAR maturation, such as PICK1 (Xu et al., 2014). 
Furthermore, a core regarding synaptic maturation during critical periods is the 
interdependence of maturation of neuronal processes and behavioral input. For example, 
the start of critical periods for synapse maturation in sensory cortices coincides with 
developmental milestones such as eye or ear opening (Hooks and Chen, 2007; Polley et 
al., 2013). It is therefore thought the initial reception of input by the auditory and visual 
sensory cortices is the main catalyst for the initiation of a critical period in development and 
synaptic maturation. However, the striatum does not directly receive sensory information. 
It has been shown that pharmacological blockade of striatal activity during, but not before 
or after, a critical period in adolescence leads to impaired performance on a motor task 
(Soiza-Reilly and Azcurra, 2009). Additionally, striatal NMDA receptor maturation has been 
shown to coincide with the initiation of coordinated locomotion as well, and the striatum 
shows a sudden development of mature activity during the start of coordinated locomotion 
(Dehorter et al., 2011). This suggests motor input to the striatum might be a catalyst for 
striatal development, similar to how sensory input signifies sensory cortex critical periods. 
However, it is not known if initial motor input to the striatum is delayed in Foxp2S321X/+ mice. 
Nonetheless, the delay of coordinated locomotion initiation in Foxp2S321X/+ mice could preface 
the slower AMPAR maturation.
Though mature AMPAR composition is described in detail in many brain regions, the relative 
expression of CP-AMPARs and CI-AMPARs is highly brain region dependent (for review see: 
(Henley and Wilkinson, 2016; Traynelis et al., 2010)). In areas such as the ventral tegmental 
area, hippocampus, and cortex, CI-AMPAR expression is high in mature synapses (Bellone 
et al., 2011; Ho et al., 2007; Liu and Cull-Candy, 2000; Murphy et al., 2012), whilst the high 
CP-AMPAR expression in cerebellar spiny stellate cells of adult mice is a notable exception 
(Liu and Cull-Candy, 2000). Furthermore, dynamic trafficking of AMPARs at the synapse is 
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essential for the induction of synaptic plasticity (Bassani et al., 2013; Diering et al., 2014; 
Esteban et al., 2003; Man, 2011), and dysregulated AMPAR subtype expression or AMPAR 
subunit trafficking is implicated in cognitive disorders, such as schizophrenia and addictive 
behavior (Bariselli et al., 2016; Bellone et al., 2011). 
The hanging bar and negative geotaxis are both common behavioral paradigms to assess the 
development of motor circuitry in rodents during early postnatal life and juvenile development 
(Aartsma-Rus and van Putten, 2014; Heyser, 2004; Wells et al., 2016). In adult life however, 
basic motor function of Foxp2S321X/+ is normal, but they show impaired motor skill learning 
function as adults by reduced performance on the accelerating rotarod (van Rhijn et al., 
2018). Though we show that impaired AMPAR maturation in D1R-MSNs of Foxp2S321X/+ mice 
is transient, it is known that AMPAR expression is reduced in adult mice with a heterozygous 
Foxp2 knockout mutation (Chen et al., 2016). This suggests impaired AMPAR trafficking is 
a persistent phenotype, which impacts both AMPAR maturation during development and 
AMPAR expression in adulthood. Intriguingly, both juvenile and adult mice with heterozygous 
Foxp2 mutations display aberrant excitatory activity in the striatum, with reduced miniature 
excitatory postsynaptic current (mEPSC) amplitude and absence of striatal LTD (French 
et al., 2012; van Rhijn et al., 2018). It could very well be that the transient impairment in 
AMPAR maturation and the persistent deficit in AMPAR trafficking affect unique aspects of 
coordinated locomotion.
In addition to these deficits in AMPAR expression and excitatory activity, increased presynaptic 
inhibitory drive has been observed in D1R-MSNs of juvenile and adult Foxp2S321X/+ mice (van 
Rhijn et al. 2018). Furthermore, intervention by blockade of inhibitory activity with picrotoxin 
in adult mice improves motor skill learning performance in Foxp2S321X/+ mice. This suggests 
the delayed start of coordinated locomotion and the motor skill learning deficits in adult 
mice could alternatively be governed by separate neurobiological mechanisms, both affected 
by changes in Foxp2 expression. Designer receptors exclusively activated by designer drugs 
(DREADDS) could be used to spatiotemporally up- or downregulate excitatory or inhibitory 
activity in D1R-MSNs in vivo in both control and Foxp2S321X/+ mice. This way, we would be able 
to investigate if manipulation of only excitatory or inhibitory activity could explain the motor 
phenotypes observed in mice with heterozygous Foxp2 mutations. 
Another way by which AMPAR trafficking is disrupted is through dysregulation of dopamine 
mediated activity, for example by exposure to drugs of abuse such as cocaine. Exposure to 
cocaine increases CP-AMPAR expression through interaction of the AMPAR subunit GluA2 
with the protein PICK1 in the ventral tegmental area (Fiuza et al., 2017). This increase in 
CP-AMPAR expression is thought to affect motivation and goal directed behavior (Bariselli 
et al., 2016; Bellone and Luscher, 2006). Activation of mGluR1 in the VTA leads to insertion 
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of CI-AMPARs and a decrease in rectification. As such balanced activity of PICK1 interaction 
and mGluR1 activation is thought to be essential for glutamatergic synaptic function in the 
VTA (He et al., 2009; Wolf and Tseng, 2012). In contrast to the function of mGluR1 in the VTA, 
mGluR1 activity leads to GluA2 endocytosis rat dorsal striatum (Ahn and Choe, 2010). We 
show here that application of the mGluR1 agonist RO67-7476 leads to increased rectification 
in mouse D1R-MSNs in dorsal striatum, possibly through endocytosis of CI-AMPARs. This 
suggests that like rat dorsal striatum, the function of mGluR1 might be reversed between the 
VTA and the dorsal striatum in mice.
To conclude, we show here that heterozygous loss of Foxp2 function leads to delayed 
maturation of Rs and that this delay might be correlate to early developmental deficits in 
motor coordination This would suggest an early phenotype related to disruptions in FOXP2 
function could be present in human individuals but is transient and disappears early in 
postnatal development. Additionally, our data suggests that symptoms displayed early in 
life in neurodevelopmental disorders could be established through different neurobiological 
mechanisms than the adult phenotype. Which aspects of neurobiology are transiently 
or persistently affected by Foxp2 is an exciting new direction for research focused on the 
molecular mechanisms behind Foxp2 function.
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MATERIALS & METHODS 
Mice
The experimental procedures were approved by the Animal Ethics Committee of the Radboud 
University Nijmegen, under DEC application number 2014-098 (Nijmegen, the Netherlands) 
and conducted in accordance with the Dutch legislation. Every effort was made to minimize 
animal discomfort and the number of animals used.
The Foxp2-S321X line was maintained on a C57BL/6J background, heterozygotes and wildtype 
littermates between PND7 and PND23 were used for electrophysiological recordings and 
mice between PND8 and 13 were used for behavioral experiments. The generation, marker-
assisted backcrossing and genotyping of this strain are fully described in (Coghill et al., 2002; 
Groszer et al., 2008; Keays et al., 2006). BACtrap mice carrying GFP under the D1R promoter 
(D1R-GFP) were originally generated by the GENSAT (Gene Expression Nervous System Atlas) 
(Gong et al., 2003) and backcrossed to C57BL6/J mice. Both male and female mice were 
used in all experiments, and care was taken to use equal numbers of male/female mice for 
behavioral experiments.
Brain slices
Experiments were conducted on 350µm thick coronal slices. Mice (PND 11-21) were 
sacrificed by decapitation following isoflurane anesthesia. Slices were cut using a vibratome 
(HM650V Thermo Scientific) in cooled (4°C) artificial cerebrospinal fluid containing (in mM): 
87 NaCl, 11 Glucose, 75 Sucrose, 2.5 KCl, 1.25 NaH 2PO4, 0.5 CaCl2, 7 MgCl2, 26 NaHCO3), 
continuously oxygenated with 95%O2/5%CO2. Collection of slices started when the striatum 
became visible and slices were collected until the hippocampus was visible. After collection, 
slices were incubated at 32°C in oxygenated ACSF for at least 1h before recording. Slices were 
transferred to the recording setup 10 minutes prior to recording and incubated in recording 
ACSF containing (in mM): 124 NaCl, 3 KCl, 1.25 NaH 2PO4, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 10 
Glucose, continuously oxygenated and heated to 32°C. Patch pipettes (3.5 – 5.5 MΩ) were 
made from borosilicate glass capillaries and filled with intracellular solution containing: 115 
CsMeSO3; 10 CsCl; 10 HEPES; 2.5 MgCl2; 4 Na2ATP; 0.4 NaGTP; 10 Na-Phosphocreatine; 0.6 
EGTA, 10 QX-314. Activity was recorded using a Digidata 1440A digitizer and a Multiclamp 
700B amplifier (Molecular Devices). Sampling rate was set at 20KHz and a lowpass 1KHz filter 
was used during recording. All recordings were conducted in the dorsolateral quadrant of the 
striatum.
Rectification index
In order to calculate rectification index, AMPA receptor mediated responses to stimulus 
evoked neurotransmitter release are measured at different membrane holding potentials 
in the presence of 0.1mM spermine (Tocris bioscience, UK) in the patch pipette. Spermine 
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blocks CP-AMPARs at positive membrane potentials, without having an effect on the 
conductivity of CI-AMPARs. Response to stimulation at -60, 0 and +40mV was measured, and 
rectification index was calculated as follows:  RI  / 1.5 The 0mV response was 
used to correct stimulation artefacts of the AMPAR stimulation. The same recording ACSF was 
used as described above, and picrotoxin (100uM, Tocris bioscience) and APV (100µM, Tocris 
bioscience) were added to block GABA and NMDA mediated currents, respectively.
Extracellular CP-AMPAR block
1mM 1-Naphthyl acetyl spermine trihydrochloride (NASPM, Tocris bioscience) was added to 
the recording ACSF during stimulus response recording to block CP-AMPARs extracellularly. 
Stimulus response was normalized to the first 10 minutes of the recording, after which wash-
in was started and NASPM was left in the recording ACSF for the further duration of the 
recording.
mGluR mediated AMPAR endocytosis
We first measured rectification index as described previously. Subsequently, 6µM of the 
mGluR1 specific agonist RO67-7476 (Tocris bioscience) was applied to the recording ACSF for 
30 minutes, and rectification index was measured again in D1R-MSNs of the same brain slice 
as the baseline measurement. ACSF was exchanged for fresh ACSF between brain slices and 
only one experiment was conducted per brain slice.
LTD induction
LTD induction experiments were conducted by stimulation of afferent corticostriatal and 
intrastriatal axons using a bipolar concentric stimulus electrode (FHC, Bowdoin, Maine) placed 
in the dorsolateral striatum. Baseline evoked responses were established for 15 minutes prior 
to LTD induction, and average baseline response was set to 200 pA. LTD was induced by 
applying 4 theta burst stimulations of 1 second at 100Hz frequency, with a 10 second inter 
burst interval. LTD was recorded for at least 20 minutes after induction. Cells with a series 
resistance of >25MΩ after recording were discarded.
Hanging bar
Foxp2+/+ and Foxp2S321X/+ mice were tested at different timepoints (Postnatal day 8, 9, 10, 13, 
17, adult) for hanging bar performance. The hanging bar was designed as shown in Figure 4A. 
In short, a H profile with a wire placed between two vertically set bars was used to suspend 
the mice by their forelimbs. Immediately when the mouse was placed, a stopwatch was 
started and the time until either the mouse dropped from the wire or manages to reach one 
of the sides of the H profile was recorded. If a mouse manages to reach the side of the H 
profile, time was recorded as 100 seconds, which was the maximum hanging time recorded if 
mice were unable to fully complete the task. Lower times indicate worse performance.
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Negative geotaxis
Mice from the same age groups as used for the hanging bar test were also subjected to 
negative geotaxis. For the experiment, animals were placed facing downward on a ramp 
covered with a cloth mesh surface which was set at a fixed 45° angle. The time for the mice to 
turn 180 degrees (from facing downward to facing completely upward with the entire body) 
was scored. Mice which rolled down during turning were scored as failures and their time to 
task completion was set as 1 second higher than the highest value for the respective group. 
Statistics
Comparisons between two groups were made with the Student’s T-test. Comparisons 
between multiple groups were conducted with repeated measures ANOVA. Normality was 
confirmed before analysis. Statistical analysis was conducted in Graphpad PRISM 7.04 (La 
Jolla, CA, USA). All experiments were conducted in at 3 mice for each genotype, with at least 
2 cells per mouse for each electrophysiological measurement
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ABSTRACT
Heterozygous mutations of FOXP2 lead to childhood apraxia of speech (CAS) in humans and 
motor skill learning impairments in mice. Examples of mutations which disrupt FOXP2 function 
include missense mutations which affect the DNA-binding domain and nonsense mutations 
leading to premature stop-codons and protein truncation. Cell and animal models have 
been used to investigate how FoxP2 affects cellular function. Two of the most well-studied 
etiological FOXP2 mutations that have been implicated in CAS are a missense mutation in 
the DNA-binding domain found in a large multigenerational pedigree (R553H mutation, the 
KE family), and a nonsense mutation observed in a smaller family (R328X mutation). Mouse 
models carrying these mutations (Foxp2-R552H matching the FOXP2-R553H mutation, and 
Foxp2-S321X as a close analogue of the FOXP2-R328X mutation) have been characterized at 
molecular, physiological and behavioral levels. However, direct comparison of these mutations 
has been limited to genetic and behavioral experiments, where overlap in phenotypes has 
been observed (Estruch et al., 2016; Gaub et al., 2016; Gaub et al., 2010; Vernes et al., 2006). 
By contrast, the neurobiological mechanisms affected by these mutations have only been 
investigated separately using different methods. We previously found that heterozygous 
S321X mutation of Foxp2 leads to decreased excitatory and increased inhibitory activity in 
dopamine type-1 receptor containing medium spiny neurons (D1R-MSNs) in the striatum. To 
investigate if the R552H DNA-binding mutation of Foxp2 similarly affects striatal D1R-MSNs, 
we assessed striatal excitatory and inhibitory activity in heterozygous R552H mice. Our data 
show that the R552H mutation, in contrast to the S321X mutation, does not affect excitatory 
activity. Furthermore, the R552H mutation leads to a reduction of inhibitory (GABA receptor-
mediated) activity in striatal MSNs. Lastly, in vivo blockade of GABAergic activity aggravates 
the motor skill learning difficulties present in heterozygous R552H mice, whilst the same 
treatment leads to improved motor performance in S321X mice. Taken together, our data 
suggest that physiological consequences of Foxp2 dysfunction may be mutation specific. 
Detailed understanding of how unique mutations in FoxP2 affect striatal function is therefore 
necessary for possible therapeutic interventions.
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INTRODUCTION
The development of striatal circuits and striatal neuronal activity are commonly affected in 
neurodevelopmental or neurogenerative disorders which affect motor control (for review, 
see (Robinson and Gradinaru, 2018)). The striatum is part of the cortico-striato-thalamic 
motor circuit, which is essential for complex motor sequencing (for review, see(Shepherd, 
2013)). Within the striatum, two main populations of GABAergic cells can be distinguished, 
which differ in their projection sites and as such regulate separate aspects of motor control 
(Calabresi et al., 2014; Surmeier et al., 2007). These are medium spiny neurons which either 
express the dopamine receptor type 1 (D1R-MSNs) or type 2 (D2R-MSNs) (Gittis and Kreitzer, 
2012). D1R-MSNs innervate the striatal direct pathway, which projects to the substantia nigra 
(SNr), such that activation leads to upregulation of cortico-striato-thalamic circuit activity. 
By contrast, D2R-MSNs project through the indirect pathway, via the globus pallidus and 
subthalamic nucleus, to the SNr and thereby inhibit SNr activity (Kravitz et al., 2010; Kravitz 
and Kreitzer, 2012). Complex motor disorders generally show one or both cortico-striato-
thalamic pathways to be affected, and behavioral phenotypes can often be correlated with 
specific circuit dysfunction (Bariselli et al., 2016; Rothwell et al., 2014).
Investigation of monogenic disorders which present with impairments in complex motor 
sequencing is an invaluable tool to further understand how the striatum governs motor 
learning. One monogenic disorder with prevalent changes in striatal function is heterozygous 
mutation of the transcription factor Forkhead box protein 2 (FOXP2) (Lai et al., 2001), 
which leads to Childhood apraxia of speech (CAS). CAS involves problems with mastering 
the complex coordinated sequences of orofacial and mouth movements that are crucial for 
proficient speech ((Lai et al., 2003; MacDermot et al., 2005), for review see (Morgan et al., 
2017)). Multiple mutations have been described for FOXP2 such as missense and nonsense 
mutations, as well as frameshifts, translocations and deletions (Morgan et al., 2017). 
Several missense mutations in FOXP2 have been found affecting different residues of the 
DNA binding domain (Laffin et al., 2012; Lai et al., 2001; Reuter et al., 2017). The first of 
these DNA-binding domain disruptions was originally described cosegregating with CAS in 
all fifteen affected members of the three-generation KE family (Lai et al., 2001). In affected 
family members, the R553H mutation leads to disrupted function of the forkhead domain, 
including aberrant cellular localization and absence of DNA binding ability, which disrupts 
transcription factor function (Vernes et al., 2006). The first nonsense mutation of FOXP2 was 
subsequently described in a smaller family in which the proband, his affected sister and the 
mother are all affected by CAS (MacDermot et al., 2005). In this family, the mutation yields 
a stop codon in exon 7 (R328X) that is predicted to lead to protein truncation before the 
Forkhead domain (Figure 1). Nonsense mediated decay and absence of protein expression in 
case of homozygous mutation have been shown in a mouse model carrying an S321X variant, 
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which is similar to this mutation (Groszer et al., 2008). Different FOXP2 mutations have been 
described since then, which lead to similar disruptions of FOXP2 function (Estruch et al., 
2016; Morgan et al., 2017). Initial comparison of brain morphology and activity using (f)MRI 
between affected KE family members, unaffected siblings and unrelated controls has revealed 
reductions in striatal grey matter density (Watkins et al., 2002) and reduced striatal activation 
during a language task (Liegeois et al., 2003) in affected individuals. These changes in brain 
morphology and activity prompted further investigation of FoxP2 function in animal models.
Q-rich domain
Leucine 
zipper
Zinc 
finger
Forkhead 
domain
Foxp2-wildtype
Foxp2-R552H
Foxp2-S321X
Figure 1: schematic representation of important Foxp2 domains and the R552H and S321X mutation. 
The R552H mutation falls within the DNA binding domain, and yields a protein with absent transcriptional ability. The 
S321X mutation results in truncation of the protein and nonsense mediated decay. Foxp2-S321X is not detectable on 
western blot analysis (Groszer et al., 2008)
Animal model systems ranging from Drosophila, to mice and songbirds, have been used to 
study behavioral and cellular effects of disrupted function for FoxP2 orthologs (here we use 
the unified nomenclature for Forkhead-box proteins by (Kaestner et al., 2000)). Behavioral 
phenotypes in animal models suggest that complex motor sequencing is impaired. For 
example, song production in zebra finch (Haesler et al., 2007) is impaired when FoxP2 
expression is reduced, and mouse models carrying heterozygous missense or nonsense 
mutations show impaired motor skill learning (French et al., 2012; Groszer et al., 2008; van 
Rhijn et al., 2018). These effects on complex motor behaviors suggest that Foxp2 is involved 
in the regulation of activity within the cortico-striatal-thalamic motor circuit. Evidence from 
in vitro and in vivo investigations does show that heterozygous Foxp2 mutation leads to 
aberrant striatal plasticity and activity in mouse (French et al., 2012; Groszer et al., 2008) and 
aberrant signal transmission in songbirds (Murugan et al., 2013). The same neuronal circuits 
are thought to be important for both these complex motor behaviors in animals, and spoken 
language production in humans (Nudel and Newbury, 2013). 
As Foxp2 is a transcription factor, disruption of its function can have widespread consequences 
for neurodevelopment, morphology and neuronal function. Firstly, primary striatal culture of 
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mice homozygous for the R552H mutation (a change that is directly equivalent to the R553H 
mutation in human FOXP2) has shown that this mutation impairs neuronal development 
(Vernes et al., 2011). Additionally, assessment of synapse development and synapse 
morphology in striatal tissue of mice with both heterozygous and homozygous knockout of 
Foxp2 has shown that synapse maturation is impaired (Chen et al., 2016). Furthermore, short 
hairpin RNA (shRNA)-mediated knockdown of Foxp2 in a song-related striatal nucleus (area X) 
of the zebra finch reduces spine density (Schulz et al., 2010). In in vitro cell models, primary 
neuronal cultures and brain tissue, it has been shown that both missense and nonsense 
mutations of Foxp2 lead to loss of transrepression capacities, and in vitro overexpression of 
these Foxp2 variants leads to aberrant protein localization (Estruch et al., 2016; Fujita et al., 
2008; Mizutani et al., 2007; Sollis et al., 2017; Vernes et al., 2006). Furthermore, it has been 
shown that brain morphology is altered in both homozygous R552H mutant mice (Groszer 
et al., 2008) and affected KE family members(Watkins et al., 2002). Foxp2 has been shown 
to regulate multiple genes important for neurodevelopment, such as MEF2C (Chen et al., 
2016; Harrington et al., 2016), SRPX2 (Roll et al., 2010; Sia et al., 2013) and RARβ (Chandra 
et al., 2017; Devanna et al., 2014; Liao et al., 2005), among others. Thus, it seems that the 
mouse R552H mutation as well as Foxp2 nonsense and knockout mutations affect similar 
neurobiological mechanisms. The R552H mutation leads to a loss of DNA-binding capacity 
of Foxp2, but the protein is still expressed. This is in contrast to the S321X mutation, which 
results in a reduction of Foxp2 expression, but all the Foxp2 which remains expressed is fully 
functional. Both these mutations have been shown to affect downstream regulation of DNA 
targets, with consequences for neurodevelopment (Spiteri et al., 2007; Vernes et al., 2011). 
Furthermore, in vivo investigations of mouse models of Foxp2 dysfunction show that the 
R552H and the S321X mutation similarly affect motor behavior. Both mice heterozygous for 
the R552H and the S321X Foxp2 mutation show aberrant motor skill learning by decreased 
performance on the accelerating rotarod (French et al., 2012; Groszer et al., 2008; van Rhijn 
et al., 2018). 
Interestingly, impairments in neuronal function have been assessed differently in the mouse 
model for the R552H mutation and the mouse model for the S321X mutation. In Foxp2R552H/+ 
mice, the focus has been on changes in synaptic plasticity ex vivo and behavior-dependent 
regulation of striatal activity in vivo. Foxp2R552H/+ mice display a lack of long-term depression 
(LTD) in the striatum (Groszer et al., 2008), as well as increased baseline striatal activity and 
aberrant modulation of synaptic activity when presented with a motor skill task (French et al., 
2012). However, in Foxp2S321X/+ mutant mice and Foxp2+/- knockout mice, research has focused 
on changes in synaptic strength and molecular mechanisms underlying changes in excitatory 
and inhibitory activity in the striatum (Chen et al., 2016; van Rhijn et al., 2018, Chapter 3). In 
these mice, which both display reduced Foxp2 expression (approximately half of the normal 
dosage of wild-type animals), decreased excitatory activity and increased inhibitory activity 
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have been shown in striatal MSNs, but in vivo investigations of neuronal function have not 
been conducted. Moreover, changes in excitatory or inhibitory activity have never been 
assessed at the single cell level in Foxp2R552H/+ mice. 
We therefore set out to comprehensively assess whether striatal D1R-MSNs of Foxp2R552H/+ 
mice show similar effects on excitatory and inhibitory activity as do striatal D1R-MSNs of 
Foxp2S321X/+ mice. Furthermore, we investigated the effect of blockade of GABAergic activity 
in vivo on motor skill learning in Foxp2R552H/+ mice, as this intervention ameliorates the 
motor skill learning deficits of Foxp2S321X/+ mice (van Rhijn et al. 2018). Our data indicate 
that the overlapping behavioral phenotype present in the Foxp2S321X/+ and Foxp2R553H/+ 
mice is established through different neurophysiological mechanisms. This finding could 
have important consequences for the development of therapeutic interventions and the 
translation of these to clinical practice.
RESULTS
Excitatory activity is not affected by a heterozygous Foxp2 DNA-binding domain mutation
Foxp2 is known to be predominantly expressed in D1R-MSNs (Fong et al., 2018; van Rhijn et 
al., 2018; Vernes et al., 2011), and the effects of the S321X mutation are constrained to D1R-
expressing MSNs in the striatum (van Rhijn et al., 2018). Therefore, we chose to select D1R-
MSNs in the striatum of Foxp2R552H/+ for physiological recording. In order to enable targeted 
recording of only D1R-MSNs, we crossed mice which express GFP under the D1R promoter 
through a Bactrap construct (D1R-GFP) with Foxp2R552H/+ mice. Bactrap-D1R-GFP is known 
to faithfully label D1R expressing cells in mouse brain (Heiman et al., 2008) and can thus 
be used to target D1R-MSNs for live cell measurements. We recorded miniature excitatory 
postsynaptic currents (mEPSCs) in striatal D1R-MSNs of juvenile (PND 10-14) Foxp2R552H/+ 
mice and wild-type littermate controls to measure the contribution of α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptors (AMPARs) to synaptic strength. Neither mEPSC 
amplitude or frequency (Figure 2a,b) were affected by the DNA-binding domain disruption of 
the R552H mutation. Thus, AMPAR-mediated synaptic strength is not changed in D1R-MSNs 
of Foxp2R552H/+ mice. This is in sharp contrast to the decrease in mEPSC amplitude shown in 
D1R-MSNs of Foxp2S321X/+ mice and suggests that striatal excitatory activity is uniquely affected 
by separate Foxp2 mutations.
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Figure 2: Normal excitatory activity in juvenile Foxp2R552H/+ mice. 
(a) representative traces of mEPSC activity in D1R-MSNs from juvenile (PND14) Foxp2R552H/+ mice and Foxp2+/+ 
littermate controls. (b) Average and cumulative amplitude and frequency of mEPSC events in D1R-MSNs indicate no 
difference in AMPA receptor mediated excitatory activity amplitude Foxp2+/+ = 14.22 pA, Foxp2R552H/+ = 15.37 pA, NS, 
frequency Foxp2+/+ = 1.32 Hz, Foxp2R552H/+ = 1.67 Hz, NS. N/n = mice/cells. Foxp2+/+ 3/29, Foxp2R552H/+ 3/32. Scale bars 
in (a) are 2 seconds / 10pA. Statistical comparison by two-sided student’s T-test. *** P<0.001 
Foxp2R552H/+ mice show decreased striatal direct pathway inhibition
In Foxp2S321X/+ mice the decrease in excitatory activity is accompanied by an increase in 
GABAergic inhibitory activity, which results in disruption of the excitatory/inhibitory balance 
of the striatal direct pathway (van Rhijn et al., 2018). Since excitatory synaptic strength is 
not altered in Foxp2R552H/+ mice, we next investigated whether inhibitory activity could still be 
affected by the R552H mutation. To measure if inhibition was changed, we used an evoked 
stimulation protocol. We assessed the AMPA receptor specific response at -60mV membrane 
potential and the GABA receptor specific response at -0mV, which is the reversal potential of 
AMPA receptors and excludes the AMPA signal from the recording. Single bipolar stimulations 
were given through a stimulus electrode placed in the dorsolateral quadrant of the striatum. 
The emergence of inhibitory GABAergic activity is delayed compared to glutamatergic activity 
during development. Therefore, we measured GABA/AMPA ratio both during early juvenile 
development (PND11) as well as at a later time window (PND17). At PND11, no difference in 
GABA/AMPA ratio was observed between Foxp2+/+ and Foxp2R552H/+ mice (Figure 3a), and the 
GABAergic response to simulation was low (Figure 3a). However, a significant decrease in 
GABA/AMPA ratio was measured at PND17 in Foxp2R552H/+ mice compared to Foxp2+/+ controls 
(Figure 3b). Our mEPSC data shows that AMPA-mediated activity is not different between 
Foxp2R552H/+ mice and Foxp2+/+ controls during the second postnatal week. Therefore, this 
reduction in GABA/AMPA ratio can only be attributed to a reduced GABAergic response. The 
reduced GABA/AMPA ratio is in contrast to the previously measured increase in GABA/AMPA 
ratio in Foxp2S321X/+ mice (van Rhijn et al., 2018). As such, both excitatory and inhibitory activity 
seem to be differently affected by the R552H mutation compared to the S321X mutation. The 
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lack of a change in excitatory activity combined with a decrease in inhibitory activity suggests 
striatal D1R-MSNs are more excitable in Foxp2R552H/+ mice. 
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Figure 3: Decreased GABA/AMPA ratio in juvenile Foxp2R552H/+ mice. 
(a) GABA/AMPA ratio measured at early juvenile development (PND11) and late juvenile development (PND17). Early 
development shows only a very weak response to activation of GABAergic systems (Foxp2+/+ = 0.21, Foxp2R552H/+ = 
0.14, NS). (b) At PND17, GABAergic responses are strong in wild-type animals, whereas a reduced GABA/AMPA ratio 
is shown in heterozygous Foxp2R552H/+ mice (Foxp2+/+ = 0.87, Foxp2R552H/+ = 0.46) N/n= 3/17 for PND11 (both Foxp2+/+ 
and Foxp2R552H/+), 5/37, PND17 Foxp2+/+, 3/13 Foxp2R552H/+. Statistical comparison by two-sided student’s T-test. *** 
P<0.001
Motor skill learning deficits in Foxp2R552H/+ mice are aggravated by inhibitory blockade
Changes in striatal activity following Foxp2 mutations have already been correlated with 
aberrant motor behavior present in both Foxp2R553H/+ (French et al., 2012) and Foxp2S321X/+ mice 
(van Rhijn et al., 2018). Thus, there are overlaps in motor deficits observed in Foxp2R552H/+ 
and Foxp2S321X/+ mice, despite the different effects these mutations seem to have on striatal 
function at the neurophysiological level. We have previously shown that intervention by in 
vivo blockade of GABAergic activity using a low intraperitoneal (IP) dose of picrotoxin (PTX) 
ameliorates motor skill learning impairments in Foxp2S321X/+ mice (van Rhijn et al., 2018). By 
contrast, wild-type mice are adversely affected in their motor skill learning by the same low 
dose of PTX. We therefore tested whether blockade of GABAergic activity affects motor skill 
learning as well in Foxp2R552H/+ mice. Firstly, we confirmed the presence of a motor skill learning 
deficit in Foxp2R552H/+ mice (French et al., 2012). We furthermore subjected our control 
animals to vehicle injection of 0.1mg/kg 0.01% dimethylsulfoxide (DMSO) 10 minutes before 
each accelerating rotarod session. This allowed us to directly compare the measurements 
in our control group with the PTX treatment group. Foxp2R552H/+ and wild-type littermate 
controls of age 6-8 weeks were subjected to 5 daily sessions of accelerating rotarod training 
for 5 consecutive days. During each session, rotarod speed increased from 4-40 rpm over a 
course of 5 minutes and the latency to fall (in seconds) was recorded. We measured both 
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average performance per session as well as learning rate (Figure 4a,b). Though all animals 
were able to improve their performance during and between training days, the latency to fall 
was significantly reduced in Foxp2R552H/+ mice compared to Foxp2+/+ littermates in all sessions, 
corroborating previous published results (French et al., 2012).
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Figure 4: Pharmacological blockade of inhibition impairs motor skill learning both in Foxp2 +/+ and Foxp2R552H/+ 
mice 
(a) Foxp2R552H/+ mice show impaired motor skill learning compared to Foxp2 +/+ mice, shown by the increased latency 
to fall (in seconds) across training sessions (day 1-5: Foxp2+/+ 102.2, 147.2, 163.6, 169.7, 174.8 Foxp2R552H/+ 47.0, 
80.1, 80.6, 90.1, 114.2 P<0.01, 2-factor ANOVA). Each session consists of 5 trials of 5 minutes, during which the 
rotarod accelerated from 4-40rpm. (b) Both Foxp2+/+ and Foxp2R552H/+ mice show a positive learning rate during most 
sessions, with learning rate not being significantly different between genotypes. Learning rate was calculated as: 
Learning rate= . (c,d) Both Foxp2+/+ and Foxp2R552H/+ mice subjected to 0.1mg/kg intraperitoneal 
injection of PTX show decreased rotarod performance and learning rates, compared to sham treatment. (Latency to 
fall: day 1-5: Foxp2+/+ 108.1, 145.7, 136.7, 138.8, 97.7 Foxp2R552H/+ 64.4, 94.5, 107.1, 102.9, 78.2). (e) Average RPM at 
which mice fail the accelerating rotarod task during session 4 and 5 in sham and PTX conditions (sham, Foxp2+/+ 24.5 
RPM, FoxpR552H/+ 16.8RPM, P<0.001. PTX, Foxp2+/+ 18.2RPM, Foxp2R552H/+ 14.1RPM, P<0.05, two-sided students T-test). 
For all treatment conditions, N = 5 mice. *** P<0.001. 
Next, we IP injected Foxp2+/+ and Foxp2R552H/+ mice with 0.1 mg/kg PTX 10 minutes before 
each training session. We previously established that this concentration of PTX induces a 
notable reduction in motor skill learning in Foxp2+/+ animals from carrying a S321X mutation, 
but general motor behavior is unaffected. Motor skill learning remained significantly 
impaired between Foxp2+/+ and Foxp2R552H/+ mice after PTX treatment (Figure 4c,d). Moreover, 
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comparison of average latency to fall between sham-injected and PTX-injected mice of the 
Foxp2R552H/+ group shows PTX injection had a significant negative effect on motor skill learning, 
similar to the effect of PTX in wild-type control mice (Figure 4e). This is opposite from the 
effect PTX has on motor skill learning in Foxp2S321X/+ mice, where PTX injection significantly 
improved accelerating rotarod performance. This opposite effect of the same in vivo 
intervention confirms that neurobiological mechanisms involved in motor skill learning are 
affected differently by the S321X or the R552H mutation.
DISCUSSION
Striatal morphology and function are affected by heterozygous mutation of the transcription 
factor FoxP2 in humans (Liegeois et al., 2003; Watkins et al., 2002) as well as animal models 
(Chen et al., 2016; French et al., 2012; Groszer et al., 2008; Schulz et al., 2010). Multiple 
different mutations of FOXP2 are known, which affect FOXP2 in distinct ways (Morgan et al., 
2017). Two of the most well-studied are; a missense mutation which disrupts the DNA binding 
domain (Lai et al., 2001), and a nonsense mutation which leads to loss of protein function, 
protein truncation and nonsense mediated decay (MacDermot et al., 2005). Intriguing 
differences between these mutations on the neurobiological level have been observed, and 
it has been suggested that the R328X and the R553H mutations could differently affect FOXP2 
function (Estruch et al., 2016; Vernes et al., 2006). However, a direct comparison of the 
neurophysiological effects these mutations have on striatal activity has not been conducted. 
Here we show for the first time in mouse models that the neurophysiological phenotype of 
the heterozygous Foxp2-R552H missense mutation differs from the effect of heterozygous 
Foxp2-S321X nonsense mutation (table 1). The heterozygous R552H mutation does not affect 
excitatory activity. Furthermore, a decreased GABA/AMPA ratio in D1R-MSNs of juvenile 
(PND17) Foxp2R552H/+ mice shows GABAergic activity is reduced. This produces an inverse 
phenotype from that described in D1R-MSNs of Foxp2S321X/+ mice, where excitatory activity is 
decrease and inhibition is increased (van Rhijn et al., 2018). Pharmacological manipulation 
of neuronal activity in vivo by IP injection with PTX negatively affects motor skill learning in 
Foxp2R552H/+ mice, in contrast to the known beneficial effect of IP PTX injection on motor skill 
learning in Foxp2S321X/+ mice (van Rhijn et al., 2018).
The molecular mechanisms affected by the S321X mutation (as well as other loss of function 
alleles) have been investigated in detail, and multiple pathways involved in neurodevelopment 
and neuronal activity have been implicated (Devanna et al., 2014; Vernes et al., 2011). 
Heterozygous Foxp2 loss of function mutations leads to reduced striatal AMPA receptor 
expression (Chen et al., 2016) as well as an increase in GAD67 (Glutamic acid decarboxylase 
67, one of the principal enzymes for the production of GABA) expression in D1R-MSNs (van 
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Rhijn et al., 2018). Interestingly, Foxp2S321X/+ mice do show similar impairments in LTD to those 
observed in Foxp2R552H/+ mice (van Rhijn et al., Chapter 3), which suggests at least a degree of 
overlap in neuronal functions which are affected by both mutations. Though in vivo data from 
Foxp2 knockout or loss of function mice is lacking, the changes in excitatory and inhibitory 
activity suggest in vivo baseline activity in the striatum could be decreased in Foxp2S321X/+ 
mice. 
Currently, it is not known if the R552H mutation leads to dysregulation of the same profile 
of downstream targets as for the S321X mutation, or if it might show unique effects (for 
example due to the existence of a mutant product that can bind to and interfere with 
function of wild-type Foxp proteins). Though both Foxp2S321X/S321X and Foxp2R552H/R552H mice 
show gross neurodevelopmental impairments (Fujita et al., 2008; Groszer et al., 2008), the 
data we present here suggest that the R552H mutation may, at least to some extent, uniquely 
affect the regulatory function of Foxp2 in striatal MSNs. Therefore, a comparison between 
expression profiles of brain tissue from mice with wildtype Foxp2, Foxp2-S321X mutation 
and Foxp2-R552H mutation might provide additional evidence that these mutations uniquely 
affect Foxp2 function. Differences between the profile of how regulatory targets are affected 
in mice with the R552H and the S321X mutation could offer important novel insight for 
functional follow-up.
Proteins in the FoxP family can dimerize through interaction of their leucine zipper domains, 
and homo- or heterodimerization of Foxp1/2/4 has been posited as necessary for the DNA 
binding of these transcription factors (Bacon and Rappo ld, 2012; Li et al., 2004; Mendoza 
and Scharff, 2017). The S321X mutation results in simple reduction of Foxp2 expression, 
decreasing to availability of Foxp2 for interaction with other Foxp proteins. However, the 
R552H mutation solely disrupts the DNA binding domain, without disturbing the potential for 
Foxp2 to dimerize (Li et al., 2004). Another effect of both the S321X and R552H mutation that 
has been shown in vitro in cell models which overexpress Foxp2 with these mutations, is that 
nuclear localization is impaired (Mizutani et al., 2007; Sollis et al., 2017; Vernes et al., 2006), 
however, the significance of this result for the in vivo function of Foxp2 is currently unclear. 
Since the homo/heterodimerization of Foxp2 with other Foxp proteins is probably essential 
for its regulatory function (Li et al., 2004), interaction between Foxp2-R552H and wild-type 
Foxp2 could lead to competitive inhibition. This might be a major difference between the 
S321X and the R552H mutation, as the S321X mutation leads to reduced Foxp2 expression 
in general, but should not affect wild-type Foxp2 (Groszer et al., 2008; Vernes et al., 2006). 
The possible competitive inhibition between Foxp2-R552H and wild-type Foxp2 might reduce 
the availability of wild-type Foxp2 even more strongly than a general reduction in functional 
protein through the S321X mutation. Alternatively, homodimers of Foxp2-R552H only or 
wild-type Foxp2 and Foxp2-R552H could have different regulatory targets compared 
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Table 1: phenotypes described for heterozygous R552H and S321X/knockout mutations
Phenotype Foxp2-S321X | 
Foxp2 knockout
Reference Foxp2-R552H Reference
Excitatory activity  
D1R-MSNs
Decreased (Chen et al., 2016; van 
Rhijn et al., 2018)
Unchanged  
(ex vivo) /increased 
(in vivo)
This manuscript / 
(French et al., 2012)
Inhibitory activity  
D1R-MSNs
Increased (van Rhijn et al., 2018) Decreased This manuscript
Long-term depression Absent (van Rhijn et al., 
Chapter 3)
Absent (Groszer et al., 2008)
Synapse maturation Delayed (Chen et al., 2016) Unknown N/A
Neurite outgrowth Unknown N/A Impaired 
(homozygous)
(Vernes et al., 2011)
Motor skill learning Negatively 
impaired
(French et al., 2012; 
van Rhijn et al., 2018)
Negatively 
impaired
(French et al., 2012; 
Groszer et al., 2008), 
This manuscript
Effect of GABA 
blockade on motor  
skill learning
Positive (van Rhijn et al., 2018) Negative This manuscript
to homodimers of wild-type Foxp2 only. Lastly, Foxp2-R552H can probably still interact with 
Foxp1 and Foxp4 and form dimers with these proteins as well, in regions of co-expression. 
Expression of both Foxp1 and Foxp2 has been shown in mouse striatum as well as songbird 
brain (Chen et al., 2013; Teramitsu et al., 2004). At the single cell-level, Foxp1 has been 
confirmed to be expressed similarly in both D1R-MSNs and D2R-MSNs, whilst Foxp2 is mainly 
expressed in D1R-MSNs. This suggests there is a population of D1R-MSNs in which Foxp1 and 
Foxp2 are both expressed, but probably this is a subpopulation of all D1R-MSNs (Fong et al., 
2018). Because of the possibility that such interactions can occur, Foxp2-R552H might have 
much more complex effects on gene regulation compared to the S321X mutation and is an 
interesting exploratory tool to investigate how dimerization of Foxp2 is involved in neuronal 
function.
We show that motor skill learning impairments due to mutations in Foxp2 can arise through 
unique mutation-dependent effects on neurobiology. Therefore, we think that a detailed 
understanding of how distinct types of mutations in the same gene affect neurobiological 
mechanisms in monogenic disorders is necessary to fully decipher gene-behavior correlations. 
Disruption of the DNA-binding domain of Foxp2 oppositely affects striatal activity compared 
to a simple loss of Foxp2 function. Moreover, blockade of GABAergic activity in mice carrying 
Foxp2R552H/+ or Foxp2S321X/+ mutations inversely affects motor performance. Similar to the shared 
motor skill impairments in mouse models of Foxp2 dysfunction (Enard et al., 2009; French et 
al., 2012; Groszer et al., 2008; van Rhijn et al., 2018), all heterozygous disruptive mutations 
of FOXP2 so far found in humans result in speech and language impairment (Morgan et al., 
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2017). However, it could be that these mutations do differently affect behaviors, but the 
current methods used to characterize the phenotype are not able to show these differences 
in mice. Tasks which require increased or decreased direct pathway activity might reveal 
behavioral differences between Foxp2R552H/+ and Foxp2S321X/+ mice. Lastly, mutation dependent 
phenotypes have been described in other neurodevelopmental disorders, for example in 
individuals with different mutations of MECP2 (Baker et al., 2013) and SHANK3 (Zhou et 
al., 2016). Taken together, our results highlight that even when the affected gene is known, 
care should be taken not to suggest intervention before the neurobiological mechanisms 
affected in the specific individual are completely understood. The current ability to generate 
human neurons which express Foxp2 (van Rhijn et al., Chapter 6) would enable us to 
investigate patient-specific neuronal phenotypes. This could be a highly interesting follow up 
investigation and would help to both validate the unique effects of different FoxP2 mutations 
and investigate patient-specific neurobiological mechanisms which are affected.   
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MATERIALS & METHODS
Mice
The experimental procedures were approved by the Animal Ethics Committee of the Radboud 
University Nijmegen, under DEC application number 2014-098 (Nijmegen, the Netherlands) 
and conducted in accordance with the Dutch legislation. Every effort was made to minimize 
animal discomfort and the number of animals used.
The Foxp2-R552H line was maintained on a C57BL/6J background, heterozygotes and wildtype 
littermates between PND11 and PND17 were used for electrophysiological recordings, and 
adult mice between 7 and 9 weeks were used for behavioral experiments. The generation, 
marker-assisted backcrossing and genotyping of this strain are fully described in (Coghill et 
al., 2002; Groszer et al., 2008; Keays et al., 2006). BACtrap mice carrying GFP under the D1R 
promoter (D1R-GFP) were originally generated by the GENSAT (Gene Expression Nervous 
System Atlas) (Gong et al., 2003) and backcrossed to C57BL6/J mice. Both male and female 
mice were used in all experiments, and care was taken to use equal numbers of male/female 
mice for behavioral experiments.
Whole-cell patch clamp
Experiments were conducted on 350µm thick coronal slices. Mice were sacrificed by 
decapitation following isoflurane anesthesia. Slices were cut using a vibratome (HM650V 
Thermo Scientific) in cooled (4°C) artificial cerebrospinal fluid containing (in mM): 87 NaCl, 
11 Glucose, 75 Sucrose, 2.5 KCl, 1.25 NaH 2PO4, 0.5 CaCl2, 7 MgCl2, 26 NaHCO3), continuously 
oxygenated with 95%O2/5%CO2. Collection of slices started when the striatum became 
visible and slices were collected until the hippocampus was visible. After collection, slices 
were incubated at 32°C in oxygenated ACSF for at least 1h before recording. Slices were 
transferred to the recording setup 10 minutes prior to recording and incubated in recording 
ACSF containing (in mM): 124 NaCl, 3 KCl, 1.25 NaH 2PO4, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 10 
Glucose, continuously oxygenated and heated to 32°C. Patch pipettes (3.5 – 5.5 MΩ) were 
made from borosilicate glass capillaries and filled with intracellular solution containing: 115 
CsMeSO3; 10 CsCl; 10 HEPES; 2.5 MgCl2; 4 Na2ATP; 0.4 NaGTP; 10 Na-Phosphocreatine; 0.6 
EGTA, 10 QX-314. Activity was recorded using a Digidata 1440A digitizer and a Multiclamp 
700B amplifier (Molecular Devices). Sampling rate was set at 20KHz and a lowpass 1KHz filter 
was used during recording. All recordings were conducted in the dorsolateral quadrant of the 
striatum.
Miniature postsynaptic currents
mEPSCs were recorded in the prescience of Tetrodotoxin (TTX, 1µM, Tocris) and Picrotoxin 
(PTX, 100µM, Tocris) at a holding voltage of -60mV.
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GABA/AMPA ratio
Stimulation experiments were conducted by stimulation of afferent corticostriatal and 
intrastriatal axons using a bipolar concentric stimulus electrode (FHC, Bowdoin, Maine) 
placed in the dorsolateral striatum.
GABA/AMPA ratio was measured in the presence of APV (100µM). Cells were voltage-clamped 
at -60mV and a 1ms stimulus from a bipolar tungsten electrode was given to record the AMPA 
response. Subsequently cells were clamped at 0mV and the GABA response was measured. 
Intraperitoneal injection
Foxp2R552H/+ mice and wild-type littermate controls were injected intraperitoneally with either 
vehicle (DMSO) or 0.1mg/kg picrotoxin (Tocris, Bristol, UK). Injection was done by hand and 
mice were placed back in their home cage for 10 minutes following injection, after which 
mice were placed on the accelerating rotarod.
Accelerating rotarod
Foxp2R552H/+ mice (6-8 weeks old) and wild-type littermate controls were placed on an 
accelerating rotarod (LE8200, Harvard apparatus) which increased rotation speed from 4 
r.p.m. to 40 r.p.m. over a 5-minute period. Mice were trained for 5 consecutive days, with 
5 trials per day. Latency to fall (in seconds or RPM at fall) was scored, and mice were placed 
back in their home cage for 5 minutes between trials.
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ABSTRACT
Speech requires precise motor control and rapid sequencing of highly complex vocal 
musculature. Despite its complexity, most people produce spoken language effortlessly. This 
is due to activity in distributed neuronal circuitry including cortico-striato-thalamic loops 
that control speech–motor output. Understanding the neuro-genetic mechanisms involved 
in the correct development and function of these pathways will shed light on how humans 
can effortlessly and innately use spoken language and help to elucidate what goes wrong 
in speech-language disorders. FOXP2 was the first single gene identified to cause speech 
and language disorder. Individuals with FOXP2 mutations display a severe speech deficit that 
includes receptive and expressive language impairments. The neuro-molecular mechanisms 
controlled by FOXP2 will give insight into our capacity for speech–motor control, but are 
only beginning to be unraveled. Recently FOXP2 was found to regulate genes involved in 
retinoic acid (RA) signaling and to modify the cellular response to RA, a key regulator of 
brain development. Here we explore evidence that FOXP2 and RA function in overlapping 
pathways. We summate evidence at molecular, cellular, and behavioral levels that suggest an 
interplay between FOXP2 and RA that may be important for fine motor control and speech–
motor output. We propose RA signaling is an exciting new angle from which to investigate 
how neuro-genetic mechanisms can contribute to the (spoken) language ready brain.
POSSIBLE INTERACTION BETWEEN RARΒ AND FOXP2
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SPEECH AND SPOKEN LANGUAGE
Speech is the primary modality by which humans use language, and human orofacial 
morphology is uniquely suited to the production of intricate vocalizations needed for 
spoken language (Lieberman, 2007). The orofacial musculature is one of the most 
complex muscle systems in the body and in order to successfully produce meaningful 
speech these muscles must be controlled and coordinated in rapid sequences involving 
distributed neuronal circuitry. This motor activity is generated in several neural loops 
that select appropriate actions and generate the necessary motor patterns. One crucial 
circuit, the cortico-basal ganglia loop, sends activity from the motor cortex to the striatum 
(a component of the basal ganglia) where activity is integrated. Subsequently, outputs 
from here modulate activity in several thalamic nuclei. Activity from the thalamus is 
then sent back to the motor cortex, where a specialized population of output neurons 
organizes the complex thalamocortical inputs (Kravitz and Kreitzer, 2012; Calabresi et 
al., 2014). These cortical output neurons send the information, via the pyramidal tract, 
to motor neurons directly controlling muscle tissue. These neurons are either located 
in the spinal cord (controlling limb and body movements), or in the brainstem’s cranial 
nerve nuclei (controlling facial and vocal tract movements). An illustration of the cortico-
basal ganglia loop (in the rodent brain) is given in Figure 1A. Proper connectivity within this 
pathway is necessary to enable the precise outputs needed for orofacial muscle control.
The striatum can be seen as a central hub within the motor pathway, making it one of the 
most intriguing regions in which to investigate properties of motor circuitry and orofacial 
control. Striatal activity is especially important for fine motor behavior and motor skill learning 
(Doyon et al., 2003) and cortical and subcortical circuitry, including the striatum, has been 
established as highly important for speech–motor control (Lieberman, 2002). Furthermore, 
increased activation of the basal ganglia (which incorporates the striatum) has been shown 
via functional brain imaging (fMRI) in specific speech–motor language tasks (Wildgruber 
et al., 2001; Booth et al., 2007). Lastly, morphological changes in the striatum have been 
described in individuals with speech problems such as stuttering (Craig-McQuaide et al., 
2014) and non-fluent aphasia (Ogar et al., 2007).
The principal cell type in the striatum is the medium spiny neuron (MSN), which makes up 
approximately 98% of all striatal cells (Kemp and Powell, 1971; Huang et al., 1992; for review, 
see Kreitzer and Malenka, 2008). MSNs can be further divided into two categories of neurons 
that have different connectivity and opposing functions: dopamine receptor type 1 (D1R) and 
dopamine receptor type 2 (D2R) expressing cells (Figure 1A). D1R expressing MSNs connect 
to thalamic nuclei via the “direct pathway” which results in excitation of the motor cortex. 
D2R expressing MSNs form an “indirect pathway” that connects to the thalamus via multiple 
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subcortical regions leading to inhibition of the thalamus and thus reduced cortical input 
(Figure 1A), (Albin et al., 1989; Kravitz and Kreitzer, 2012; Calabresi et al., 2014).
This balance between excitation (resulting in more movement) and inhibition (less movement) 
is crucial for coordinated motor function (Calabresi et al., 2014) including fine orofacial motor 
control. In order to unravel the fundamental components that enable humans to effortlessly 
use spoken language, we will need to understand the neuro-genetic mechanisms involved in 
establishment, function, and maintenance of speech–motor pathways.
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Figure 1: Foxp2 and retinoic acid receptors (RARs) show overlapping expression patterns in motor associated 
circuitry. 
(A) An overview of the direct and indirect pathways represented in the sagittal view showing connectivity between 
different regions. Dopamine receptor type 1 (D1R) and Dopamine receptor type 2 (D2R) expressing cells in the 
striatum are separated to highlight direct and indirect pathways. (B) Sagittal Schematic of the mouse brain showing 
that Foxp2, RARα, and RARβ are all expressed in motor associated circuitry. RARα and RARβ are expressed in distinct 
regions, but each receptor partially overlaps with Foxp2. RARα and Foxp2 can be found in deep layers of the cortex, 
thalamus, subthalamic nucleus (STN), the internal (GPi) and external (GPe) globus pallidus, cerebellum, and olfactory 
bulbs (OB). Foxp2 and RARβ overlap in the striatum. RARα shows non-overlapping expression in the hippocampus 
(hi.), RARβ in the hypothalamus (hy), and Foxp2 in the substantia nigra (SN). Connectivity between regions involved 
in motor processing (including outputs to brain stem nuclei and spinal cord) is shown by solid lines. The direct 
(excitatory) and indirect (inhibitory) pathways, which are the two outputs from the striatum, are shown by dashed 
lines.
SPOKEN LANGUAGE AND FOXP2
A breakthrough in speech and language genetics came with the identification of the first gene 
to cause a speech/language disorder: FOXP2 (Lai et al., 2001). Mutations in FOXP2 were found 
in a large pedigree known as the KE family (Hurst et al., 1990; Fisher et al., 1998; Lai et al., 
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2001). Affected family members were diagnosed with a severe speech impairment known as 
developmental verbal dyspraxia (also known as childhood apraxia of speech; OMIM: 602081) 
and carried a mutation in one copy of their FOXP2 gene. In addition to speech impairments, 
affected family members demonstrated receptive and expressive language problems (Watkins 
et al., 2002a). Although rare, FOXP2 mutations have been found in a number of unrelated 
families and individuals with similar speech/language phenotypes (MacDermot et al., 2005; 
Feuk et al., 2006; Shriberg et al., 2006; Lennon et al., 2007; Palka et al., 2012; Rice et al., 
2012; Zilina et al., 2012; for review, see Bacon and Rappold, 2012). In depth investigations 
of the KE family phenotype indicated a severe impairment in orofacial praxis tasks (Vargha-
Khadem et al., 1995; Lai et al., 2001; Watkins et al., 2002a). In addition, impairments in 
language production tasks (e.g., phoneme addition, word repetition) were found between 
control and affected individuals (Vargha-Khadem et al., 1995). Different aspects of speech are 
thus impaired in KE family members (Watkins et al., 2002a). Orofacial praxis deficits underlie 
impaired lexicon building and subvocal (internal) speech representations which can affect 
irregular verb grammar (Doyon et al., 2003) and rule based grammar learning (Ullman, 2001). 
Thus, some of the language impairments in the KE family could be related to the core speech 
production deficits observed.
FOXP2, and its murine homolog Foxp2, are found across many regions of the developing 
and postnatal brain (FoxP2 will be used when referring to both species). Intriguing is the 
high expression of FoxP2 throughout the mouse and human cortico-striato-thalamic motor 
circuitry (Lai et al., 2003). During early development FoxP2 is broadly expressed in these 
regions, but in later developmental and postnatal stages expression becomes more restricted 
(Figure 1B depicts Foxp2 expression in the postnatal mouse brain). In adults, Foxp2 is limited 
to deep layer cortical neurons (layer 5 motor cortex and layer 6 throughout; Ferland et al., 
2003; Morikawa et al., 2009; Hisaoka et al., 2010; Tomassy et al., 2010; Reimers-Kipping et 
al., 2011; Tsui et al., 2013). Within the striatum, Foxp2 is highly expressed in both types of 
MSN, though more commonly in D1R MSNs compared to D2R neurons (Vernes et al., 2011). 
Corresponding with its expression pattern, imaging studies have shown humans with FOXP2 
mutations display structural and functional differences in motor areas. Affected members 
of the KE family showed structural gray matter volume differences in the motor cortex 
and striatum (Watkins et al., 2002b). Furthermore, functional imaging studies showed an 
underactivation of the striatum and altered cortical activation (including speech/motor areas 
such as the left anterior insular cortex) during word generation and word repetition tasks 
(Liegeois et al., 2003).
Converging evidence from FoxP2 expression pattern studies and phenotypic characterization 
of human mutations suggests that FOXP2 may play an important role in the development of 
the speech–motor pathway. The high expression of Foxp2 in a specific subset of neurons (D1R 
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MSNs) in the striatum indicates a functional specificity related to motor tasks requiring the 
striato-thalamic connections of the direct pathway. Malfunctions within this pathway could 
ultimately affect aspects of the motor circuitry related to fine motor control and contribute 
to the observed speech–motor deficit in humans.
FOXP2 AS A MOLECULAR ENTRY POINT INTO SPEECH-MOTOR 
PATHWAYS 
FoxP2 is a transcription factor; its molecular function is to regulate the expression of other 
genes, switching them on or off in a temporally and spatially controlled manner. FoxP2 
has been shown to regulate 100s of different genes involved in processes crucial to brain 
development and function, ranging from neurogenesis and migration, to neurite outgrowth 
and synaptic activity (Spiteri et al., 2007; Vernes et al., 2007, 2011; Konopka et al., 2009; 
Devanna et al., 2014). Recently, evidence has suggested that FOXP2 regulates a number of 
genes involved in the retinoic acid (RA) signaling pathway (Devanna et al., 2014). RA is a 
vitamin-A derivative essential to mammalian development. Disruption of the RA signaling 
pathway (caused by genetic disruptions or dietary deficiencies) can have severe consequences 
during development and adulthood (Holson et al., 1997; Krezel et al., 1998)
Retinoic acid induces genetic and morphological changes in cells. When neuronal precursors 
(cells that generate neurons during development) differentiate into neurons they switch 
on genes normally found in mature neurons, stop dividing and grow long processes known 
as neurites (Siegenthaler et al., 2009; Korecka et al., 2013). We previously compared how 
neuron-like cells with or without FOXP2 responded to RA and found that cells showed stronger 
genetic and morphological changes in response to RA if FOXP2 was present (Devanna et 
al., 2014). In addition we discovered that FOXP2 changed the expression of RA receptors – 
proteins that directly control the cellular response to RA (Devanna et al., 2014). Of particular 
interest, FOXP2 upregulated retinoic acid receptor β (RARβ) and a number of other genes 
involved in transport or modification of RA were also transcriptionally regulated (e.g., RORβ, 
CRABPII, and ASCL1). These experiments suggest an intriguing link between FOXP2 and the 
RA pathway, in which FOXP2 seems to contribute to or modify the cellular response to RA.
Given the importance of the RA pathway for development, this raises new questions about 
how FOXP2 might mediate its effects on brain and neural circuit development. Could the 
relationship between FOXP2 and the RA pathway be relevant for (1) normal motor circuitry 
development and function, and/or (2) effects of FOXP2 dysfunction in patients? To address these 
questions, we need to understand how FoxP2 and the RA pathway might interact, and in what 
way FoxP2 mutations might affect the RA pathway on a cellular, functional and behavioral level.
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RA, FOXP2 AND MOTOR BEHAVIOR
Retinoic acid is a key compound during embryogenesis, affecting a multitude of critical 
developmental pathways. Precise control of RA levels is essential for normal brain development 
as either an excess or a deficiency of RA results in widespread adverse effects on the brain.
Gestational treatment of rats with excess RA results in behavioral deficits in learning, 
memory and motor function (Holson et al., 1997). Rats treated with excess RA displayed poor 
generalized motor control including impairments in the ‘righting reflex’ (the ability to return 
to upright position), and the ability to sit only on the back paws. In addition, gestationally 
treated adult rats showed problems with learning and memory, such as decreased learning 
rates in a water filled T maze (Butcher et al., 1972; Holson et al., 1997). Rats lacking dietary 
vitamin A (of which RA is a metabolite) also perform poorly on motor learning and motor 
performance tasks (Carta et al., 2006). Furthermore, mice engineered to lack a key facilitator 
of RA signaling (RARβ) develop severe locomotion deficits and are highly impaired on motor 
learning tasks (Krezel et al., 1998).
The displayed motor deficits are similar to phenotypes observed in mouse models of Foxp2 
dysfunction. Mouse models of two well characterized patient mutations of FOXP2 have 
been created that have comparable phenotypes. One mouse model reflects the R553H 
missense mutation found in the KE family (Lai et al., 2001). The second mouse model mirrors 
an early stop codon in exon 7 introduced by a nonsense mutation that leads to a loss of 
FOXP2 protein in an independent family with speech/language disorder (MacDermot et 
al., 2005; Groszer et al., 2008). Mice that have a homozygous Foxp2 mutation show severe 
general motor impairments, reminiscent of animals treated with excess RA. However these 
Foxp2 homozygous mutants do not survive beyond 3–4 weeks after birth, possibly due to a 
requirement for Foxp2 in other organs such as the lungs or heart (Groszer et al., 2008). In 
mice where a single copy of Foxp2 is affected (as per the heterozygous state of the mutations 
observed in patients) general motor control is normal but motor learning is impaired (Groszer 
et al., 2008; French et al., 2012). This more subtle phenotype closely resembles the motor 
learning phenotype observed in RA deprived rats (Carta et al., 2006). For an overview of the 
different phenotypes exhibited by Foxp2 mutation, RAR mutation, and RA treatment, see 
Table 1.
FOXP2 AND RA SIGNALING AFFECT NEURONAL FUNCTION
In addition to the behavioral deficits, vitamin A deprivation/supplementation adversely affects 
striatal development and function. Cells in the developing lateral ganglionic eminence (the 
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precursor region of the striatum) do not differentiate into the appropriate neuronal subtypes 
when RA signaling is blocked (Toresson et al., 1999; Chatzi et al., 2011). However restoring 
RA levels rescued this phenotype and resulted in normal differentiation into appropriate 
neuronal cell types (Chatzi et al., 2011). Separately, mice engineered to knockout the RARβ 
gene display gross morphological striatal defects including impaired neurogenesis and deficits 
in acquiring proper neuronal identities (Liao et al., 2008). Lastly, chronic postnatal vitamin A 
supplementation has been linked to oxidative cell toxicity in the striatum (de Oliveira et al., 
2007).
Foxp2 also contributes to striatal cell morphology and function. Foxp2 mutant neurons 
exhibit reduced neurite growth and branching in primary striatal cultures (Vernes et al., 2011) 
and the in vivo striatum displays aberrant neuronal activity. Mice with a heterozygous Foxp2 
mutation showed unusually high activity in the dorsomedial striatum during active motor 
behavior (French et al., 2012). This suggests striatal cells can no longer properly modulate 
their activity following input from motor areas when lacking Foxp2. Moreover, the increased 
striatal activity normally seen when animals perform motor learning tasks was absent in 
mutant mice. Instead, a decrease
in firing rate was seen, again suggesting aberrant modulation of responses to cortical and/or 
thalamic input (French et al., 2012). Additionally, extracellular measurements on striatal brain 
slices from heterozygous Foxp2 mutant animals show these cells fail to respond to induction 
of long term depression (LTD; Groszer et al., 2008). An inability to induce long term plasticity 
[either LTD or long term potentiation (LTP)] has debilitating consequences as scaled activity 
(plasticity) is necessary for circuits to properly regulate their input and output. Synaptic 
long term plasticity changes underlie information storage and are necessary for learning 
and memory (Novkovic et al., 2015; Zhu et al., 2015). Interestingly, in the striatum, synaptic 
plasticity has been strongly linked to motor learning (Dang et al., 2006; Kreitzer and Malenka, 
2007). Defects specifically related to striatal LTD and LTP are known to affect procedural 
motor learning and the acquisition of new motor paradigms (Gubellini et al., 2004).
Aberrant induction of synaptic scaling has also been found in mice following acute RA 
depletion, which results in a complete lack of hippocampal LTP or LTD (Misner et al., 2001). 
This phenotype was specific to RA depletion and was reversible, as vitamin A supplementation 
rapidly restored normal synaptic plasticity (Misner et al., 2001). At a molecular level, RA 
signaling is mediated by the action of RA receptors (RARs; RARα, RARβ, and RARγ) and 
similar plasticity defects have been shown for mice lacking RARα (Sarti et al., 2012) or RARβ 
(Chiang et al., 1998). Hippocampal cells from these mice fail to establish LTD when subjected 
to low frequency stimulation – the paradigm necessary to induce LTD in the hippocampus. 
By contrast, excess RA induced the reverse effect in cultured hippocampal slices, where 
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increased excitatory activity was observed (Aoto et al., 2008). It is not yet known if RA 
signaling affects synaptic plasticity in the striatum. However, the similarity in synaptic activity 
phenotypes between Foxp2-, RARα-, and RARβ-deficient animals (albeit focusing on different 
brain regions) does indicate these transcription factors may play a role in similar intracellular 
pathways regulating neuronal activity and synaptic plasticity.
The aforementioned plasticity (LTD and/or LTP) deficits in Foxp2, RARα, and RARβ mutant 
animals suggests an improper reaction of neuronal circuits to changes in external input. 
Induction of LTD or LTP leads to a decrease or an increase, respectively, in the amount of 
glutamate receptors (of the AMPA- receptor class) at the synaptic membrane (Seidenman et 
al., 2003; Briand et al., 2014; for review, see Luscher and Huber, 2010). This change in AMPA 
receptor abundance modifies the response strength of a cell when it is excited. The change in 
stimulus–response strength is transient, and in time the normal AMPA receptor distribution 
will be restored, returning synaptic responses to normal levels. RA treatment of hippocampal 
cultures has shown an increase of AMPA receptors on the cell surface (Aoto et al., 2008), but 
no data on the striatum is currently present. The shared synaptic plasticity defect following 
disruption of RA signaling pathways or Foxp2 mutation does suggest that they both may 
influence receptor abundance or localization at the synapse in the striatum, an intriguing 
area for further study.
A thorough investigation of the mechanisms leading to LTD and LTP deficits resulting from 
RA/RAR and Foxp2 malfunction will be necessary to understand if they function in the same 
pathways. Understanding the molecular mechanisms underlying striatal function, especially 
related to complex motor circuitry function, will lead to a better understanding of striatal 
speech– motor control.
MOLECULAR LINKS BETWEEN RARΒ AND FOXP2
Retinoic acid receptors canonically function as transcription factors, regulating genes 
responsible for directing normal embryogenesis and brain development. Interestingly, FoxP2 
and RARs share some of the same target genes (Balmer and Blomhoff, 2002; Delacroix et al., 
2010; Devanna et al., 2014). RARs are highly expressed in the brain (Krezel et al., 1999) and are 
present throughout embryonal development (Mollard et al., 2000), postnatal development 
(Wei et al., 2011), and in adults (Krezel et al., 1999; Zetterstrom et al., 1999). Notably high 
expression of RARs can be found throughout the motor circuitry, including cortical, striatal, 
and multiple thalamic regions (Krezel et al., 1999), (Figure 1B). We focus on two key receptors 
found in the motor circuitry: RARα and RARβ. RARα is found in layer 5 of the cortex and 
in the thalamus – both regions that overlap with murine Foxp2 expression (Krezel et al., 
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1999; Zetterstrom et al., 1999; Ferland et al., 2003; Lai et al., 2003; Hisaoka et al., 2010). 
Interestingly, Foxp2 only overlaps with RARα in the motor cortex layer 5, because Foxp2 
expression is largely restricted to layer 6 of other mature cortical areas. RARβ is strongly 
expressed only in the striatum, another site where Foxp2 expression is highest (Figure 1B). 
Notably, FOXP2 has been shown to directly drive RARβ expression in human cells (Vernes 
et al., 2007; Devanna et al., 2014), although this is yet to be shown in the striatum. This 
high level of overlap, combined with shared target genes and molecular interactions, strongly 
supports interplay between FoxP2 and RARs in motor pathways.
CONCLUDING REMARKS
In addition to its canonical role during embryogenesis, studies described here suggest RA 
signaling plays a specific role in the development and function of striatal motor circuitry and 
may link to FoxP2 function. Disruption of the RA pathway results in strikingly similar phenotypes 
to FoxP2 mutation on multiple levels, which suggests a potential mechanistic interaction. 
FoxP2 and RARs can regulate some common target genes, affect similar cellular phenotypes 
and show highly overlapping expression patterns in the cortico-striato-thalamic motor 
circuitry. In the striatum, aberrant function of Foxp2 and RA signaling contributes to altered 
development and, in the case of mutations of mouse Foxp2, altered synaptic plasticity similar 
to that seen in the hippocampus of RARα mutant animals. Given that RARβ is predominantly 
expressed in the postnatal striatum, it seems likely that its disruption will also affect striatal 
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plasticity, however, this is yet to be experimentally determined. Lastly, animals with mutated 
Foxp2 or RA signaling defects show comparable motor control/learning impairments. Thus 
at multiple levels (molecular, cellular, circuit, and behavioral) there is evidence that interplay 
between FoxP2 and RA signaling may facilitate proper development and function of motor 
circuitry. This evidence from mice is strengthened by findings in songbirds which show both 
FoxP2 and RA influence song learning by acting in circuits that have parallels with human 
vocal-motor pathways (Haesler et al., 2007; Wood et al., 2008). In the future it will be of great 
value to understand if these signaling cascades interact to influence neuronal mechanisms 
related to song learning or speech–motor control, and if RA signaling deficits are involved in 
aberrant speech–motor development in humans. The capacity for human speech and spoken 
language is dependent on multiple molecular and neural building blocks. With the link 
between FoxP2 and RA signaling, a new block has been suggested, giving us new opportunities 
to investigate the evolution and development of the (spoken) language ready brain.
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ABSTRACT
Heterozygous mutations of the transcription factor FOXP2 in humans lead to childhood 
apraxia of speech (CAS). FOXP2 is highly expressed in GABAergic and dopaminergic neurons 
throughout the basal ganglia, including expression in the striatum, substantia nigra and 
multiple thalamic nuclei. fMRI data from individuals with CAS shows that basal ganglia activity is 
affected by heterozygous mutation of FOXP2. In mouse models of Foxp2 dysfunction, aberrant 
striatal development and impaired striatal activity and plasticity have been established at the 
single-cell level. This commonality of how FoxP2 dysfunction affects striatum across species 
suggests human and mouse FoxP2 might affect the same neurobiological pathways. In order 
to investigate the effect of FOXP2 mutation in human neurons at single-cell resolution, we 
developed a protocol to generate human excitatory induced dopaminergic neurons (DA 
iNeurons), via controlled differentiation of human induced pluripotent stem cells (hiPSCs). 
We confirmed the dopaminergic identity of these cells as well as the expression of FOXP2 
in mature DA iNeurons. Next, we used an isogenic FOXP2 knockout line (FOXP-/-) to compare 
excitatory activity between control and FOXP2 knockout neurons. FOXP2-/- DA iNeurons 
showed reduced excitatory activity both on the single cell and network level. The effects 
of FOXP2 mutation on excitatory activity are similar to findings in mouse models for FoxP2 
dysfunction and suggest human and mouse FoxP2 regulate excitatory striatal activity through 
the same neurobiological pathways. 
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INTRODUCTION 
The production of spoken language is a uniquely human feature, which depends on higher 
cortical function, as well as subcortical circuits (Lieberman, 2002, 2007). Generation of 
the complex motor sequences necessary for speech requires rapid control of the relevant 
musculature, achieved through strict regulation of activity within cortico-striato-thalamic 
circuitry (Ackermann et al., 2014; Barbas et al., 2013; Booth et al., 2007; Jurgens, 2002; 
Ziegler and Ackermann, 2013). Moreover, neurodevelopmental disorders which dysregulate 
cortico-striato-thalamic circuit function severely impair complex motor sequencing in both 
humans and animal models (Shepherd, 2013). With speech production being a specialization 
of complex motor sequencing (Ackermann et al., 2014), a number of disorders that 
disproportionately affect speech production have been described (Deriziotis and Fisher, 
2017; Newbury and Monaco, 2010). One of these is disruption of the transcription factor 
FOXP2 (Fisher et al., 1998; Lai et al., 2001; Lai et al., 2003; MacDermot et al., 2005; Morgan 
et al., 2017). Mutation of FOXP2 was first described for the KE-family, in which half of the 
family members are affected by childhood apraxia of speech (CAS), accompanied by wide-
ranging problems with expressive and receptive language (Lai et al., 2001). CAS is defined 
as ‘a disorder of speech motor programming or planning that affects the production, 
sequencing, timing and stress of sounds’(Morgan et al., 2017). Investigations into FOXP2 
protein function have shown that this transcription factor is able to regulate many genes, 
including genes involved in neurodevelopment and synaptic function (Spiteri et al., 2007; 
Vernes et al., 2011). Furthermore, investigation of brain morphology and activity in KE family 
members and controls has revealed that grey matter volume is reduced (Watkins et al., 2002) 
and brain activity is altered in affected KE family members in areas relevant for complex 
motor sequencing. Overactivation of the head of the caudate nucleus was seen during a 
word repetition task (Vargha-Khadem et al., 1998), and underactivation of the putamen and 
thalamus in a different study during a covert verb generation task (Liegeois et al., 2003). 
Animal models for FoxP2 dysfunction (we use here the standard nomenclature from (Kaestner 
et al., 2000)) have been used to investigate how this transcription factor is involved in the 
regulation of motor sequencing and motor skill learning (Campbell et al., 2009; French et al., 
2012; Gaub et al., 2010; Groszer et al., 2008; Haesler et al., 2007; Murugan et al., 2013). It has 
been shown that mutations and/or localized knockdowns of FoxP2 lead to morphological and 
functional changes in the striatum in mice (Chen et al., 2016; French et al., 2012; Groszer et 
al., 2008; van Rhijn et al., 2018) and in the striatal song nucleus area X in zebra finch (Murugan 
et al., 2013; Schulz et al., 2010). Foxp2 affects both excitatory and inhibitory activity in the 
striatum. In mice with a heterozygous Foxp2 nonsense mutation, excitatory activity is reduced 
and inhibitory activity is increased in Dopamine receptor type 1 expressing striatal medium spiny 
neurons (D1R-MSNs) (van Rhijn et al., 2018). It has been shown that heterozygous knockout 
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of Foxp2 leads to changes in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptor abundance (Chen et al., 2016) yielding a reduction of excitatory activity. Furthermore, 
expression of GAD67, one of the main enzymes involved in the synthesis of GABA, is increased 
in mice with heterozygous Foxp2 loss of function. This leads to increased presynaptic GABA 
content and can explain the increased inhibitory drive of D1R-MSNs (van Rhijn et al., 2018). 
Three amino-acid substitutions distinguish the human FOXP2 protein from its mouse 
ortholog. Two of these changes occurred on the hominid lineage after splitting from that of 
chimpanzees and are present in exon 7 of FOXP2 (T303N and N325S). These evolutionary 
changes have been hypothesized to confer unique properties to human FOXP2 that may be 
relevant for its involvement in speech and language production (Enard et al., 2002; Zhang et 
al., 2002). The substitutions have been shown as present in older hominids (Neanderthals and 
Denisovans (Krause et al., 2007)), and highly detailed investigation of FOXP2 has suggested 
that no other changes to FOXP2 which can convey additional functionality occurred later 
during human evolution (Atkinson et al., 2018). The third change is a conservative change 
exclusive to the mouse evolutionary lineage and is present towards the start of Foxp2 (D80E) 
(Enard et al., 2002). Mice have been generated in which normal Foxp2 has been substituted 
with a version of the gene which encodes the T303N and N325S human substitutions (Enard 
et al., 2009). Assessments of cell morphology have shown that synapse density and striatal 
MSN complexity are increased in these partially ‘humanized’ mice (Chen et al., 2016; Enard 
et al., 2009; Reimers-Kipping et al., 2011). Furthermore, both long term potentiation (LTP) 
and long-term depression (LTD) can be more readily induced in striatal brain slices of the 
‘humanized’ mice (Schreiweis et al., 2014). Lastly, on the behavioral level these amino-acid 
substitutions have been associated with faster switching from declarative to procedural 
learning (Schreiweis et al., 2014) as well as to changes in exploratory behavior (Enard et al., 
2009). These findings suggest that incorporation of the human amino-acid substitutions is 
able to modify functionality of mouse Foxp2. 
The recent advancements in the generation of human neurons from induced pluripotent stem 
cells (iPSCs), have made it possible to investigate genetically mediated neurodevelopmental 
disorders using human cellular models (Brennand et al., 2011; Chailangkarn et al., 2012; 
Chailangkarn et al., 2016; Linda et al., 2018; Tamburini and Li, 2017). FOXP2 is expressed in 
distributed areas the basal ganglia, both in humans and mice (Campbell et al., 2009; Lai et al., 
2003). For the striatum, it is known that FoxP2 is expressed highly in GABAergic medium spiny 
neurons, which are a category of dopamine neuron (Fong et al., 2018; van Rhijn et al., 2018; 
Vernes et al., 2011). Furthermore, FoxP2 is also expressed in areas where almost exclusively 
excitatory dopaminergic neurons are present. For example, FoxP2 expression has been shown 
in parts of the substantia nigra pars reticulata (SNr) and throughout the substantia nigra pars 
compacta (SNc), though it is currently unknown in which cell populations in these areas FoxP2 
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is predominantly expressed (Campbell et al., 2009; Lai et al., 2003). In order to investigate the 
functions of FOXP2 in excitatory human neurons, we generated a human iPSC derived culture 
of excitatory DA neurons, hereafter referred to as DA iNeurons using a protocol adapted 
from (Sundberg et al., 2013). Neuronal identity was confirmed by immunofluorescent 
staining and we furthermore confirmed that mature DA iNeurons express FOXP2. We used 
this protocol to generate neurons from a control cell line and a cell line with homozygous 
deletion of FOXP2 (FOXP2-/-) generated by CRISPR/Cas9 mediated genome editing. Control 
and FOXP2-/- DA iNeurons showed comparable active and passive intrinsic properties. Further 
electrophysiological analysis revealed a clear reduction in excitatory activity in the FOXP2-
/- neurons at the single-cell and network level. Our data therefore suggest that homozygous 
deletion of FOXP2 in human neurons affects synaptic maturation and neuronal network 
development. Investigation of FOXP2 function in a human neuron model is an important step 
towards understanding how FOXP2 might regulate brain circuits involved in the generation 
of spoken language and if this might differ from the conserved roles Foxp2 has played in 
complex motor skill learning during evolution.
RESULTS 
DA iNeurons are viable and express FOXP2 in mature DA iNeurons
To assess the effects of homozygous deletion of FOXP2 on DA iNeurons, we first developed 
a differentiation protocol to produce excitatory DA iNeurons from human iPSCs (Figure 
1a). Our protocol is adapted from a previously published protocol which reliably produces 
functional DA iNeurons (Sundberg et al., 2013). Supplementation with DAPT was used to 
promote differentiation toward a DA lineage. For a detailed list of the compounds used during 
iPSC culturing and differentiation, see table 1. At days in vitro (DIV)55, DA iNeurons show a 
mature complexity by staining of dendrites with MAP2 (Figure 1b). Reconstruction of individual 
stained neurons further highlights that these neurons show multiple dendrites, which span 
>100 µm within the culture dish (Figure 1c). DA identity of the iNeurons was confirmed at 
DIV55 by tyrosine hydroxylase (TH) staining (Figure 1d), and all neurons in the DA iNeuron 
culture express TH. Furthermore, at DIV55, at least 60% of the DA iNeurons express FOXP2, 
as shown by co-expression of TH and FOXP2 (Figure 1d). These data demonstrate that our 
differentiation protocol generates DA iNeurons with mature complexity similar to DA neurons 
from mouse primary culture (Gaven et al., 2014), and that FOXP2 is expressed in these neurons. 
This expression pattern of FOXP2 shows similarities to the distributed expression of FOXP2 in 
dopaminergic neurons in the mouse, zebra finch and human, where the sparse labeling of cells 
within for example the SNr and SNc suggests specific cell populations express FoxP2. (Campbell 
et al., 2009; Lai et al., 2003; Teramitsu et al., 2004) Subsequently, we used this differentiation 
protocol to investigate the effect homozygous deletion of FOXP2 on neuronal activity.
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Both FOXP2+/+ and FOXP2‑/‑ iNeurons show comparable active and passive intrinsic 
properties
Homozygous knockout or mutation of FOXP2 is known to affect neurodevelopment in 
vitro in primary striatal cell cultures (Vernes et al., 2011) and mouse brain tissue (Groszer 
et al., 2008). Furthermore, mice with heterozygous Foxp2 mutations develop normally, 
but display aberrant neuronal activity during development as well as in adulthood. 
FOXP2
Hoechst
TH
TH
FOXP2
d
MAP2
Figure 1: iPSCs differentiated into DA iNeurons express TH and FOXP2. 
(a) Timeline for differentiation of iPSCs toward a dopaminergic lineage. For details on the protocol see methods. 
(b) MAP2 staining of dopaminergic neurons shows high complexity and >100µm neurite length. (c) reconstruction 
of a single dopaminergic neuron including all dendrites. The axon is not visible with MAP2 staining. (d) FOXP2 is 
expressed in a subset of dopaminergic iNeurons, as shown by the incomplete overlap between HOECHST (which 
stains all nuclei) and FOXP2. (e) Dopaminergic neuron identity is confirmed by Tyrosine hydroxylase expression, and 
dopaminergic neurons express FOXP2 shown by overlap between FOXP2 and TH. Scalebar for b,d,e = 20µm.Scalebar 
for c = 50µm
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By contrast, mice with homozygous Foxp2 mutations show severe developmental impairments 
and die between the third and fourth postnatal week (Groszer et al., 2008). This suggests 
cellular physiology might be severely impaired by homozygous FOXP2 knockout. We therefore 
assessed initially if intrinsic membrane properties might be affected by homozygous FOXP2 
knockout in our human DA iNeuron model. Intrinsic properties can be divided into active 
properties and passive properties. Active properties describe the possibility of neurons to 
generate strong action potential firing when presented with a depolarizing current, whereas 
passive properties give a measure of the excitability and maturity of a cell (Planert et al., 
2013). In order to investigate FOXP2 dysfunction in human DA iNeurons we used an isogenic 
line generated from our control line in which FOXP2 was homozygously deleted through a 
disruption of exon 7, which leads to a lack of the encoded protein, and hence loss of function. 
Loss of FOXP2 function has been previously described in multiple cases of FOXP2 associated 
CAS (MacDermot et al., 2005; Morgan et al., 2017). Reported cases include nonsense 
mutations that lead to insertion of a STOP codon in exon 7 of FOXP2, such as the R328X 
mutation, predicted to result in protein truncation and nonsense mediated decay. Reduction 
of Foxp2 expression has been shown in mice carrying a similar (but not identical) mutation 
(S321X) (Groszer et al., 2008). 
To investigate active and passive intrinsic properties, we used a current-voltage protocol in 
which depolarizing current steps of increasing current amplitude were given until reliable 
action potential firing was elicited (Figure 2a). We measured intrinsic properties of DA 
iNeurons at DIV55 and found that both control and FOXP2-/- DA iNeurons are able to generate 
action potentials (Figure 2b). Active and passive properties were extracted from either a 10 
mV square voltage step (cell capacitance of membrane resistance, Figure 2d,e) or from the 
I-V traces (resting membrane potential, max AP amplitude and AP threshold, Figure 2f,g,h). 
Intrinsic properties were comparable for the different lines at DIV55, with a similar resting 
membrane potential, action potential threshold, membrane resistance and cell capacitance. 
We did not observe any changes in intrinsic properties, which suggests that DA iNeurons 
lacking any FOXP2 expression are generally healthy and develop into fully functional neurons. 
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Figure 2: Intrinsic properties are similar between FOXP2+/+ and FOXP2‑/‑ DA iNeurons 
(a) Current-voltage protocol. A two second square step of fixed current size was given. Step size increased with 
each consecutive recording. Scalebar = 500ms/20pA. (b) Example trace of action potentials generated by FOXP2+/+ 
and FOXP2-/- DA iNeurons at DIV55, scalebar = 20mV/1sec. (c-g) Membrane resistance, cell capacitance, resting 
membrane potential, action potential threshold and maximum action potential amplitude for FOXP2+/+ and FOXP2-/- 
iNeurons (Resistance: FOXP2+/+ 925.5±130 MΩ, FOXP2-/- 856±156 MΩ, NS. Capacitance: FOXP2+/+ 38.2±2.8 pF, FOXP2-
/- 34.1±2.6 pF, NS. RMP: FOXP2+/+ -51.6±2.6mV, FOXP2-/- -46.9±3.3 mV, NS. AP threshold: FOXP2+/+ -30.2±1.4 mV 
FOXP2-/- -29.1±2.0 mV, NS, max AP amplitude: FOXP2+/+ 82.0±11.2 mV FOXP2-/- 72.3±17.3mV NS).
Excitatory activity is reduced in human DA iNeurons with reduced FOXP2 expression
Heterozygous and homozygous Foxp2 loss of function leads to decreased excitatory activity 
in mouse striatal neurons (Chen et al., 2016; van Rhijn et al., 2018). Therefore, we next 
investigated if spontaneous synaptic activity might be impaired in human DA iNeurons with 
homozygous FOXP2 deletion. In mice, excitatory activity is reduced both in neurons from 
juvenile (postnatal day 10-15) as well as adult (postnatal day 55-60) mice (van Rhijn et al., 
2018). Activity is furthermore only decreased for those MSNs which would normally express 
FOXP2, which predominantly are D1R-MSNs. In mice excitatory input onto D1R-MSNs is 
mainly achieved through corticostriatal connections (Hunnicutt et al., 2016; Smith et al., 
2004) However, the DA iNeurons we generate are excitatory and form a network in vitro. 
Therefore, an effect of FOXP2 on excitatory neurotransmission would likely be aggravated. To 
investigate if homozygous FOXP2 deletion affects excitatory activity in human DA iNeurons, 
we measured spontaneous excitatory postsynaptic currents (sEPSCs) and compared FOXP2+/+ 
neurons with isogenic FOXP2-/- neurons. Two developmental time points (DIV55 and DIV73, 
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Figure 3a,c) were chosen to investigate if differences in activity between genotypes would 
persist during maturation. sEPSC amplitude was reduced in cells with homozygous FOXP2 
deletion (Figure 3b,d) whereas sEPSC frequency was increased (Figure 3c,f). The decreased 
amplitude and increased frequency are persistent and present at both DIV55 and DIV73. 
Though the decreased sEPSC amplitude is in line with the data obtained from mice with 
heterozygous and homozygous loss of Foxp2 function, such mice did not show an increase in 
sEPSC frequency. This difference might be explained by the fact that presynaptic excitatory 
striatal connections are not established by cells which express FoxP2 in vivo. sEPSC frequency 
is mostly affected by release probability and presynaptic strength (Planert et al., 2013), and 
our data suggest that FOXP2 might affect presynaptic mechanisms as well in DA iNeurons, in 
addition to its effects on the postsynapse, both in DA iNeurons and mouse D1R-MSNs.
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Figure 3: FOXP2‑/‑ DA iNeurons show reduced sEPSC amplitude and increased sEPSC frequency.
(a) Example traces of sEPSC activity at DIV55. (b) cumulative graph of sEPSC amplitude (Average: FOXP2+/+ 
27.0±4.5pA, FOXP2-/- 19.4±3.1- P<0.01) and frequency (Average: FOXP2+/+ 0.86±0.15Hz, FOXP2-/- 1.93±0.8 P<0.01) 
at DIV55 . (d) Same as (a) but for DIV73. (e) cumulative graph of sEPSC amplitude (Average: FOXP2+/+ 32.11±8.7 pA, 
FOXP2-/- 20.36±2.72 pA- P<0.01) and frequency (Average: FOXP2+/+ 1.88±0.36 Hz, FOXP2-/- 5.27±1.4 Hz P<0.01) at 
DIV73. ***=P<0.01, Kolmogorov-Smirnoff nonparametric test. Scalebar = 10pA/1sec.
Network activity is impaired in human iNeurons with reduced FOXP2 expression
The change in sEPSC amplitude and frequency shows that excitatory inputs are affected 
by homozygous FOXP2 deletion. Intriguingly, our cells show both a reduction in amplitude 
(suggesting reduced excitatory input) and an increase in frequency (suggesting increased 
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excitatory input). Because of this, it is unclear how the changes at the single cell level affect 
the general network activity. We therefore investigated if a network phenotype is present 
in human DA iNeuron cultures with homozygous FOXP2 deletion. To investigate the roles 
of FOXP2 at the network level, we cultured FOXP2+/+ and FOXP2-/- human DA iNeurons on 
multi-electrode arrays (MEAs). This enabled us to measure population activity, as each MEA 
is equipped with a high number of electrodes which can measure action potential generation 
at the single spike level. We measured activity in DA iNeurons from both the FOXP2+/+ and 
FOXP2-/- lines in a single multi-well MEA. Network activity was measured at both DIV55 and 
DIV73 (Figure 4a,b). Activity was highly reduced in the FOXP2-/- lines, shown by a strong 
reduction in the mean firing rate (Figure 4c,e). Intriguingly, the increased sEPSC frequency 
shown at the single cell level is not visible at the network level, which suggests that increased 
sEPSC frequency due to homozygous FOXP2 deletion does not lead to an overall increased 
network activity. Furthermore, burst duration did not seem to be affected (Figure 4d,f), which 
suggests that FOXP2 deficient cells still form a well-connected network in which correlated 
activity can propagate through the culture (Bisio et al., 2014; Frega et al., 2017).
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Figure 4: Homozygous FOXP2 deletion leads to impaired network activity. 
(a) Raster plot of 1 minute of spontaneous activity recorded on a 6 well MEA device of either FOXP2+/+ (left) or 
FOXP2-/- (right) DA iNeurons at DIV55 and DIV73. Each horizontal line is a single electrode. Each vertical line displays 
a single recorded event. Reduced activity can be seen as a reduction of events recorded. (b) Quantitative analysis of 
mean firing rate and burst duration between FOXP2+/+ and FOXP2-/-- cells at DIV55 and DIV73 (Mean firing rate DIV55: 
FOXP2+/+ 9.6±1.95Hz FOXP2-/- 1.34±1.04Hz, P<0.01. Mean firing rate DIV73 FOXP2+/+ 7.13±2.12Hz, FOXP2-/- 1.6±0.6, 
P<0.04. Burst duration DIV55 FOXP2+/+ 353±16.3ms, FOXP2-/- 402.4, NS., Burst duration DIV73 FOXP2+/+ 363.3±24.4ms 
FOXP2-/- 338.1±23.2 NS)
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DISCUSSION
FoxP2 is a transcription factor with high conservation across species. However multiple amino 
acids which could potentially affect FoxP2 function distinguish between mouse and human 
orthologs. In order to investigate if human and mouse FoxP2 affect the same neurobiological 
processes, we studied human iPSCs with either intact FOXP2 or homozygous FOXP2 deletion. 
We subsequently generated human DA iNeurons which express FOXP2 and characterized 
neuronal activity at a single-cell and network level. Our data show reduced excitatory sEPSC 
amplitude, similar to the decrease in excitatory synaptic strength shown in D1R-MSNs 
from mice with a heterozygous loss of Foxp2 function mutation. Intriguingly, whilst in mice 
the frequency of excitatory events is not affected, sEPSC frequency is increased in human 
FOXP2-/- DA iNeurons. This finding suggests that FOXP2 affects both pre- and postsynaptic 
mechanisms. We show for the first time that FOXP2 is important for network activity in vitro. 
Homozygous FOXP2 knockout leads to a reduced firing rate, whereas bursting behavior seems 
to not be affected by a lack of FOXP2 expression.
Different FOXP2 mutations, including nonsense mutations, have been found in individuals 
with CAS (Morgan et al., 2017). Despite variation in mutation type, all individuals with 
etiological heterozygous mutations in FOXP2 show similar behavioral phenotypes, with CAS 
accompanied by wide-ranging language impairments. Furthermore, mice with heterozygous 
mutations in Foxp2 display impaired motor skill learning, and behavioral phenotypes are 
conserved between mutations (French et al., 2012; Groszer et al., 2008; van Rhijn et al., 
2018). However, it seems that different mutations of FOXP2 can uniquely affect underlying 
neurobiological mechanisms. For example, the missense R553H mutation of the KE family 
leads to an increase in striatal activity in vivo (French et al., 2012) and in vitro (van Rhijn et 
al., Chapter 3) in the Foxp2R552H/+ mouse model of this mutation. This is in contrast to the 
decreased excitatory activity shown for the S321X nonsense mutation (van Rhijn et al., 2018) 
and Foxp2 knockout (Chen et al., 2016). Investigation of a human FOXP2R553H/+ cell line would 
be an intriguing addition to the emerging view that different FoxP2 mutations have unique 
effects on cellular function.
Both Foxp2 knockouts as well as missense mutations have been shown to affect 
neurodevelopment. In mouse primary cultures, Foxp2R552/R552H leads to gross impairments 
in neurite outgrowth and neurodevelopment (Vernes et al., 2011). Similarly, homozygous 
knockout of Foxp2 leads to reduced excitatory spine density of MSNs. In affected individuals 
from the KE family changes in gray matter density are seen for a number of regions, including 
the caudate/putamen and the cerebellum, where FOXP2 is highly expressed (Watkins et 
al., 2002). Our control human DA iNeurons form a functional neuronal network in vitro and 
FOXP2-/- neurons show similar intrinsic properties to control neurons. This finding suggests 
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that general neuronal development is not grossly impaired, even with complete loss of 
FOXP2 expression. However, smaller deficits on the level of synapse development could still 
be present, and in fact are suggested by our single cell electrophysiology data. An in-depth 
characterization of control and affected neurons through immunofluorescent staining and 
morphological reconstruction will unveil exactly how neurodevelopment in human neurons 
is affected by homozygous FOXP2 deletion. Furthermore, mice with heterozygous knockout 
of Foxp2 show a reduction in AMPA receptor expression (Chen et al., 2016), which would be 
a logical explanation for the reduction in excitatory amplitude that we observed in our human 
DA iNeurons. The physiological effects that absence of FOXP2 expression has on excitatory 
activity indicate that excitatory pre- and postsynapses are affected. 
FOXP2 expression is high in a range of different types of neurons throughout the brain (Ferland 
et al., 2003; Hisaoka et al., 2010; Takahashi et al., 2003). Research on the physiological 
effects of Foxp2 mutations has largely focused on striatal GABAergic MSNs, and these show 
a clear reduction in excitatory event amplitude following heterozygous Foxp2 loss of function 
mutation (van Rhijn et al., 2018). However, the increased excitatory event frequency that we 
observed in our human DA iNeurons with homozygous FOXP2 knockout is absent in mouse 
MSNs with heterozygous mutations. This can possibly be explained by the difference in 
neuronal identity between the cells. Our DA iNeurons are glutamatergic, which contrasts with 
the GABAergic identity of MSNs. Striatal MSNs only receive excitatory connections from the 
cortex and the thalamus. Though there are cortical and thalamic cells which express Foxp2, 
it unclear whether these cell populations project to the striatum (Hunnicutt et al., 2016; 
Smith et al., 2004). The lack of a change in excitatory event frequency in mouse striatal D1R-
MSNs suggests that presynapses which terminate on striatal D1R-MSNs are probably not 
affected by changes in Foxp2 levels. In contrast to this, our human DA cells form an excitatory 
network with excitatory pre- and postsynaptic connections between cells which normally 
express FOXP2. The measured increase in excitatory activity, combined with the reduction of 
sEPSC amplitude in FOXP2 knockout DA iNeurons, suggests that FOXP2 affects both pre- and 
postsynaptic mechanisms in these cells. Alternatively, the increased frequency could be a cell-
autonomous response to a reduction in excitatory amplitude following FOXP2 knockout, to 
restore the balance of excitatory activity within the network. Compensatory neurobiological 
mechanisms have been described in the context of neurodevelopmental disorders (Marder 
and Goaillard, 2006; Nelson and Valakh, 2015), and the homogenous network established 
by DA iNeurons could enable compensation for the effects of FOXP2 knockout on neuronal 
activity. Further investigation of the mechanisms which lead to the changes in excitatory 
amplitude and frequency would give novel insights into how FOXP2 affects homeostasis and 
how different neuronal networks are affected by disruptions of this transcription factor.
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Importantly, the use of iNeurons from a human background enables us to investigate possible 
human-specific functions of FOXP2. Human FOXP2 is distinct from orthologs of other animal 
species (Enard et al., 2002). It has been suggested that the T303N and N325S amino-acid 
substitutions specific to the hominind lineage might convey unique functionality to FOXP2 
(Enard, 2011). In the past, mice have been generated that express Foxp2 with these human 
substitutions. Mice which express a partially ‘humanized’ Foxp2 show increased neuron 
complexity, increased plasticity, changes in exploratory behavior and a faster switch from 
declarative to procedural learning (Reimers-Kipping et al., 2011; Schreiweis et al., 2014). Such 
findings suggest evolutionary modification of the ways that FOXP2 can regulate neuronal 
activity. Furthermore, it is known that FOXP2 exhibits human specific regulation of genes 
involved in brain development compared to chimpanzee FoxP2 (Konopka et al., 2009). Though 
the mouse data suggests unique properties of FOXP2 in cell physiology, these data lack 
translational ability to the human situation. Our DA iNeurons provide a unique opportunity to 
generate cells from a human lineage which express FOXP2 and investigate these on a genetic, 
morphological and functional level. Furthermore, the successful generation of DA iNeurons 
from human material also enables the generation of functional neurons from individuals 
who carry CAS-associated mutations in FOXP2. These could be used to investigate whether 
different mutations of FOXP2 or other CAS related genes uniquely affect neuronal function in 
human neurons and might provide a platform to investigate possible therapeutic treatments 
in vitro which restore neuronal activity to control conditions. Though we are currently 
constrained to the generation of glutamatergic cells, loss of FOXP2 function clearly affects 
these neurons. A next step should be to generate inhibitory neurons with FOXP2 expression, 
as this transcription factor strongly affects inhibitory activity as well (van Rhijn et al., 2018). 
This combination of excitatory and inhibitory cells which express FOXP2 will be a powerful 
tool to further understand how the gene affects neuronal function.
Lastly, the ability to generate human neurons which express FOXP2 is of interest as well from 
an evolutionary perspective. The ability to generate FOXP2 with specific mutations through 
CRISPR/Cas9 editing enables the generation of human cell lines, which recapture ancestral 
states of FOXP2 in evolution of our ancestors. In a similar fashion to the partially ‘humanized’ 
mice it is possible to generate a cell line where the T303S and N325S substitutions have been 
reverted. This would result in DA neurons in which the FOXP2 protein is the same as that of 
chimpanzees (Enard et al., 2002). Investigation of differences in FOXP2 function between 
control human neurons and these ‘ancestralized’ neurons can show us the commonalities 
and differences between human FOXP2 and orthologs of closely related species. How FOXP2 
might have changed during evolution and which role it might play in our ability to produce 
speech and language is still a largely unresolved issue. Our human DA iNeurons could be a 
valuable tool for providing novel insights into the neuronal processes which have enabled 
emergence of spoken language during human evolution.
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To conclude, we have for the first time generated human functional neurons which 
endogenously express FOXP2. In these neurons, FOXP2 regulates excitatory activity and loss 
of its expression by homozygous knockout leads to a marked reduction of excitatory activity. 
This recapitulates the excitatory phenotype found in mice with heterozygous loss of Foxp2 
function, validating DA iNeurons as a novel tool to study FOXP2. The ability to culture cell 
lines from individuals with mutations in FOXP2, as well as to generate cell lines which can 
recapture ancestral evolutionary states of this gene, will be a powerful way to further help 
us understand how it is involved in the uniquely human ability to produce spoken language.
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MATERIALS & METHODS
Genome editing
IPSC lines which express either FOXP2+/+ or FOXP2-/- were generated from a control IPSC line 
(A161A) by the research group of Svante Pääbo (MPI for Evolutionary Anthropology, Liepzig, 
Germany). In short, one 80% confluent well with a control IPSC line A161A of a one six-well 
plate was treated with Accutase for 15 minutes and cells were filtered through a 40 um sieve. 
DNA was added to cells and electroporated with Nucleofector 2b Device (Lonza) using B-16 
program. Electroporation mixture contained ~1 million cells, plasmid pSpCas9n(BB)-2A-Puro 
(PX462) V2.0 (Addgene #62987), dsDNA encoding for gRNA (1ug), donor ssDNA (200pm) 
and Scr7 (1uM). Cells were treated with puromycin (1ug/mL) for two days to select for cells 
transfected with DNA.
Loss of function mutations on both alleles were generated in sequence. First, one mutation 
was introduced (heterozygous). Positive clones were expanded and sequenced. Subsequently, 
the second mutation was introduced in a previously selected positive clone. Two different 
target sequences were designed, one for each allele. Target sequences and corresponding 
DNA donor sequence for genome editing are shown in Table 1.
Table 1:Target and donor sequences:
Target 
sequence 1
GATGCTTTGGAAGTGTTGG
Target 
sequence 2
GTCTAAGTGCAAGACGAGAC
Donor 
sequence 1
CATTCACTATGGAATGATGAGTTATTGGTGGTGATGCTTTGGAAGTGGTGGAGGAGGTAGTCGAGGAGGAATTGTTAGTAGTGAGGTCTAGCCC;
Donor 
sequence 2
ACCAATAACTCATCATTCCATAGTGAATGGACAGTCTTCAGTTCTAAATGCAAGACGAGACAGGTAAATCTCATGAGCTTTATTCTATATTTATCTATT.
Generation of dopaminergic iNeurons
Frozen iPSCs were thawed and reprogrammed to a dopaminergic lineage as outlined in Figure 
1A according to a protocol modified from (Sundberg et al., 2013). In short, iPSC colonies 
were split into single cells by Accutase treatment for 5 min at 37oC 2 days before the start 
of differentiation and 2.0*104 cells were plated on vitronectin-coated plates in E8 medium 
supplemented with 1x RevitaCell (Thermo Fisher). From DIV0 to DIV5 E8 medium was replaced 
with knockout DMEM supplemented with 15% knockout serum replacement, 1x GlutaMAX 
100U/ml, Penicillin-Streptomycin (100U/ml) and 1x MEM-NEAA. β-Mercaptoethanol (0.1mM) 
was added to the stock medium fresh before each medium change. Between DIV6 and 9, KO-
DMEM was gradually replaced by 25%, 50%, 75% and 100% N2 medium (DMEM/F2 with 1x 
N2 supplement). From DIV12 iNeurons were cultured in neurobasal medium supplemented 
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with 1x B27 and 1x Glutamax, and half the medium was replaced every two days. Cells were 
passaged by dissociation with Accutase at 100% confluency. At DIV20, immature iNeurons 
were dissociated to single cell state and 2.0*104 cells were re-plated on poly-L-ornithine 
(Sigma, 50µg/ml) and mouse laminin (Sigma 10µg/ml) coated coverslips or MEAs. From 
DIV24, cells were co-cultured with rat astrocytes prepared according to (Frega et al., 2017) 
on a 1:1 ratio to promote maturation. For the concentrations and timepoints of the small 
molecules and growth factors which were added during culturing, see Table 2. 
Table 2: Compounds and small molecular used during differentiation and maturation of Dopaminergic iNeurons.
Compound DIV when added Concentration Company
LDN-193189 DIV 1-11 10µM Stemgent inc.
SB431542 DIV 1-5 10µM Stemgent inc.
Purmorphamine DIV 2-11 10µM Stemgent inc.
FGF-8a DIV 2-11 100ng/ml R&D system
CHIR99021 DIV 3-12 3µM Stemgent inc.
SHH(C24II) DIV 6-12 100ng/ml R&D system
BDNF DIV 12-22 20ng/ml Peprotech
GDNF DIV 12-22 20ng/ml Peprotech
cAMP DIV 12-22 0.5mM Enzo Life Science
TGFβ3 DIV 12-22 2ng/ml Millipore
Ascorbic acid DIV 12-22 200µM Sigma
DAPT DIV 12-22 10nM Millipore
DAPT DIV 22-end maturation 10µM Millipore
Immunocytochemistry
Coverslips containing at least 2.0*104 cells were immersion-fixated in 4% paraformaldehyde/
sucrose solution for 15 minutes at room temperature. Non-specific antibody binding was 
prevented by incubating the cells with 10% normal donkey serum or normal goat serum 
(blocking solution) at RT for 1 hour. Nuclei were stained with Hoechst and the coverslips 
were mounted with DAKO fluoromount medium. Primary antibodies used were Tyrosine 
Hydroxylase (TH-16, Sigma, 1:500) and Foxp2 (Sc-21069, Santa Cruz, 1:500). Imaging 
was done using a Zeiss upright fluorescent microscope with apotome (Zeiss Axio Images, 
Oberkochen, Germany).
Neuronal reconstruction
Wide field fluorescent images of the fixated and MAP2-labelled hiPSC derived dopaminergic 
neurons were taken at 20x magnification using ApoTome microscopy (Zeiss Axio Imager Z1/
Z2). The images were stitched using Fiji (Fiji Is Just ImageJ) 2017 software. Subsequently 
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digital 3D reconstructions of neuronal morphology were created from the MAP2 images 
using Neurolucida 360 (Version 2017.01.4, Microbrightfield Bioscience). An overlay drawing 
was made of the somatodendritic morphology of dopaminergic neurons. Only dopaminergic 
neurons with at least two primary dendrites and at least one dendritic branch point were 
selected for the reconstruction. 
Single-cell electrophysiology
Intrinsic properties and spontaneous excitatory postsynaptic currents (sEPSCs) were 
measured in dopaminergic iNeurons cultured on glass coverslips. Activity was measured at 
DIV55 and DIV73. At the day of measurement, coverslips were transferred to the recording 
setup and incubated in recording artificial cerebral spinal fluid (ACSF) containing (in mM): 124 
NaCl, 1.25 NaH2PO4, 3 KCl, 26 NaHCO3, 10 glucose, 2 CaCl2, and 1 mM MgCl2 continuously 
oxygenated with 95% O2/5% CO2.  The recording bath temperature was kept constant at 32°C. 
Patch pipettes (5–7 MΩ) were made from borosilicate glass capillaries with filament and an 
inner diameter of 0.86mm (Fine Science Tools, Heidelberg, Germany). Patch pipettes were 
filled with intracellular solution containing (in mM): 130 K-Gluconate, 5 KCl, 10 HEPES, 2.5 
MgCl2, 4 Na2ATP, 0.4 Na3GTP, 10 Na-phosphocreatine, 0.6 EGTA (PH 7.2-7.3, 285-295 mOsm). 
sEPSC, cell capacitance and membrane resistance were recorded at -60mV membrane 
potential. Resting membrane potential, action potential amplitude and action potential 
threshold were recorded by I-V curve. sEPSC activity was analyzed using minianalysis 6.0.2. 
software (synaptosoft). All other parameters were extracted using Clampfit 10.7 (Molecular 
devices, San Jose, CA).
Micro-electrode array measurements
Network activity was measured using a 6-well multi-electrode array (MEA) device (Multichannel 
systems, Reutlingen, Germany). MEAs contained 60 TiN/SiN planar round electrodes (30 
μm diameter; 200 μm center-to-center inter-electrode distance). Dopaminergic iNeurons 
were cultured as described above and spontaneous activity was measured at DIV55 and 
DIV73. Medium was refreshed at least 24 hours before the measurement. At the start of the 
measurement, the MEA was transported from the incubator to the setup and placed in a 
separate incubation chamber, continuously perfused with 95% O2/5% CO2 and kept at 37°C. 
Baseline activity was measured for 10 minutes after the MEA was placed in the recording 
chamber. When baseline acitvity was stable, recording was started, and 20 minutes of 
spontaneous activity was recorded. After recording, the MEA was immediate placed back in 
the incubator at 37°C degrees. Activity was quantified using a customized software package 
in MATLAB (SpyCode, (Bologna et al., 2010)). 
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Statistics
All statistical analysis was conducted between two groups (FOXP2+/+ or FOXP2-/-) and average 
data was analyzed by students’ T-test. Cumulative data was analyzed by Kolgomorov-Smirnov 
test (KS-test). Significance was set at P<0.05. All data is represented as average ± SEM.
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FOXP2 AND ITS FUNCTION IN REGULATION OF STRIATAL ACTIVITY
The transcription factor FoxP2 is involved in motor skill learning in rodents, and speech and 
spoken language production in humans. Heterozygous mutation of FOXP2 leads to childhood 
apraxia of speech (CAS) in humans. Previous research has shown that mutations in Foxp2 
affect striatal activity and lead to impaired motor behavior in animal models. However, a 
detailed investigation of how Foxp2 regulates striatal activity on the single cell level has not 
been conducted before. In this thesis, we have shown that Foxp2 regulates both excitatory 
and inhibitory activity specifically in dopamine receptor type-1 expressing medium spiny 
neurons (D1R-MSNs). Nonsense mutation of Foxp2 results in a persistent decrease of 
excitatory and an increase of inhibitory activity, disrupting striatal E/I balance. Blockade of 
inhibitory activity in vivo results in amelioration of the motor skill learning deficit in these mice 
(chapter 2). Next, we have shown that Foxp2 is involved in the early postnatal maturation of 
striatal glutamatergic neurotransmission, as nonsense mutation of Foxp2 leads to delayed 
maturation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). 
Furthermore, we provided evidence that that impaired excitatory receptor trafficking might 
underlie impairments in long term depression known to be present in striatum of both Foxp2 
missense and nonsense mutation mice (chapter 3). We further provided the first evidence 
that different mutations of Foxp2 differently affect striatal activity. Comparison of the effects 
of the nonsense mutation described in chapter 2 and missense mutation (chapter 4) on 
striatal D1R-MSNs revealed that they inversely affect striatal D1R-MSN activity. Missense 
mutation Foxp2 leads to decreased inhibition, and in vivo blockade of inhibition aggravated 
the motor skill learning impairments in these mice. Next, we investigated if retinoic acid 
signaling, through regulation of transcription factor RARβ by Foxp2, is possibly a novel 
mechanism through which Foxp2 affects striatal activity. We comprehensively analyzed the 
current literature on retinoic acid (RA) signaling and concluded that regulation of striatal 
retinoic acid receptor expression and function are highly involved in motor skill learning, 
striatal neurodevelopment and striatal plasticity (chapter 5). This overlaps with the current 
knowledge on Foxp2 and its involvement in regulation of striatal development activity. The 
ability of Foxp2 to regulate RARβ suggests interaction between these two transcription factors 
may have a key function in striatal circuit function. Lastly, we generated human dopaminergic 
neurons and used these to assess how dysfunction of human FOXP2 affects neuronal activity 
(chapter 6). We show that FOXP2 is expressed in excitatory induced dopaminergic neurons 
(DA iNeurons) and that homozygous deletion of FOXP2 leads to reduced excitatory activity 
and impaired network function in these cells. In this chapter, we will discuss these findings 
and where we think future research into FoxP2 should be aimed.
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The function of FOXP2 at the level of human speech and spoken language
The first possible genetic underpinnings for speech were described by studies of the KE family, 
in which more than half of the family members were described as affected by developmental 
verbal dyspraxia (DVD): ‘difficulty in organizing and coordinating the high speed movements 
necessary to produce intelligible speech’ (Hurst et al., 1990). After the clinical description 
of the speech impairment present in this family, additional investigation into affected family 
members by linguists led to the proposal that they have expressive and receptive deficits in 
usage of grammatical rules (Gopnik and Crago, 1991). This led some researchers to suggest 
that affected family members have impaired higher order cognitive processing, resulting in 
specific deficits in spoken language production and comprehension. The possible genetic 
nature of the disorder in turn fueled a discussion that genes for uniquely human traits such 
as spoken language or grammar might exist. Though it has been shown that both verbal and 
nonverbal IQ are lower in affected individuals compared to unaffected family members of 
the KE family (Vargha-Khadem et al., 1995), nonverbal IQ is much more preserved compared 
to verbal IQ. Advancements in genetic screening reignited the investigation of this family 
and unveiled mutation of the gene FOXP2 as the genetic cause of their disorder (Fisher et 
al., 1998; Lai et al., 2001). From subsequent research into FOXP2-associated disorders, and 
related speech problems in other cases, the description of DVD or (the currently more used) 
childhood apraxia of speech (CAS) has been refined: ‘a disorder of speech motor programming 
or planning that affects the production, sequencing, timing and stress of sounds’ (Morgan et 
al., 2017). This description places the speech impairment at the core of the spoken language 
difficulties displayed by individuals with mutations in FOXP2. As such, it may be argued that 
the grammar, sentence, and phonological impairments could be secondary consequences 
of impaired control over the motor sequencing programs which enable speech production. 
Since the initial discovery and characterization of FOXP2, functional studies of various kinds 
have been conducted to investigate whether and how mutations in this gene affect the 
brain. Imaging of brain structure and recordings of brain activity in human participants have 
unveiled that mutations in FOXP2 lead to alterations in brain anatomy and function (Liegeois 
et al., 2003; Watkins et al., 2002). Convergent findings especially implicate the caudate and 
putamen, which has prompted detailed investigation of analogues of this region in animal 
models for FoxP2 dysfunction. In animal studies, striatal impairment has been shown to be a 
key factor in Foxp2 dysfunction (French et al., 2012; Groszer et al., 2008; Haesler et al., 2007; 
Schulz et al., 2010). The results obtained from the initial genetic and functional investigations 
in both human individuals and animal models show clearly the striatal activity is affected by 
mutations in FoxP2. In order to better understand how Foxp2 regulates striatal activity, we 
set out to investigate changes in striatal physiology following Foxp2 mutation at the single-
level. This detailed assessment of how Foxp2 regulates striatal activity can provide novel 
insight into the complex regulation of circuit activity underlying motor sequencing in animals 
and ultimately the generation of speech/spoken language in humans. This lack of a detailed 
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physiological analysis on the function of Foxp2 in the striatum was the starting point for the 
work presented in this thesis.
Foxp2 affects striatal direct pathway E/I balance during development and in adulthood
Until now, all research into how FoxP2 regulates striatal activity has focused on extracellular 
recordings in vivo (French et al., 2012) and in vitro (Groszer et al., 2008), and intracellular 
recordings of excitatory activity (Chen et al., 2016; Schreiweis et al., 2014). However, these 
investigations lack detail on the striatal cell populations affected by Foxp2. Furthermore, no 
investigation of the effect of Foxp2 on inhibitory activity or if Foxp2 affects striatal activity 
during development has been conducted. The distinction between striatal cell populations 
is highly relevant, as suggestions that FoxP2 expression is segregated between MSNs of the 
striatal direct and indirect pathways have been made (Fong et al., 2018; Vernes et al., 2011). 
Furthermore, heterozygous knockout of Foxp2 affects many genes with preferential expression 
in direct pathway MSNs (Enard et al., 2009; Heiman et al., 2008). This distinction between 
the direct and indirect pathway is highly relevant for how striatal activity is involved in the 
generation of complex motor sequences (Kravitz and Kreitzer, 2012; Kreitzer and Malenka, 
2008). Generally, neuronal activation of the direct pathway leads to increased activity of the 
movement circuit and is involved in initiation and maintenance of motor sequences. On the 
other hand, activation of the indirect pathway leads to decreased activity in the movement 
circuit and these neurons are mainly involved in switching behavior and adaptation (Andre et 
al., 2011; Calabresi et al., 2014). 
In this thesis, we have shown that mutations of Foxp2 affect striatal activity in a cell population 
specific manner. We and others quantitatively established that Foxp2 is predominantly 
expressed in direct pathway MSNs (Fong et al., 2018; van Rhijn et al., 2018; Vernes et al., 
2011), we are the first to show that heterozygous mutation of Foxp2 specifically affects activity 
in D1R-MSNs (Figure 1a). Since Foxp2 did not affect activity in D2R-MSNs, this demonstrated 
that the regulation of activity is only disrupted in the direct pathway mice with heterozygous 
Foxp2 mutations. Balanced excitation of MSNs within both the direct and indirect pathway is 
important for motor circuit function and disruptions in pathway specific regulation of activity 
have been implicated in motor dysfunction (Andre et al., 2011; Rothwell et al., 2014). To 
study how aberrant Foxp2 function affects striatal activity on the single-cell level, we used 
mice in with a bacterial artificial chromosome (BAC)-eGFP construct was expressed under the 
D1R-promoter. This enabled identification of D1R-MSNs in ex vivo brain slices. We crossed 
these mice to two different mouse models of Foxp2 dysfunction. The R552H mouse model 
has a substitution in the DNA- binding domain of Foxp2, directly matching the mutation 
described in the KE family. This substitution disrupts DNA-protein interaction of Foxp2 and 
leads to impaired transcriptional activity (Vernes et al., 2006). The S321X mutation, similar 
to a R328X mutation described in another family with CAS, (MacDermot et al., 2005) leads 
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Figure 1: Foxp2 affects D1R-MSN E/I balance, schematic overview of main findings. 
(a) Foxp2 is predominantly expressed in D1R-MSNs and we have shown Foxp2 only affects activity in these cells in 
the striatum. (b) Inhibitory and excitatory activity are affected by Foxp2 mutations, with different effects dependent 
on the specific mutation. (c) These effects lead to dysregulation of E/I balance in D1R-MSNs. (d) The motor circuit 
in Foxp2R552H/+ and Foxp2S321X/+ is inversely affected by the changes in the striatum. (e) Though motor behavior 
impairments are shown in both genetic backgrounds, in vivo blockade of activity differently affected motor learning 
skills. (f) AMPAR maturation and AMPAR expression are affected by the S321X mutation. (g) GAD67 production and 
presynaptic GABA content are increased in D1R-MSNs of Foxp2S321X/+ mice
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to loss of function, protein truncation and nonsense mediated decay of Foxp2, which results 
in a reduction of Foxp2 expression (Groszer et al., 2008). On the behavioral level, mice with 
the R552H mutation were shown to exhibit clear reductions in motor skill learning (French 
et al., 2012; Groszer et al., 2008). Though a similar behavioral phenotype was suggested for 
mice with the S321X mutation, this mutation seemed to result in a less severe phenotype on 
motor skill learning (French et al., 2012). We confirmed the presence of similar motor skill 
learning deficits as in Foxp2R552H/+ mice in Foxp2S321X/+ mice, with reduced accelerating rotarod 
performance and impaired motor learning. Therefore, we can conclude that the R552H/
R553H and the R328X/S321X mutations lead to similar behavioral phenotypes: in human 
individuals to CAS, and in both mouse models to motor skill learning impairments.
It is well established that Foxp2 affects striatal activity from previous research (Chen et 
al., 2016; Enard et al., 2009; French et al., 2012; Groszer et al., 2008; Liegeois et al., 2003; 
Murugan et al., 2013; Schreiweis et al., 2014). However, detailed investigation of how 
striatal activity is affected was lacking until now. Furthermore, previous evidence has shown 
that heterozygous mutation of Foxp2 (both the R552H mutation and the S321X mutation) 
affects striatal activity in adult mice (French et al., 2012; Groszer et al., 2008). However, in 
humans, FOXP2-associated CAS typically manifests already during early childhood (Morgan 
et al., 2017), which suggests the gene has functions earlier in life as well. Additionally, 
FoxP2 expression has been confirmed in 9-weeks post conception human fetal tissue and 
mouse tissue from embryonic day 13.5 onwards and continues throughout life (Ferland et 
al., 2003; Fong et al., 2018). Furthermore, homozygous mutation of Foxp2 strongly affects 
neurodevelopment and the generation of mature neurons in mice (Chen et al., 2016; Vernes 
et al., 2011). Despite this evidence that Foxp2 functions during development, we are the 
first to show that Foxp2 affects striatal activity from as early as postnatal day (PND) 7 in 
mice and continues to affect striatal activity throughout development until adulthood. This is 
especially relevant as heterozygous mutation of FoxP2 already leads to a clear phenotype in 
humans early in life whilst in mice effects of heterozygous Foxp2 mutation on behavior have 
only been investigated during adulthood. Therefore, we have used the Foxp2-S321X mouse 
model to assay the functions of Foxp2 through different stages of postnatal development 
on the physiological and behavioral level (Chapter 2 and 3). Early in development, reduced 
Foxp2 expression affects the maturation of AMPARs in the striatum (Figure 1f). During 
development, striatal glutamatergic synapses change their ratio of calcium-impermeable 
(CI) AMPARs to calcium-permeable (CP) AMPARs (CI:CP-AMPAR ratio) (Bellone et al., 2011). 
Mature striatal synapses predominantly express CI-AMPARs, and the possibility to change 
the CI:CP-AMPAR ratio is essential as well for induction of long-term depression (LTD) and 
long-term potentiation (LTP) (Man, 2011). We are the first to show the temporal specificity by 
which this switch occurs in the striatum, where in wild-type D1R-MSNs juvenile CI:CP AMPAR 
ratios are present until PND 9, but mature CI:CP ratios are present at PND11. This switch 
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coincides with the emergence of coordinated locomotion, which suggests fast maturation 
of AMPAR expression is necessary for motor circuit function. We have shown in Foxp2S321X/+ 
mice that the emergence of an adult CI:CP-AMPAR ratio is delayed, as is the emergence of 
coordinated locomotion. Furthermore, in control mice, activation of the mGluR1 pathway 
leads to endocytosis of CI-AMPARs in the striatum, which results in LTD. In Foxp2S321X/+ mice 
this mechanism is impaired, as there is no change in the relative expression of CP-AMPARs 
nor can LTD be induced in these mice. Intriguingly, we have also shown that excitatory 
activity is reduced throughout development in Foxp2S321X/+ mice. This finding corroborates 
previously published data showing that AMPAR expression is reduced in juvenile mice with 
a heterozygous Foxp2 knockout mutation (Chen et al., 2016). We suggest that this aberrant 
AMPAR expression already arises early in development. Though the CI:CP-ratio does 
eventually show adult expression in Foxp2S321X/+ mice, the reduced excitatory activity in adult 
mice as well as the lack of LTD suggest that regulatory mechanisms which govern AMPAR 
expression remain affected in Foxp2S321X/+ mice throughout life. This suggests Foxp2 might 
have unique functions in the regulation of D1R-MSN excitatory and striatal plasticity during 
development and adulthood, with different consequences for motor behavior.
In addition to showing reduction of excitatory activity during development and in adulthood, 
we have also investigated if Foxp2 affects inhibitory striatal activity. Is has previously been 
shown that Foxp2 can regulate targets involved in inhibitory activity (Vernes et al., 2011). 
However, the consequence of this regulation, and the effect of Foxp2 dysfunction, on striatal 
inhibition was not explored to date. We have shown that Foxp2 regulates inhibitory activity 
in D1R-MSNs by repression of GAD67 expression, which was a ChIP target in (Vernes et al., 
2011) (Figure 1b,f). GAD67 is one of the principal enzymes for the production of GABA. 
Changes in GAD67 expression strongly impact on inhibitory activity. For example, Gad1 
(the gene which codes for GAD67) knockout mice show highly reduced inhibitory synaptic 
strength (Lau and Murthy, 2012). Foxp2S321X/+ mice show an increase in GAD67 expression, as 
well as an increase in inhibitory synaptic strength. Our detailed assessment of how the S321X 
mutation leads to increased inhibitory activity has established that GABA content at striatal 
D1R-MSN presynapses is increased. Combined with the previous data on excitatory activity, 
this means that the direct pathway is much more strongly inhibited in Foxp2S321X/+ (chapter 2). 
However, it is currently unknown if this increased inhibition directly related to the motor skill 
learning impairments in these mice. Therefore, we manipulated inhibitory activity in vivo in 
Foxp2S321X/+ mice, which is the first time that possible therapeutical intervention to ameliorate 
Foxp2-associated behavioral phenotypes in mice has been reported. Blockade of GABAergic 
inhibitory activity in the entire brain by intraperitoneal injection of the noncompetitive GABA 
antagonist Picrotoxin leads to impaired motor skill learning in wild-type mice. By contrast, the 
same treatment leads to marked increase in motor skill learning in Foxp2S321X/+ mice compared 
to vehicle control (Figure 1e). This clearly shows that Foxp2 normally regulates inhibitory 
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activity, at least in the striatum but possibly also in other brain regions where it is expressed. 
The difference in affinity to inhibitory blockade between wild-type mice and Foxp2S321X/+ mice 
furthermore suggests that the concentration of picrotoxin that we injected leads to partial 
blockade of inhibitory activity. This novel mechanism by which Foxp2 can regulate E/I balance 
at the single cell level generates new opportunities to unravel how this transcription factor is 
involved in the generation of complex activity within the motor circuit. The ways that Foxp2 
affects other brain regions downstream of the striatum is an exciting new avenue which can 
build upon the results we obtained.
Most of our work has been conducted in the Foxp2-S321X loss of function mouse model. 
However, previous results which show Foxp2 affects striatal activity have mostly been 
obtained in mice heterozygous for the R552H DNA-binding domain mutation. As these two 
mutations differently affect Foxp2 function, they might influence striatal activity differently. 
Moreover, the physiological data currently available on these mutations has been amassed 
using different methods. Previous data on Foxp2R552H/+ mice has been obtained through 
extracellular measurements of activity, whilst we have assessed the effect of the S321X 
mutation at the single cell level (chapter 2). To enable a direct comparison of these two 
different mutations, we used the same single cell methods used in brain slices from Foxp2S321X/+ 
mice to assess striatal activity in vitro in Foxp2R552H/+ mice (chapter 4). We show that the 
R552H leads to increased direct pathway function, whilst the S321X mutation produces 
the inverse phenotype. Intriguingly, our data suggest that the mechanisms through which 
these mouse mutations affect neuronal activity are different. The S321X mutation reduces 
excitatory activity, possibly through a reduction in AMPAR maturation and impaired AMPAR 
trafficking, and increases inhibition by increased presynaptic GABA content. By contrast, 
the R552H mutation does not affect excitatory activity, and instead leads to a decrease in 
inhibitory activity in D1R-MSNs. This mechanistic finding suggests that these mutations 
inversely affect the output of the striatal direct pathway (Figure 1c,d). The S321X mutation 
leads to increased inhibition of D1R-MSNs as well as reduced excitability. D1R-MSNs are in 
turn less prone to activation and therefore there is a reduction in inhibitory drive down to the 
substantia nigra (SNr). By contrast, the reduced inhibition due to the R552H mutation leads 
to increased inhibitory drive from the striatum toward the SNr (Figure 1c). This is contrary to 
the current state of knowledge in the field, as the fact that both mutations produce similar 
behavioral phenotypes in humans and mouse models (French et al., 2012; Groszer et al., 
2008; Kurt et al., 2012; Nudel and Newbury, 2013; van Rhijn et al., 2018), suggested that they 
likely affect the same neurobiological mechanisms in a similar way. Though the behavioral 
phenotype is the same in these mouse models, the inverse effects on striatal activity between 
Foxp2R552H/+ and Foxp2S321X/+ mice suggested that blockade of in vivo inhibitory activity could 
differently affect motor performance in these mice. Indeed, in Foxp2R552H/+ mice, blockade of 
inhibitory activity aggravates the motor skill learning impairment, whilst the same treatment 
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in Foxp2S321X/+ mice leads improved motor skill learning compared to vehicle controls (Figure 
1e). Our data confirm that aberrant striatal activity as a consequence of Foxp2 dysfunction 
contributes to the behavioral phenotype observed in mutant mice. Furthermore, changes in 
striatal activity seem to have predictive value toward which therapeutical intervention may 
be most effective. However, it is still an open question how both increased and decreased 
striatal inhibition can lead to similar impairments in motor skill learning. Our results thus 
add complexity to models of how Foxp2 affects striatal activity, opening up new areas for 
future research. Further molecular genetic studies may help to establish whether mutations 
specifically affecting the DNA binding domain generate novel transcriptional targets which 
might help explain the mechanistic differences from other loss of function alleles.
Taken together, We show that Foxp2 only affects the striatal direct pathway, during early 
development as well as in adulthood. Furthermore, we show that Foxp2 affects both excitation 
and inhibition, however the direction in which they are affected is mutation dependent. The 
mouse R552H mutation leads to decreased inhibition, whilst the S321X mutation results 
in both decreased excitation and increased inhibition. For the S321X mutation, we have 
provided evidence that deficits in AMPAR maturation and trafficking could underlie the 
aberrant excitatory deficit, whilst increased presynaptic GABA content is likely to explain the 
increased inhibitory drive. Despite the different effects on striatal activity, both mutations 
lead to a change in the striatal direct pathway E/I balance and result in similar behavioral 
deficits in motor skill learning. However, the effect of manipulation of inhibitory activity in 
vivo on behavior is mutation dependent. The novel role of Foxp2 in inhibition as well as its 
possible contributions to AMPAR maturation during early development give insights into how 
Foxp2 is involved in the development and maintenance of the striatal motor circuit, whilst 
the mutation specific effects provide new opportunities for future research into how Foxp2 
regulates striatal activity as a transcription factor.
Looking outside the striatum – conditional knockout of Foxp2 in movement circuity areas
The striatum is one of the central hubs which modulates activity from the cortex and attunes 
activity in downstream regions such as the SNr and thalamus (Kravitz and Kreitzer, 2012). In 
wild-type mice, reduction of inhibitory activity in the brain in vivo by intraperitoneal injection 
of the GABA receptor blocker negatively affects motor behavior in a dose dependent manner 
(chapter 2, 3) (Buckett, 1981; Kamal, 2012; Kryzhanovskii et al., 1989). However, we have 
shown that blockade of inhibitory activity in Foxp2S321X/+ mice positively affects motor skill 
learning (chapter 2, figure 5). Contrary to the positive effects of GABA blockade in Foxp2S321X/+ 
mice, GABA blockade aggravates the motor skill learning deficits in Foxp2R552H/+ mice (chapter 
4, figure 3). Further investigation into manipulation of the movement circuit is an essential 
step toward translation of our findings to the human situation. From our data, it is plausible 
that the regulatory function Foxp2 has on striatal activity also affects downstream brain 
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areas. A next step in Foxp2 research will be to investigate to which extent Foxp2 affects the 
entire movement circuit. Foxp2 is expressed in other areas of the movement circuitry as well, 
including lower layer cortex and multiple (sub)thalamic nuclei (Ferland et al., 2003; Lai et al., 
2003; Takahashi et al., 2008; Yin et al., 2017). Furthermore, Foxp2 is expressed in cerebellar 
Purkinje cells as well as deep cerebellar nuclei (Ferland et al., 2003; Fujita and Sugihara, 
2012). Though the cerebellum is not part of the canonical movement circuit, it is highly 
involved in smooth and precise execution of motor programs (Manto et al., 2012; Zhang 
et al., 2014). This means that Foxp2 may affect motor circuits at multiple levels: either by 
modulation of activity within a brain region by Foxp2 (as shown for the striatum), or its effects 
on connections between brain regions. Spatially restricted modulation of Foxp2 expression by 
conditional knockout of Foxp2 (French et al., 2007) will be an essential step to understand its 
relative contributions in cortex, striatum or thalamus to normal movement circuitry function 
(French et al., 2018). Investigation of motor behavior and neuronal physiology in mice with 
spatially restricted Foxp2 expression can reveal how Foxp2 regulates different areas of the 
motor circuit necessary for complex motor behavior.
Modulation of motor behavior by manipulation of movement circuit activity
In addition to spatially restricted manipulation of Foxp2 expression in mice, targeted 
manipulation of activity within the movement circuit will be an invaluable step to understand 
how complex motor sequencing in mice is encoded in the brain. Such studies might also 
ultimately shed light on circuits that are recruited in humans towards proficient speech. Since 
we now know how Foxp2 dysfunction affects striatal direct pathway activity in Foxp2R552H/+ 
and Foxp2S321X/+ mutant mice, we can make informed decisions how circuit activity should be 
manipulated in such mouse models to ameliorate motor skill learning deficits.
In the past years, multiple molecular genetic tools have become available to manipulate 
neuronal activity in a cell population specific manner. Optogenetics relies on activation of 
light sensitive ion channels to activate or inactivate neurons. Channelrhodopsin (ChR2) 
is a light sensitive cation channel, and activation of this channel with blue light (~470nm) 
leads to increased neuronal activation (Arenkiel et al., 2007; Lin et al., 2009). By contrast, 
the chloride channel halorhodopsin (NpHR) can be activated by yellow (~520nm) light and 
such activation leads to increased inhibition of neuronal activity (Zhang et al., 2007; Zhao 
et al., 2008). High temporal and spatial specificity are easy to achieve with this method, but 
in vivo use of optogenetic tools requires implantation of optic fibers, which is an invasive 
procedure. However, after implantation, it is feasible to use optogenetic stimulation in freely 
moving animals and rotarod experiments are routinely combined with this method (Bonin 
et al., 2016; Gutierrez et al., 2011). Thus, it should be possible to manipulate activity with 
high spatial and temporal specificity during a motor learning task. Another approach to 
manipulate neuronal activity in vivo is via the use of designer receptors exclusively activated 
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by designer drugs (DREADDs). hM3Dq and hM4Di are the most commonly used DREADDs 
used to respectively increase excitability (Alexander et al., 2009) or presynaptic inhibition 
(Armbruster et al., 2007; Zhu and Roth, 2014). These DREADDs are activated by Clozapine 
N-oxide (CNO), and in vivo injection of CNO rapidly and transiently affects neuronal activity 
and behavior in mice which express DREADDs (for review see (Smith et al., 2016)). Recently, 
DREADDs expressed specifically in direct- or indirect pathway neurons have been used to 
investigate motor performance in a mouse model for Parkinson’s disease (Alcacer et al., 2017). 
DREADDs can be delivered through viral transfection and use of a D1R or D2R promoter can 
restrict DREADD expression to cells of either the direct or indirect pathway. Mouse models 
carrying the R552H or the S321X Foxp2 mutations would be an ideal tool to investigate the 
effect of spatially restricted modulation of activity. We have shown (in chapter 2 and 4) that 
blockade of inhibitory activity by intraperitoneal injection of picrotoxin brain affects motor 
skill learning. Furthermore, modulation of activity in the direct and indirect pathway, either 
through optogenetics or chemogenetics, has clearly observable effects on motor behavior 
(Alcacer et al., 2017; Freeze et al., 2013). Using DREADDs, we would be able to restore the 
aberrant activity in direct pathway MSNs of Foxp2S321X/+ and Foxp2R552H/+ mice. This approach 
would allow us to investigate whether restoration of striatal activity is sufficient to ameliorate 
Foxp2 mutation induced motor skill learning impairments or if other Foxp2-expressing brain 
regions provide a substantial contribution to the motor skill learning phenotype.
Interestingly the different effects of the R552H and the S321X mutations on striatal activity 
in these mouse models mean that we would have to use mutation specific approaches 
to manipulate activity. The reduced inhibition in mice with the R552H mutation can be 
ameliorated by increase of inhibitory drive in D1R-MSNs, whilst the phenotype in the S321X 
mice necessitates a reduction of inhibitory activity, possibly combined with an increase in 
excitability of D1R-MSNs. It would be intriguing to investigate whether these bidirectional 
manipulations lead to the same amelioration of motor skill impairments in Foxp2R552H/+ 
and Foxp2S321X/+ mice, respectively. Additionally, selective manipulation of either excitatory 
or inhibitory activity in D1R-MSNs of Foxp2S321X/+ mice can help to give insights into the 
relative contributions of excitation and inhibition to the behavioral phenotype. Lastly, both 
optogenetics and DREADDs can be used to highly efficiently activate or inhibit cell populations 
in vitro. This way, it is possible to activate or inhibit D1R-MSNs in the striatum and measure 
how changes in striatal activity contribute to downstream activity in other areas of the motor 
circuit in wild-type cells as well as cells with disrupted Foxp2 function.
Disentangling the unique effects of different FoxP2 mutations on activity and behavior
In addition to the previous investigations of the R552H and S321X mutation on the genetic 
and functional level, we have investigated the effect of these different FoxP2 mutations on 
striatal activity (chapter 2 and 4). On the genetic level, the R553H mutation of the KE family 
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affects the DNA-binding domain of human FOXP2 (Lai et al., 2001), and the R328X mutation 
of a second smaller family leads to loss of FOXP2 function, protein truncation and nonsense 
mediated decay (Groszer et al., 2008; MacDermot et al., 2005). Despite this difference in how 
the mutations affect FoxP2 at the molecular level, both mutations lead to CAS in humans and 
motor skill learning deficits in mice, with highly similar phenotypes (French et al., 2012; Groszer 
et al., 2008; van Rhijn et al., 2018). The key difference between the R328X and the R553H 
mutation is that the R328X mutation leads to protein truncation of the mutated product. 
This reduces overall protein expression by approximately half in the case of a heterozygous 
mutation (Groszer et al., 2008), but the function of the remaining wild-type FoxP2 is not 
affected. By contrast, the R553H mutation leads a loss of transcription factor function, but 
the protein is still expressed. The transcription factor function of FoxP2 requires dimerization, 
either by homodimer formation between Foxp2 proteins, or by heterodimerization of Foxp2 
with FoxP1 or FoxP4 (Li et al., 2004). This dimerization is established through the leucine 
zipper domain, which is not altered in FoxP2 with the R552H/R553H DNA binding domain 
mutation. Therefore, it is plausible that mutant FoxP2 can interact with wild-type FoxP1/2/4, 
and lead to altered function of these dimers. Additionally, in vitro cell model studies have 
shown that overexpression of FOXP2-R553H disrupts the nuclear localization (Mizutani et 
al., 2007; Sollis et al., 2017; Vernes et al., 2006), though this phenotype has not yet been 
confirmed in mouse or human brain. The possibility for FOXP2-R553H to still interact with 
other proteins could convey additional functionality to this variant of FOXP2, and a difference 
in regulatory properties between FOXP2-R553H and FOXP2-S321X has been suggested 
(Vernes et al., 2006).
We have investigated excitatory and inhibitory activity mouse models for both these 
mutations. The Foxp2R552H/+ mouse model is similar to the KE family DNA-binding domain 
mutation (Groszer et al., 2008), whilst the Foxp2S321X/+ is comparable to the heterozygous loss 
of Foxp2 function in another small family (Groszer et al., 2008). These mutations differently 
affect striatal activity, with decreased inhibition of direct pathway activity in de Foxp2R552H/+ 
mice, whilst inhibition is strongly increased following heterozygous Foxp2 loss of function. On 
the molecular level, it is known that the R328X and R553H mutations differently affect Foxp2 
function. The R328X mutation results in a reduction of Foxp2 expression. However, gene 
regulatory function is retained in the Foxp2 that is still expressed. This means that although 
reduced Foxp2 expression can have a major impact on regulation of gene expression, the 
targets which can be regulated in cells from Foxp2S321X/+ mice should not be altered, whilst 
Foxp2-dependent regulation is abolished in homozygous mutant material (Vernes et al., 
2006; Vernes et al., 2011). On the other hand, the R553H mutation affects the ability of 
Foxp2 to regulate gene transcription, but Foxp2-R553H remains expressed. This mutation 
might however lead to aberrant regulation of Foxp2 transcription through interaction of 
mutant Foxp2 with other Foxp2 proteins. As dimerization is necessary for the transcriptional 
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function of Foxp2 (Li et al., 2004). As such, the R553H mutation could have a different effect 
on transcriptional regulation compared to the R328X mutation, due to competitive effects 
on wild-type Foxp function. Possible different effects on gene regulation between the R328X 
and R553H mutation have been suggested from in vitro data (Estruch et al., 2016; Vernes 
et al., 2006). Our data suggests that the interaction between Foxp2-R553H and other Foxp 
proteins leads to unique transcriptional regulation of targets involved in synaptic function. 
Targeted investigation of the interactome in MSNs of Foxp2R552H/+ mice and wild-type controls 
can shed light on how this mutation uniquely affects Foxp2 function and explain the different 
phycological phenotypes in D1R-MSNs of Foxp2S321X/+ and Foxp2R553H/+ mice.
Intriguingly, the decrease in inhibition we show in D1R-MSNs of Foxp2-R552H mice is in line 
with previously conducted in vivo activity measurements, where an increase in baseline 
activity was observed (French et al., 2012). Moreover, the increased negative modulation 
of activity when mice were presented with a motor task suggests that behavior dependent 
activity might be regulated by Foxp2 as well (French et al., 2012). Our findings in vitro 
furthermore corroborate the increase in baseline activity, as we show decreased inhibition in 
D1R-MSNs of Foxp2R552H/+ mice. By contrast, similar measurements of in vivo baseline activity 
or task-dependent activity modulation have not been conducted in Foxp2S321X/+ mice. From 
our data, we can conclude that baseline activity in the striatum should be decreased in vivo in 
Foxp2S321X/+ mice, due to the increased inhibitory drive in the direct pathway. Measurement of 
baseline and task-dependent modulation of activity in Foxp2S321X/+ mice in turn could provide 
evidence that the R552H and S321X mutations differentially affect Foxp2 function in vivo. 
Nonetheless, the inverse changes in striatal activity between both mouse models result in 
similar impairments in motor skill learning. Investigation of the motor skill learning deficits by 
use of behavioral paradigms which specifically necessitate control of direct pathway activity 
might reveal subtle differences in behavioral deficits between genetic backgrounds. For 
example, investigation of step size variation, which is governed by regulation of striatal direct 
pathway inhibition (Rothwell et al., 2014), might be informative with regard to mutation 
specific differences in striatal direct pathway activity.
Until now it has been suggested that the neurobiological mechanisms affected by nonsense 
and DNA-binding domain mutations of Foxp2 are likely to be the same. The different genetic 
mutations result in the same behavioral impairments in human and mouse (French et al., 
2012; Groszer et al., 2008; Morgan et al., 2017; van Rhijn, 2018). However, our data indicates 
this presumption stems from an incomplete understanding of the neurobiological pathways 
affected by FoxP2. This conclusion could have important consequences for translation of 
results found in animal models for genetic disorders to the human situation, as care should 
be taken not to generalize effects found for one mutation to other mutations within the same 
gene.
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A role for FOXP2 beyond movement disorders?
Language impairment has been associated with other neurodevelopmental disorders, 
including schizophrenia (Radanovic et al., 2013; Stephane et al., 2007) and ADHD (Mueller 
and Tomblin, 2012). Genetic evidence has provided tentative links between intronic single 
nucleotide polymorphisms (SNPs) in Foxp2 and these disorders. Case-control studies have 
suggested that multiple SNPs are associated with schizophrenia (Li et al., 2013; Rao et al., 
2017; Sanjuan et al., 2005; Sanjuan et al., 2006; Tolosa et al., 2010) and ADHD (Demontis et 
al., 2017). This might indicate that common SNPs which affect FOXP2 function (as opposed to 
rare coding mutations that have large disruptive effects on protein properties) can increase 
risk of a different phenotype from CAS. However, it should be noted that large genome-
wide screens did not report any association between SNPs in FOXP2 and schizophrenia 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014). Though FoxP2 is 
predominantly expressed in brain regions involved in the motor circuitry, the protein is also 
found in parts of the brain which are not involved in complex motor sequencing, as well as 
other regions of the body outside of the nervous system. Within the brain, in addition to the 
expression in striatal D1R-MSNs, FoxP2 is present as well in the ventral tegmental area (VTA) 
and the nucleus accumbens (NAc) (Campbell et al., 2009). From human and mouse data, 
we know that striatal activity is increased in affected family members as well as Foxp2R552H/+ 
mice. However, no change in morphological of functional organization of the VTA or NAc 
was reported in members of the KE family, and the function of Foxp2 in these areas has not 
been investigated in mouse models of Foxp2 dysfunction. As such it is unknown if Foxp2 can 
affect activity in these brain regions to a similar extent as in the striatum. Changes in activity 
in the VTA and the NAc have been shown in individuals with schizophrenia, where increased 
activity has been associated with auditory hallucinations (Rolland et al., 2015). Furthermore, 
it has already been shown that auditory-motor association learning is impaired in the R552H 
and S321X mouse models (Kurt et al., 2012). However, it is not known if deficits in auditory 
perception could underlie this phenotype. We could use conditional knockout of Foxp2 to 
selectively manipulate expression in the VTA or NAc and investigate in vivo how Foxp2 might 
be involved in non-motor behaviors. 
Furthermore, areas such as the dorsal striatum additionally govern other aspects of 
behavior outside complex motor sequencing. Reduced dopamine signaling in the dorsal 
striatum decreases the motivation to repeat a task until a reward is received (Palmiter, 
2008), and impairs reward based learning (Higa et al., 2017). Intriguingly, striatal dopamine 
concentration is suggested to be increased in Foxp2+/- mice (Enard et al., 2009). A large screen 
of spontaneous behavior in Foxp2+/- mice has shown that exploratory behavior is increased 
in these mice. This suggests that non-motor behavior might be affected by FoxP2 loss of 
function as well. Despite these indications, evoked behaviors dependent on motivation and 
reward-based learning have not been investigated in mouse models for Foxp2 dysfunction. 
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Behavioral paradigms to investigate motivation and reward-based learning in mice are 
well established (Drew et al., 2007; Higa et al., 2017; Palmiter, 2008) and can be readily 
implemented for investigating Foxp2 function. The previously mentioned ability to measure 
in vivo neuronal activity combined with conditional knockout of Foxp2 in cell types or brain 
regions involved in specific behaviors will be a powerful tool to investigate if Foxp2 regulates 
non-motor behaviors as well. Many of the brain regions where Foxp2 is present are canonically 
associated with motor circuit function. However, the current knowledge on non-motor 
behaviors governed by the striatum, combined with high Foxp2 expression throughout the 
entire striatum (Fong et al., 2018) invites further exploration of Foxp2-associated behavioral 
phenotypes. Results obtained from such an investigation can inform us about possible non-
speech related symptoms present in individuals with disrupted FOXP2 and could broaden the 
clinical FOXP2-associated phenotype.
Towards a human neuron model for speech impairment
Mouse models are a valuable tool to investigate neurodevelopmental disorders with a genetic 
origin and have provided us the means to assess Foxp2 on the cellular, circuit and behavioral 
level. However, there are potential human specific aspects of FOXP2 function which we cannot 
investigate in a mouse model. Human FOXP2 differs from FoxP2 of any other species, as two 
amino acid changes within exon 7 (T303N and N325S) have occurred only in the hominid 
lineage, at the latest prior to the Neanderthal/Denisovan split. These might convey unique 
function to FOXP2, as has been suggested from mouse models in which these substitutions 
were introduced (Enard et al., 2009; Reimers-Kipping et al., 2011; Schreiweis et al., 2014). 
Striatal neurons from mice with ‘humanized’ Foxp2 show increased complexity (Enard et al., 
2009) and plasticity (Schreiweis et al., 2014). Based on differences between mouse and human 
FoxP2, it has been proposed that human FOXP2 exhibits specific functionality which helps to 
enable the highly complex facial muscle movements necessary to produce coherent speech 
(Enard et al., 2002; Konopka et al., 2009). Detailed investigation of these human specific 
functions necessitates a human model of FOXP2 function. In the last decade, human neuronal 
models have become a staple of functional investigation in neurodevelopmental disorders 
(Chailangkarn et al., 2012; Tamburini and Li, 2017). Currently, multiple different types of 
neurons can be generated, including cortical excitatory and inhibitory upper layer neurons 
(Frega et al., 2017), hippocampal neurons (Sarkar et al., 2018) and excitatory dopaminergic 
neurons (Sundberg et al., 2013). We have shown that the excitatory dopaminergic neurons, 
generated by a protocol adapted from (Sundberg et al., 2013) express FOXP2 and form a 
coherent neuronal network (chapter 6). This has enabled us to for the first time investigate 
how mutation of FOXP2 affects neuronal activity in human neurons. We show that human 
FOXP2 similarly affects excitatory activity as mouse Foxp2, with reduced excitatory activity in 
dopaminergic iNeurons which express FOXP2. Furthermore, we used multi-electrode arrays to 
for the first time investigate if mutation of FoxP2 affects neuronal network formation. Though 
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network activity is impaired, it seems homozygous deletion of FOXP2 in human neurons 
does not overtly impact neurodevelopment or network formation. However, more detailed 
analyses of the effect of FOXP2 knockout on neurodevelopment, neuronal morphology and 
synapse maturation in vitro should be conducted in the future.
An important consideration for comparison of current data on the role of FOXP2 in human 
neurons and data obtained from mouse brain is the mismatch in neuronal identity. The 
function of FOXP2 has been explored in depth in striatal GABAergic MSNs. However, the 
dopaminergic neurons we generated have a glutamatergic identity, which means they are not 
striatal in origin. FoxP2 is expressed in the mammalian brain in other areas than striatum as 
well such as SNr and thalamus, where excitatory dopaminergic are present. Though currently 
it is unknown is FoxP2 affects activity in excitatory dopaminergic cells in mouse or human 
brain, our data shows that in vitro FOXP2 is required for normal formation of excitatory 
neuronal networks. However, in order to directly compare mouse and human data, inhibitory 
striatal MSNs have to be generated from induced pluripotent stem cells (iPSCs). Multiple 
protocols exist which results in differentiation of iPSCs into neurons with an MSN identity 
(Noakes et al., 2015; Stanslowsky et al., 2016; Yuan et al., 2015). The ability to generate 
inhibitory cells which express FOXP2 would be an incredible asset. Though we know that 
excitatory postsynaptic activity is affected in mouse MSNs, formation of an excitatory/
inhibitory network in vitro will enable us to assess if excitatory activity is affected as well in 
human neurons of similar identity. Next, with inhibitory MSNs we can verify whether human 
FOXP2 regulates inhibitory activity through similar neurobiological mechanisms as mouse 
Foxp2. Inhibitory neurons would also enable us to verify if therapeutic interventions aimed 
at modulation of inhibitory activity affect human dopaminergic neurons with mutations in 
FOXP2. 
Another avenue for exploration of human specific features of FOXP2 concerns tracing the 
evolution of FOXP2 on a genetic level. It has been suggested that human FOXP2 differently 
regulates targets in vitro compared to chimpanzee FoxP2, including targets related to central 
nervous system development (Konopka et al., 2009). However, conclusions about potentially 
unique functions of the human version of FOXP2 from this research remain limited. The 
generation of human neurons, which express FOXP2 also enables us to utilize novel molecular 
methods such as CRISPR/Cas9 to generate human neuron lines with specific alterations of 
FOXP2. This way we can generate human neurons in which either the human specific amino 
acid changes are eliminated, and/or we can introduce the additional single amino acid change 
(D80E) which occurred specifically in mice. This approach could help to answer whether 
changes to FoxP2 during evolution have uniquely affected mouse or human FoxP2 function 
at the genetic and physiological level. Revealing how FoxP2 function has changed during 
evolution can help us understand how FOXP2 has contributed to the emergence of capacities 
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for spoken language in our species. Specialization of FOXP2 function during human evolution 
is one of the mechanisms through which this transcription factor may have contributed to the 
uniquely human ability to acquire and use spoken language (Enard et al., 2002).
CONCLUDING REMARKS
The work presented in this thesis reveals that FoxP2 regulates striatal circuit activity only 
in the striatal direct pathway and the behavioral effects of blockade of inhibitory activity 
provide the first evidence for possible therapeutic intervention. Manipulation of specific cell 
populations and brain areas is the next important step to understand how Foxp2 regulates 
the motor circuitry more broadly in addition to its role in the striatum. The ability to generate 
human neurons which express FOXP2 will enable us to investigate human-specific functions 
of FOXP2 in unprecedented detail. Our novel data on Foxp2 also generates many new 
questions. We think follow-up investigation of the potential mutation specific effects of DNA-
binding domain and loss of Foxp2 function mutations on motor circuit physiologic is highly 
important. It has been suggested that DNA-binding domain mutation of FOXP2 generate a 
more complex phenotype compared to stop-gain mutations (Kurt et al., 2012; Mizutani et al., 
2007; Sollis et al., 2017; Vernes et al., 2006), possibly through interaction with wild-type FoxP 
proteins. A direct comparison of Foxp2R552H/+ and Foxp2S321X/+ mice on the genetic, physiological 
and behavioral level will help to understand how these mutations uniquely affect motor 
circuit function. Furthermore, our evidence that Foxp2 also regulates inhibitory activity in 
the striatum shows the complex functions it may play in E/I balance. This validates the need 
for further research into the function of FoxP2 in the entire motor circuit. Current evidence 
shows the intricate role Foxp2 has in the regulation of striatal development and activity. 
However, FoxP2 is also expressed in other areas of the motor circuit and additionally cells 
which express Foxp2 generate projections outside of the brain region where they reside. This 
necessitates a thorough investigation of Foxp2 in other areas of the motor circuit, to further 
disentangle its complex role in motor circuit function. Lastly, we think that this thesis has shed 
a novel light on how FoxP2 is involved in the regulation of motor circuit activity. Dysfunction 
of FoxP2 produces highly recognizable phenotypes in mice, songbirds and humans, which 
impinge on impairments in the generation of complex motor sequences. In mice, these 
are important for motor skill learning and seem to play a role in the complexity of innate 
vocalizations (Castellucci et al., 2016; Chabout et al., 2016). In songbirds, complex motor 
sequencing is necessary for song reproduction, variability and quality (Olveczky et al., 2011). 
The role of FoxP2 in the circuit which underlies the ability to generate such behaviors shows 
that it is intricately involved in the development and function of brain circuits necessary for 
the generation of complex motor sequences, making it well-placed to contribute to human 
capacities for proficient spoken language.
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Communiceren door gesproken taal is een unieke menselijke eigenschap en lijkt heel 
vanzelfsprekend. Al vanaf de geboorte maken we geluidjes. Tijdens het eerste levensjaar 
nemen ons begrip van geluiden en onze vaardigheden om geluiden te maken snel toe, en na 
een jaar kunnen we onze eerste woordjes zeggen. Daarna leren we snel meer woorden, en 
tegen de tijd dat we naar de basisschool gaan kunnen we simpele gesprekjes houden. Het 
leren praten is een proces waar onderzoekers erg geïnteresseerd in zijn, en we weten dat je 
hersenen veel informatie verwerken tijdens het leren van een taal. Maar net zo belangrijk is 
de fysieke mogelijkheid om spraak te produceren. Je kan alle woorden kennen die er bestaan, 
maar als je ze fysiek niet uit kunt spreken, zul je nooit kunnen communiceren via gesproken 
taal.
Om duidelijk te kunnen praten moet de aansturing van de spieren in je gezicht, mond 
en tong goed werken. Activatie van deze spieren wordt mede geregeld door specifieke 
hersengebieden. Spraakstoornissen kunnen optreden wanneer dit proces is verstoord. Een 
van deze stoornissen is de taalontwikkelingsstoornis verbale apraxie bij kinderen (childhood 
apraxia of speech, CAS). Bij veel mensen met CAS is dit probleem te wijten aan mutatie van 
het gen FOXP2. Mensen met mutaties in dit gen hebben problemen met het uitspreken van 
moeilijke woorden, terwijl ze taal prima begrijpen. Alleen met logopedie kunnen ze leren 
om zich verstaanbaar te maken. Door de hersenactiviteit van mensen zonder mutatie te 
vergelijken met die van mensen met een mutatie in FOXP2 kunnen we beter begrijpen hoe 
de hersenen de fysieke kant van taal regelen (zoals de fijne motoriek in het gezicht, de tong 
en de keel).
In mijn onderzoek heb ik muismodellen gebruikt om te onderzoeken hoe mutaties in Foxp2 
de  activiteit van individuele hersencellen beïnvloeden. Eerder is al aangetoond dat FoxP2 
de hersenactiviteit beïnvloedt bij mensen en muizen, en dat ook het gedrag van muizen 
verandert als Foxp2 is gemuteerd. Muizen kunnen niet praten, maar ze kunnen wel moeilijke 
opdrachten uitvoeren waarbij activatie van dezelfde hersencellen nodig is als die bij mensen 
belangrijk zijn voor spraak. Mutatie van Foxp2 zorgt ervoor dat muizen deze opdrachten 
minder goed uit kunnen voeren. Hoewel bekend is dat mutaties in Foxp2 de hersenactiviteit 
beïnvloeden, was nog niet bekend hoe Foxp2 dit precies doet. Mijn onderzoek richt zich 
op het een specifiek hersengebied, het striatum, waar Foxp2 aanwezig is in een deel van 
alle cellen. Het striatum is heel belangrijk voor het aansturen van complexe bewegingen bij 
muizen, maar ook voor het aansturen van spraak bij mensen. Ik heb onderzocht hoe mutatie 
van Foxp2 leidt tot verandering van activiteit in deze cellen en of deze veranderingen de 
bewegingsproblemen bij muizen en de spraakproblemen bij mensen kunnen verklaren.
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In hoofdstuk 2 laat ik zien dat de activiteit in het striatum is verstoord als er minder Foxp2 
aanwezig is. Excitatie (activatie) is lager, terwijl inhibitie (inactivatie) hoger is. Dit leidt tot een 
verstoring in het evenwicht tussen het activeren en inactiveren van de celpopulatie in het 
striatum waar Foxp2 aanwezig is. De juiste balans tussen activatie en inactivatie van deze 
cellen is belangrijk, omdat ze signalen sturen naar andere hersengebieden en betrokken zijn 
bij het initiëren van beweging. Het omkeren van de verhoogde inactivatie (door de inactivatie 
deels te blokkeren) zorgt ervoor dat muizen met minder mutatie weer beter complexe 
bewegingsopdrachten uit kunnen voren. Het medicamenteus herstellen van de balans van 
activatie en inactivatie kan dus interessant zijn in het kader van therapeutische interventie.
Mutaties in Foxp2 beïnvloeden de activiteit van hersencellen in zowel jonge als volwassen 
dieren. Tot op heden was het nog niet bekend of ook processen die betrokken zijn bij de 
ontwikkeling van volwassen hersenactiviteit beïnvloed worden door Foxp2, omdat dit 
proces nog niet is onderzocht in muizen met mutaties in Foxp2. In hoofdstuk 3 onderzocht 
ik of Foxp2 een invloed heeft op bepaalde kritieke processen tijdens de ontwikkeling van 
het striatum. Tijdens de ontwikkeling wordt de aanwezigheid van verschillende soorten 
membraanreceptoren sterk gereguleerd. Ik ontdekte dat mutaties in Foxp2 ervoor zorgen 
membraanreceptoren voor volwassen cellen pas later tijdens de ontwikkeling van de cel 
aanwezig zijn. Mijn data laten ook zien dat de aanwezigheid van deze receptoren samenvalt 
met het starten van gecoördineerde beweging. Jonge muizen met minder Foxp2 kunnen 
minder goed simpele opdrachten uitvoeren waarvoor ze gecoördineerd moeten kunnen 
bewegen. Foxp2 heeft dus een effect op hersenactiviteit en op de uitrijping van de cellen 
tijdens de ontwikkeling. 
Een van de essentiële functies van Foxp2 is het aan- en uitzetten van de expressie van andere 
genen, waarvoor het aan DNA moet kunnen binnen. In hoofdstuk 4 beschrijf ik een andere 
mutatie van Foxp2 dan de mutatie waardoor minder Foxp2 aanwezig is. Deze mutatie zorgt 
ervoor dat Foxp2 niet meer aan DNA kan binden, maar de gemuteerde variant van Foxp2 
blijft wel aanwezig in de cel. Ook in mensen met CAS wordt deze mutatie gevonden. Mijn 
onderzoeksresultaten laten zien dat deze mutatie een ander effect heeft op activiteit van 
hersencellen dan mutaties die ervoor zorgen dat Foxp2 minder aanwezig is. In plaats van 
verhoogde inhibitie, is de inhibitie bij deze mutatie juist verlaagd. Daardoor zijn cellen actiever 
in plaats van minder actief. Desondanks leidt deze mutatie wel tot dezelfde verminderde 
bewegingsvaardigheid in muizen. Ook mensen met deze verschillende mutaties vertonen 
dezelfde taalontwikkelingsstoornis. Dit suggereert dat mutatie-afhankelijke verschillen in 
hersenactiviteit kunnen leiden tot dezelfde stoornis, en dat we nog steeds niet helemaal 
begrijpen hoe Foxp2 precies werkt.
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Foxp2 reguleert de expressie van heel veel genen in de hersenen. Een van die genen is de 
retinolzuur-beta-receptor (RARβ), en regulatie van RARβ door Foxp2 speelt mogelijk een 
rol bij de hersenontwikkeling en regulering van hersenactiviteit. In hoofdstuk 5 bespreek 
ik vanuit de literatuur hoe RARβ en Foxp2 hersenactiviteit beïnvloeden en of ze mogelijk 
invloed hebben op dezelfde processen in de hersenen. Er zijn ook diverse aanwijzingen dat 
de regulatie van RARβ door Foxp2 hersenactiviteit betrokken bij beweging kan beïnvloeden. 
Meer onderzoek naar het samenspel tussen Foxp2 en RARβ kan een waardevolle stap kan zijn 
om beter te begrijpen hoe Foxp2 complexe hersenactiviteit reguleert.
Recent zijn er nieuwe technieken ontwikkeld waarbij hersencellen gemaakt kunnen 
worden van menselijk celmateriaal. In plaats van het uitvoeren van een hersenbiopsie (wat 
onmogelijk is) nemen we huidcellen van mensen en maken we daar eerst stamcellen van. 
Van deze stamcellen maken we daarna hersencellen. In hoofdstuk 6 heb ik menselijke 
hersencellen gemaakt uit stamcellen om te onderzoeken hoe FOXP2 activiteit in menselijke 
cellen beïnvloedt. Ik laat zien dat we werkende hersencellen kunnen maken die FOXP2 in zich 
hebben. Deze cellen heb ik vervolgens vergeleken met cellen waarin FOXP2 door een mutatie 
niet aanwezig is. Menselijke cellen zonder FOXP2 zijn minder actief dan cellen met FOXP2, 
net als in de muis. Deze methode biedt nieuwe mogelijkheden om te onderzoeken welke 
eigenschappen van FOXP2 hetzelfde zijn in mens en muis.
De nieuwe data die ik in dit proefschrift presenteer zijn een bijdrage aan het onderzoek naar 
hoe complexe bewegingen (inclusief de mogelijkheid om te praten) worden aangestuurd 
door de hersenen. Mutaties in Foxp2 veroorzaken kleine veranderingen in de balans tussen 
activatie en inactivatie  van hersencellen. Dit heeft een grote invloed op het succesvol 
uitvoeren van bewegingsopdrachten door muizen. Gebalanceerde activatie en inactivatie 
blijkt dus een van de belangrijkste processen is voor een gezonde werking van processen 
belangrijk voor complexe aansturing van de spieren. Als we meer te weten komen over de 
mechanismes die aan deze balans ten grondslag liggen, en hoe deze te beïnvloeden zijn, 
kunnen we nieuwe mogelijkheden voor therapeutische interventie ontwikkelen voor mensen 
waarbij deze balans is verstoord. 
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Communication trough spoken language is a uniquely human behavior, and seems very 
natural to us. As soon as we are born, we start making sounds. Within the first year of our life 
our understanding of and ability to make sounds rapidly increases and this leads us to utter 
our first word. Then, quickly, we learn to say more words, and when we were at kindergarten 
age we could already have simple conversations. The acquisition of language is a process that 
has fascinated many researchers, and it is known that learning a spoken language requires 
a large amount of information processing. However, just as important is the physical ability 
to produce speech. You can know all the words in the world, but if you lack the capacity to 
physically speak them you will not be able to communicate using spoken language. 
To be able to speak clearly, you need good control over the muscles in your face, mouth and 
tongue. The activation of these muscles is controlled by specific areas in the brain. Speech 
related disorders can arise when the control over these muscles is impaired. One such 
disorder is childhood apraxia of speech (CAS). In many cases of CAS, the disorder is directly 
attributed to the mutation of the gene FOXP2.  Individuals with mutations in this gene are less 
able to clearly pronounce complex words, though their language comprehension is normal. 
They require extensive speech therapy in order to speak understandably. By comparing brain 
activity between individuals with and without mutations in  FOXP2, we can better understand 
how the brain directs the physical side of language (i.e. the fine motor movements in the 
face, tongue and throat).
In my research I have used mouse models to investigate how mutations in Foxp2 affect activity 
in single brain cells. It has already been shown that activity in both human and mouse brains is 
changed when Foxp2 is mutated, and that this also affects behavior in mice. Though mice do 
not speak, they can perform complex movement tasks, which require the same brain activity 
as speaking does in humans. In mice with mutations in Foxp2, the performance on these tasks 
is impaired.  Though it was known that Foxp2 affects brain activity, it was not established how 
mutations of Foxp2 lead to changes in brain activity. My investigation focuses on a brain 
region called the striatum, where Foxp2 is present in a specific cell population. These cells are 
involved in control of brain activity necessary for complex movement in mice and speaking 
in humans. Throughout my research, I have investigated by which mechanisms mutations 
in Foxp2 affect activity in these cells and if the changes in activity can explain the impaired 
movement behavior in mice and possibly the childhood apraxia of speech in humans.
In Chapter 2, I show that activity in the striatum is disrupted if less Foxp2 is present. Excitation 
(activation) of cells is decreased, whilst inhibition (inactivation) of cells in increased. This 
leads to disbalance of activation and inactivation of the cell population in the striatum in 
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which Foxp2 is expressed. Balanced activation and inactivation of these cells is important, as 
this population sends signals to other brain regions and is involved in initiation of movement. 
I therefore investigated if the impaired complex movement in these mice can be corrected 
by blockade of inactivating signals in the brain. This indeed improves walking performance 
in mice with less Foxp2 expression, which might be a mechanism to explore for possible 
therapeutic intervention.
Though mutations in Foxp2 affect neuronal activity in both young and adult mice, it was not 
known if Foxp2 also affects the maturation of striatal neurons during development. I therefore 
investigated if reduced Foxp2 expression affects hallmarks of maturation in striatal neurons. 
In chapter 3, I show that reduced expression of Foxp2 delays the maturation of membrane 
receptors involved in the activation of neurons. Mature receptor function is essential for 
mice to start with coordinated movement, and in mice with reduced Foxp2 expression the 
development of coordinated movement is delayed. From this I conclude that Foxp2, next to 
its effect on activity, also affects the maturation of striatal neurons.
As Foxp2 regulates expression of other genes, this ability to bind to DNA is essential for 
its function. In Chapter 4 I explored a different mutation of Foxp2 from mutations which 
reduce Foxp2 expression. This mutation only affects a specific part of Foxp2, which results 
in an inability of Foxp2 to bind to DNA. This specific mutation is found as well in individuals 
with CAS. However, compared to the mutation described in chapter 2 and 3, this mutated 
version of Foxp2 is still present in the cell. My results show that the effect of this mutation 
on activity in the striatum is opposite from that of mutations which reduce Foxp2 expression. 
The mutation which impairs DNA-binding leads to reduced inhibitory activity of cells which 
express Foxp2. These cells are thus more active. However, this increased activity results in 
the same changes in movement behavior as reduced Foxp2 expression, and individuals with 
this mutation also display CAS. This suggests different changes in neuronal activity can result 
in the same change in behavior, and that our understanding of how Foxp2 regulates brain 
activity is still incomplete. 
Foxp2 regulates the expression of many different genes in the brain. Recently, regulation of 
the retinoic acid receptor beta (RARβ) emerged as a possible mechanism by which Foxp2 can 
affect brain development and neuronal activity. In chapter 5, I discuss the current literature 
on the function of RARβ and Foxp2 in regulation of activity in the brain and compare the 
similarities and differences in their function. Furthermore, I suggest that investigation of how 
Foxp2 regulates RARβ and how this interaction affects activity related to control of complex 
movement is an intriguing opportunity to better understand how Foxp2 influences complex 
activity in the brain.
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In the past years multiple methods to generate functional neurons from cellular material 
taken from humans have been established. Instead of taking a brain biopsy (which is 
impossible), we can take skin cells, make them into stem cells and generate brain cells 
from those. In chapter 6, I have used human stem cell derived neurons to investigate how 
FOXP2 affects neuronal activity in human cells. I show that we are able to generate neurons 
with FOXP2 expression and compare these to neurons in which FOXP2 is made completely 
absent through mutation. The lack of FOXP2 expression in human neurons leads to a similar 
decrease in activity as we found in mouse neurons with reduced FOXP2 expression. This 
method opens new possibilities to investigate which functions of FOXP2 might be conserved 
between mouse and human brain.
Taken together, the data presented in this thesis increase our understanding of how complex 
movement (including word production) is governed by the brain. Mutations in Foxp2 lead to 
small changes in balanced activation and inactivation, which profoundly affects execution of 
complex movement tasks. This shows that balanced activation and inactivation is essential 
for normal function of brain processes necessary for complex muscle control. Increased 
knowledge about the mechanisms underlying balanced neuronal activity, and how these can 
be affected, opens new avenues for possible therapeutic intervention in disorders where the 
neuronal activity balance might be upset. 
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als we bij elkaar zijn. Joris en Irene, we wonen blijkbaar al sinds we in Ede wonen bij jullie 
om de hoek, maar hebben jullie pas afgelopen jaar mogen leren kennen. Gelukkig blijven we 
allemaal volgens mij nog wel even in Ede wonen, dus op naar meer dansjes, bordspellen en 
gezelschap! 
Rita en Herman, papa en mama. Van jullie heb ik mijn interesse voor de natuur en alles wat 
leeft gekregen, naar mijn idee al van jongs af aan. Bedankt dat jullie mij hebben gesteund door 
mijn opleiding heen. Biologie was eigenlijk niet mijn eerste keuze, maar het is de beste keuze 
gebleken die ik ooit kon maken. Jullie hebben mee kunnen maken hoe mijn enthousiasme 
groeide en zich ontwikkelde naar hersenonderzoek. Daar ontspoorde het en was waar ik het 
over had als ik op bezoek was vaak niet meer te volgen voor jullie, en nu ligt dit boekje er.  
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Wimmie en Rinze, pa en ma Brouwer, jullie interesse naar wat ik doe was, is en blijft altijd 
aanstekelijk. Dat ik soms even moet stoppen met vertellen zodat pa het op kan schrijven 
alsof ik college geef laat alleen maar zien hoe groot jullie interesse is. Nu ik doorga in het 
hersenonderzoek zullen er nog meer en wildere verhalen volgen, want mijn enthousiasme 
zal nog wel even blijven en hopelijk dat van jullie ook.
De rest van de familie aan de van Rhijn en Brouwerskant, bedankt voor alle gezelschap en 
steun de afgelopen jaren. Ontspanning is ook belangrijk, en verjaardagen, familiedagen en 
dergelijke dragen daar ook zeker aan bij. Het is altijd fijn om samen te zijn, met wie van de 
broers, zussen, neven en nichten dat ook is. Opladen door fijne gesprekken is een goede 
motor om daarna weer de chaos van een PhD in te duiken. Diede, het is fijn om te merken 
hoe vaak we elkaar vinden in goede gesprekken als we bij elkaar zijn, ook al zijn onze levens 
zo verschillend. Jesse, hoe jij je weg vindt in de wetenschap is mooi om te zien, en soms ook 
een voorbeeld voor mij. Ik hoop dat ik ook soms een voorbeeld (of een voorbeeld hoe het 
niet te doen) ben geweest voor jou tijdens mijn PhD en dat kan blijven zijn in de toekomst. 
Dylan het is altijd fijn als jij erbij bent en ben ik blij dat ik je mijn jonge broertje mag noemen.
 
En als laatste natuurlijk de belangrijkste: Femke. Mijn partner in alles. Tegelijk een PhD doen 
is een wilde rit geweest, en deze rit gaat door nu we allebei  doorgroeien in onze carrière. Wat 
een voorrecht is het voor mij dat ik me jouw man mag noemen. Wat is het fijn om iemand 
te hebben die begrijpt hoe raar het leven van een PhD’er is. Iemand die ook diep in de nacht 
een presentatie wil oefenen, of graag in slaap valt op een college over elektrofysiologie. Wat 
wij hebben komt nooit meer goed, en kan tegelijkertijd niet beter. Bedankt dat jij altijd mijn 
steun wilt zijn in alles, en dat we samen van onze beestenboel kunnen genieten. Echte liefde 
is: om 03:00 elkaars artikel verbeteren!
DANKWOORD
197
198
CURRICULUM VITAE
199
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Jon-Ruben van Rhijn werd op 25 november 1990 geboren te Leiden. Na zijn VWO diploma te 
hebben gehaald in 2008 is hij algemene biologie gaan studeren en haalde zijn Bachelordiploma 
biologie in 2011 aan de Vrije Universiteit Amsterdam. Hierna volgde een Research Master 
Neuroscience aan de Vrije Universiteit Amsterdam, waar hij zijn masterdiploma behaalde 
in 2013. Zijn promotieonderzoek heeft hij uitgevoerd op de afdelingen Cognitieve 
neurowetenschappen en Humane genetica aan het Radboudumc en het Max Planck Instituut 
voor Psycholinguistiek in Nijmegen onder supervisie van Nael Nadif Kasri, Sonja Vernes en 
Simon Fisher. Tijdens dit onderzoek heeft hij zich gespecialiseerd in cellulaire neurofysiologie 
op dier- en celmodellen. Hij ontdekte dat het gen Foxp2 de balans tussen activatie en 
inactivatie van hersencellen betrokken bij complexe bewegingen beïnvloedt.
Op dit moment past Jon-Ruben zijn ruime ervaring in de cellulaire neurofysiologie toe in 
een postdoctoraal onderzoek dat zich richt op de neurofysiologische achtergrond van 
schizofrenie. In dit onderzoek zal hij complexe elektrofysiologie op cel- en populatieniveau 
combineren met moleculaire technieken zoals CRISPR-CAS en het maken van geïnduceerde 
hersencellen uit menselijk materiaal.  
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For a successful research Institute, it is vital to train the next generation of young scientists. 
To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established the 
Donders Graduate School for Cognitive Neuroscience (DGCN), which was officially recognised 
as a national graduate school in 2009. The Graduate School covers training at both Master’s 
and PhD level and provides an excellent educational context fully aligned with the research 
programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in biology, 
physics, psycholinguistics, psychology, behavioral science, medicine and related disciplines. 
Selective admission and assessment centers guarantee the enrolment of the best and most 
motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, e.g. 
Stanford University, University of Oxford, University of Cambridge, UCL London, MPI 
Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, North 
Western University, Northeastern University in Boston, ETH Zürich, University of Vienna etc. 
Positions outside academia spread among the following sectors: 
- specialists in a medical environment, mainly in genetics, geriatrics, psychiatry and neurology,
- specialists in a psychological environment, e.g. as specialist in neuropsychology, psychological 
diagnostics or therapy, 
- higher education as coordinators or lecturers. 
A smaller percentage enters business as research consultants, analysts or head of research 
and development. Fewer graduates stay in a research environment as lab coordinators, 
technical support or policy advisors. Upcoming possibilities are positions in the IT sector and 
management position in pharmaceutical industry. In general, the PhDs graduates almost 
invariably continue with high-quality positions that play an important role in our knowledge 
economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/

